424B5
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-124358
The information
contained in this preliminary prospectus supplement is not
complete and may be changed. This preliminary prospectus
supplement and the accompanying prospectus are not an offer to
sell nor do they seek an offer to buy these securities in any
jurisdiction where the offer or sale is not
permitted.
|
Subject to Completion.
Preliminary Prospectus Supplement Dated
June 1, 2005.
Prospectus Supplement
(To Prospectus dated April 27, 2005)
Shares
Floating Rate Non-Cumulative Preferred Stock,
Series A
MetLife, Inc. is
offering shares
of its Floating Rate Non-Cumulative Preferred Stock,
Series A, $25 liquidation preference per share (the
series A preferred shares).
Holders of series A preferred shares will be entitled to
receive dividend payments only when, as and if declared by
MetLife, Inc.s board of directors or a duly authorized
committee of the board. Any such dividends will be payable from
the date of original issue on a non-cumulative basis, quarterly
in arrears on
the day
of March, June, September and December of each year (each, a
dividend payment date), commencing on
September , 2005, at an annual rate
of the greater of
(a) %
above three month LIBOR on the related LIBOR determination date
or
(b) %.
Dividends on the series A preferred shares are not
cumulative. Accordingly, in the event dividends are not declared
on the series A preferred shares for payment on any
dividend payment date, then those dividends will cease to accrue
and be payable. If we have not declared a dividend before the
dividend payment date for any dividend period, we will have no
obligation to pay dividends accrued for that dividend period,
whether or not dividends on the series A preferred shares
are declared for any future dividend period.
The Certificate of Designations for the series A preferred
shares prohibits the declaration of dividends on the
series A preferred shares if we fail to meet specified
capital adequacy, net income and shareholders equity
levels. In addition, under Federal Reserve Board policy,
MetLife, Inc. may not be able to pay dividends if it does not
earn sufficient operating income. See Description of the
Series A Preferred Shares Dividend Payment
Restrictions.
So long as any series A preferred shares remain
outstanding, no dividend shall be paid or declared on MetLife,
Inc.s common stock or any of its other securities ranking
junior to the series A preferred shares (other than a
dividend payable solely in common stock or in such other junior
securities), unless the full dividends for the latest completed
dividend period on all outstanding series A preferred
shares have been declared and paid or provided for.
The series A preferred shares are not redeemable prior
to ,
2010. On and after that date, the series A preferred shares
will be redeemable at MetLife, Inc.s option, subject to
the Federal Reserve Boards prior approval, in whole or in
part, at a redemption price of $25 per series A
preferred share, plus declared and unpaid dividends.
The series A preferred shares will not have voting rights,
except as set forth under Description of the Series A
Preferred Shares Voting Rights on
page S-69.
See Risk Factors beginning on page S-12 of
this prospectus supplement to read about important factors you
should consider before buying series A preferred shares.
Neither the Securities and Exchange Commission nor any other
regulatory body has approved or disapproved of these securities
or passed upon the accuracy or adequacy of this prospectus
supplement or the accompanying prospectus. Any representation to
the contrary is a criminal offense.
|
|
|
|
|
|
|
|
|
|
|
Per Series A | |
|
|
|
|
Preferred | |
|
|
|
|
Share | |
|
Total | |
|
|
| |
|
| |
Initial public offering price(1)
|
|
$ |
|
|
|
$ |
|
|
Underwriting discount
|
|
$ |
|
|
|
$ |
|
|
Proceeds, before expenses, to MetLife, Inc.
|
|
$ |
|
|
|
$ |
|
|
|
|
(1) |
The initial public offering price does not include accrued
dividends, if any, that may be declared. Dividends, if declared,
will accrue from the date of original issuance, which is
expected to be , 2005. |
The underwriting discount will be
$ per
series A preferred share offered hereby with respect to any
series A preferred shares sold in an aggregate liquidation
preference of $500,000 or more to a single purchaser, which
decreases the total underwriting discount and increases the
total proceeds to MetLife, Inc. by
$ .
To the extent that the underwriters sell more
than series A
preferred shares, the underwriters have the option to purchase
up to an
additional series A
preferred shares from MetLife, Inc. at the initial public
offering price less the applicable underwriting discount.
Application will be made to list the series A preferred
shares on the New York Stock Exchange under the symbol
METPrA. Trading of the series A preferred
shares on the New York Stock Exchange is expected to commence on
the date of initial delivery.
The underwriters expect to deliver the series A preferred
shares, in book-entry form only, through the facilities of The
Depository Trust Company, against payment on or
about ,
2005.
|
|
|
Banc of America Securities LLC |
Goldman, Sachs & Co. |
Merrill Lynch & Co. |
|
|
|
|
|
Citigroup |
Lehman Brothers |
Morgan Stanley |
UBS Investment Bank |
Wachovia Securities |
|
|
|
|
|
|
|
Advest, Inc.
|
|
A.G. Edwards |
|
HSBC |
|
JPMorgan |
Janney Montgomery Scott LLC
|
|
KeyBanc Capital Markets |
|
Morgan Keegan & Company, Inc. |
|
Piper Jaffray |
RBC Capital Markets
|
|
Raymond James |
|
SunTrust Robinson Humphrey |
|
Wells Fargo Securities |
Prospectus Supplement
dated ,
2005.
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page | |
|
|
| |
Prospectus Supplement |
|
|
|
S-3 |
|
|
|
|
S-4 |
|
|
|
|
S-12 |
|
|
|
|
S-31 |
|
|
|
|
S-36 |
|
|
|
|
S-54 |
|
|
|
|
S-55 |
|
|
|
|
S-56 |
|
|
|
|
S-57 |
|
|
|
|
S-62 |
|
|
|
|
S-73 |
|
|
|
|
S-78 |
|
|
|
|
S-80 |
|
|
|
|
S-80 |
|
|
Prospectus |
About This Prospectus
|
|
|
1 |
|
Where You Can Find More Information
|
|
|
1 |
|
Special Note Regarding Forward-Looking Statements
|
|
|
2 |
|
MetLife, Inc.
|
|
|
3 |
|
The Trusts
|
|
|
3 |
|
Use of Proceeds
|
|
|
5 |
|
Ratio of Earnings to Fixed Charges
|
|
|
5 |
|
Description of Securities
|
|
|
5 |
|
Description of Debt Securities
|
|
|
6 |
|
Description of Capital Stock
|
|
|
15 |
|
Description of Depositary Shares
|
|
|
21 |
|
Description of Warrants
|
|
|
23 |
|
Description of Purchase Contracts
|
|
|
24 |
|
Description of Units
|
|
|
25 |
|
Description of Trust Preferred Securities
|
|
|
26 |
|
Description of Guarantees
|
|
|
28 |
|
Plan of Distribution
|
|
|
31 |
|
Legal Opinions
|
|
|
33 |
|
Experts
|
|
|
33 |
|
You should rely only on the information contained or
incorporated by reference in this prospectus supplement and the
accompanying prospectus. Neither we nor the underwriters have
authorized anyone to provide you with additional or different
information. If anyone provided you with additional or different
information, you should not rely on it. Neither we nor the
underwriters are making an offer to sell these securities in any
jurisdiction where the offer or sale is not permitted. You
should assume that the information contained in this prospectus
supplement, the accompanying prospectus and the documents
incorporated by reference, is accurate only as of their
respective dates. MetLifes business, financial condition,
results of operations and prospects may have changed since those
dates.
S-2
ABOUT THIS PROSPECTUS SUPPLEMENT
You should read this prospectus supplement along with the
accompanying prospectus carefully before you invest. Both
documents contain important information you should consider
before making your investment decision. This prospectus
supplement and the accompanying prospectus contain the terms of
this offering of series A preferred shares. The
accompanying prospectus contains information about our
securities generally, some of which does not apply to the
series A preferred shares covered by this prospectus
supplement. This prospectus supplement may add, update or change
information in the accompanying prospectus. If the information
in this prospectus supplement is inconsistent with any
information in the accompanying prospectus, the information in
this prospectus supplement will apply and will supersede the
inconsistent information in the accompanying prospectus.
Unless otherwise stated or the context otherwise requires,
references in this prospectus supplement and the accompanying
prospectus to MetLife, we,
our, or us refer to MetLife, Inc.,
together with Metropolitan Life Insurance Company
(Metropolitan Life), and their respective direct and
indirect subsidiaries, while references to MetLife,
Inc. refer only to the holding company on an
unconsolidated basis.
S-3
SUMMARY
|
|
This summary contains basic information about us and this
offering. Because it is a summary, it does not contain all of
the information that you should consider before investing in the
series A preferred shares. You should read this entire
prospectus supplement carefully, including the section entitled
Risk Factors, our financial statements and the notes
thereto incorporated by reference into this prospectus
supplement, and the accompanying prospectus, before making an
investment decision. Except as otherwise noted, all information
in this prospectus supplement and the accompanying prospectus
assumes no exercise of the underwriters option to purchase
additional series A preferred shares. |
|
MetLife
We are a leading provider of insurance and other financial
services to individual and institutional customers. We offer
life insurance, annuities, automobile and homeowners insurance
and retail banking services to individuals, as well as group
insurance, reinsurance, and retirement & savings
products and services to corporations and other institutions. We
serve individuals in approximately 13 million households in
the United States and provide benefits to 37 million
employees and family members through their plan sponsors,
including 88 of the top one hundred FORTUNE® 500
companies. Outside the United States, we serve approximately
9 million customers through direct insurance operations in
Argentina, Brazil, Chile, China, Hong Kong, India, Indonesia,
Mexico, South Korea, Taiwan and Uruguay.
We are one of the largest insurance and financial services
companies in the United States. We believe that our franchises
and brand names uniquely position us to be the preeminent
provider of protection and savings and investment products in
the United States. In addition, our international operations are
focused on markets where the demand for insurance, savings and
investment products is expected to grow rapidly in the future.
We divide our business into five operating segments:
|
|
|
|
|
Institutional (41% of 2004 revenues). Our
Institutional segment offers a broad range of group insurance
and retirement & savings products and services to
corporations and other institutions. |
|
|
|
|
|
Our group insurance products and services include group life
insurance, non-medical health insurance products such as
accidental death and dismemberment, long-term care, short- and
long-term disability and dental insurance, and related
administrative services. We offer group insurance products as
employer-paid benefits or as voluntary benefits where all or a
portion of the premiums are paid by the employee. We have built
a leading position in the U.S. group insurance market
through long-standing relationships with many of the largest
corporate employers in the United States. We distribute our
group insurance products and services through a regional sales
force consisting, as of December 31, 2004, of 374 marketing
representatives. Voluntary products are sold through the same
sales channels, as well as by specialists for these products. |
|
|
|
Our institutional retirement & savings products and
services include an array of annuity and investment products, as
well as bundled administrative and investment services sold to
sponsors of small- and mid-sized 401(k) and other defined
contribution plans, guaranteed interest products and other
stable value products, accumulation and income annuities, and
separate account contracts for the investment of defined benefit
and defined contribution plan assets. We distribute
retirement & savings products and services through
dedicated sales teams and relationship managers located in 21
offices around the country, as well as through the distribution
channels in the Individual segment and in the group insurance
area, which enable us to better reach and service customers,
brokers, consultants and other intermediaries. |
|
|
|
|
|
Individual (33% of 2004 revenues). Our Individual
segment offers a wide variety of protection and asset
accumulation products aimed at serving the financial needs of
our individual customers throughout their entire life cycle.
Individual segment products include traditional, universal and
variable life insurance and variable and fixed annuities, as
well as disability insurance, long-term care |
S-4
|
|
|
|
|
insurance products, mutual funds and other products offered by
our other businesses. |
Our Individual segment products are distributed nationwide
through three main sales channels:
|
|
|
|
|
The MetLife Financial Services career agency system, which
focuses on large middle-income and affluent markets, including
multicultural markets, had 5,597 agents under contract in 126
agencies at December 31, 2004. |
|
|
|
New England Financials general agency system, which
targets high net-worth individuals, owners of small businesses
and executives of small- to medium-sized companies, and included
58 general agencies providing support to 2,383 agents and a
network of independent brokers throughout the United States at
December 31, 2004. |
|
|
|
Independent distribution, which is managed primarily by
GenAmerica Financial, a company that markets a portfolio of
individual life insurance, annuity contracts, and related
financial services to high net-worth individuals and small- to
medium-sized businesses through 1,654 independent general
agencies as of December 31, 2004. The GenAmerica
distribution system includes 380 independent general agents who
act as independent contractors and produced at least $25,000 in
first-year insurance sales in 2004. Other independent
distribution channels include independent general agents,
financial advisors, consultants, brokerage general agencies and
other independent marketing organizations. |
|
|
|
|
|
Reinsurance (10% of 2004 revenues). Our
Reinsurance segment is primarily comprised of our interest in
the life reinsurance business of Reinsurance Group of America,
Incorporated (RGA), a publicly traded company (NYSE:
RGA), and our ancillary life reinsurance business. MetLife, Inc.
owned approximately 52% of RGAs outstanding common shares
at December 31, 2004. |
|
|
|
Auto & Home (8% of 2004 revenues). Our
Auto & Home segment offers personal lines property and
casualty insurance directly to employees through
employer-sponsored programs, as well as through a variety of
retail distribution channels, including the MetLife Financial
Services career agency system, independent agents, property and
casualty specialists and direct response marketing. |
|
|
|
International (7% of 2004 revenues). Our
International segment provides life insurance, accident and
health insurance, annuities and retirement & savings
products to both individuals and groups. We focus on emerging
markets primarily within the Latin America and Asia/Pacific
regions. In Latin America, we operate in Mexico and Chile (which
generated approximately 93% of our 2004 Latin America premiums
and fees), as well as Brazil, Argentina and Uruguay. In the
Asia/Pacific region we operate in South Korea and Taiwan (which
generated approximately 95% of our total 2004 Asia premiums and
fees), as well as Hong Kong, Indonesia, India and China. |
Corporate & Other contains the excess capital not
allocated to the operating segments, various start-up entities,
including MetLife Bank, N.A., a national bank, and run-off
entities, as well as the elimination of all intersegment
amounts. Additionally, our asset management business, including
amounts reported as discontinued operations, is included in the
results of operations for Corporate & Other.
For the year ended December 31, 2004, we had total revenue
of $38.8 billion and net income of $2.8 billion. At
March 31, 2005, we had cash and invested assets of
$244.9 billion, total assets of $362.7 billion and
shareholders equity of $23.0 billion.
S-5
Acquisition of the Citigroup Life Insurance and Annuities
Business
On January 31, 2005, MetLife, Inc. entered into a
definitive agreement to acquire for $11.5 billion, subject
to certain closing adjustments, all of the outstanding shares of
capital stock held by Citigroup Inc. (Citigroup) and
its affiliates, of certain of the domestic and international
life insurance subsidiaries of Citigroup, referred to as the
Citigroup Life Insurance and Annuities business (Citigroup
L&A) (the Acquisition). The closing of the
Acquisition is subject to certain conditions. Although no
assurances can be given that these conditions will be timely
satisfied or waived, we expect the Acquisition to close in the
summer of 2005. In connection with the Acquisition, MetLife,
Inc. will enter into ten-year distribution agreements with
Citigroup, under which we will expand our distribution by making
products available through certain Citigroup distribution
channels, subject to appropriate suitability and other
standards, including the competitiveness of our products and the
financial strength of our providers. These channels include
CitiStreet Retirement Services, Smith Barney, Citibank branches
and Primerica Financial Services in the United States and
various Citigroup consumer businesses internationally.
Overview of Citigroup L&A
Citigroup L&A provides insurance and other financial
services to a broad spectrum of individual and institutional
customers in the United States and select international markets.
Citigroup L&As U.S. business principally operates
through The Travelers Insurance Company (TIC) based
in Hartford, Connecticut. Citigroup L&As international
business operates in several countries, which include
wholly-owned subsidiaries in Australia, Brazil, Argentina, the
United Kingdom, Belgium and Poland and a joint venture in each
of Japan and Hong Kong. Citigroup L&A also includes certain
individual life and retail annuity businesses in run-off status
since 2003.
At December 31, 2004, Citigroup L&As total assets
were $97.3 billion, approximately 96% of which was
associated with domestic operations. Citigroup L&As
net income for the year ended December 31, 2004 was
$901 million, to which domestic and international
operations contributed 91% and 9%, respectively.
|
|
|
Citigroup L&A U.S. Operations |
Citigroup L&As principal U.S. product offerings
include:
|
|
|
|
|
Retail annuity products, including fixed and variable
deferred annuities and payout annuities. Citigroup L&A
distributes its individual annuity products through Citigroup
affiliated channels ($3.9 billion of individual annuity
premium and deposits in 2004) and non-affiliated channels
($1.8 billion of individual annuity premium and deposits in
2004). The Citigroup affiliated channels include CitiStreet
Retirement Services, Smith Barney, Citibank branches and
Primerica Financial Services. Non-affiliated channels include a
nationwide network of independent financial professionals and
independent broker-dealers, including Morgan Stanley, Merrill
Lynch & Co., Fidelity, AXA and Wachovia Securities. |
|
|
|
Individual life insurance products, including term,
universal and variable life insurance. Citigroup L&As
individual life insurance products are primarily marketed by
independent financial professionals, who accounted for
$745 million of the $964 million of total life
insurance sales for 2004. |
|
|
|
Institutional annuity products, including institutional
pensions, guaranteed investment contracts (GICs),
payout annuities, group annuities sold to employer-sponsored
retirement and savings plans, structured settlements and funding
agreements. Citigroup L&As institutional annuity
products are sold through direct sales and various
intermediaries. |
|
|
|
Citigroup L&A International Operations |
Citigroup L&As international operations offer a
variety of insurance products, including credit insurance, basic
indemnity policies (such as accident and health products),
traditional term life, group life, whole life, endowment, fixed
and variable annuities, pension annuities and unit-linked
policies. Citigroup L&A distributes its products in
international markets primarily through Citigroups
consumer businesses, including its retail banking, credit card
and consumer finance franchises, as well as through
non-proprietary channels.
S-6
International sales are also conducted through direct mail and
telemarketing, branch sales, wholesaling networks, agencies and
direct sales agents.
Financing of the Purchase Price
Our definitive agreement with Citigroup to acquire the Citigroup
L&A business (the Acquisition Agreement) permits
us to pay up to $3 billion of the $11.5 billion
purchase price (with the amount to be determined by us) to
Citigroup in MetLife, Inc.s common stock (or, in the
circumstances described below in Proposed Acquisition of
the Citigroup Life Insurance and Annuities Business,
non-voting convertible participating preferred stock). We
currently intend to pay $1 billion of the purchase price in
common stock. The remainder of the purchase price must be paid
in cash.
We intend to finance the cash portion of the purchase price
through a combination of cash on hand, dividends from our
insurance subsidiaries, net proceeds from the sale of a real
estate property and available-for-sale fixed maturity
securities, and the net proceeds from the issuance of commercial
paper and various other forms of securities, including:
|
|
|
|
|
the series A preferred shares offered hereby; |
|
|
|
a class of newly-issued fixed rate preferred stock; |
|
|
|
mandatorily convertible equity units; and |
|
|
|
senior debt. |
In the event that any of the proposed offerings of securities
cannot be completed on commercially acceptable terms, we may
borrow up to $7 billion under a bridge financing facility.
We currently expect to commence the offerings of fixed-rate
preferred stock, mandatorily convertible equity units and senior
debt shortly after the pricing of this offering of series A
preferred shares. The form, manner and timing of the financing
of the Acquisition is subject to change. Please refer to
Unaudited Pro Forma Condensed Consolidated Financial
Information for further discussion of the financing
transactions.
Strategic Rationale
We believe the Acquisition will provide both immediate and
long-term increases in shareholder value through the following
strategic and financial benefits:
|
|
|
|
|
Substantially enhanced scale and market position in
individual life and annuity products. The Acquisition
significantly enhances our position in products we know well. In
particular, it increases the operating earnings of our
Individual segment and reinforces our position as a leader in
the individual life and annuity markets. As a result of the
Acquisition, as of March 31, 2005, based on data from
LIMRA, we will become the leading seller of individual life
insurance products in the United States, as measured by premium
dollars, and the second largest seller of individual annuities
in the United States, as measured by total individual annuity
sales. |
|
|
|
Highly complementary distribution channels. There
is very little overlap between our distribution systems and
those of Citigroup L&A. As part of the Acquisition, we will
enter into ten-year distribution agreements with Citigroup,
which will give us access to certain Citigroup distribution
channels. In addition, we will gain expanded distribution
capabilities to sell individual life products through
independent financial professionals, with whom we have had only
a limited presence until now. Citigroup L&A adds independent
agents, national marketing organizations, Smith Barney and
Citibank to our sales channels for life insurance products. Our
individual annuity distribution capabilities will be
significantly expanded by new distribution relationships with
Citigroup-affiliated channels, including CitiStreet Retirement
Services, Smith Barney, Citibank branches and Primerica
Financial Services, as well as by non-affiliated channels,
including a nationwide network of independent financial
professionals and independent broker-dealers. |
|
|
|
Substantially increased international presence.
The Acquisition increases our presence and adds new distribution
channels in Brazil and Hong Kong and introduces us to new
markets in Japan, Australia, Belgium, Poland and the United
Kingdom. In total, as a result of the Acquisition, we will have
a presence in 16 foreign countries. |
S-7
The Offering
|
|
|
Issuer |
|
MetLife, Inc. |
|
Securities Offered |
|
shares
of Floating Rate Non-Cumulative Preferred Stock, Series A,
$0.01 par value per share, with a liquidation preference of
$25 per share, of MetLife, Inc. |
|
|
|
To the extent that the underwriters sell more
than series A
preferred shares, the underwriters have the option to purchase
up to an
additional series A
preferred shares. In addition, MetLife, Inc. may from time to
time elect to issue additional series A preferred shares,
and all the additional shares would be deemed to form a single
series with the series A preferred shares. |
|
Dividends |
|
Dividends on the series A preferred shares, when, as and if
declared by MetLife, Inc.s board of directors or a duly
authorized committee of the board, will accrue and be payable on
the liquidation preference amount from the original issue date,
on a non-cumulative basis, quarterly in arrears on each dividend
payment date, at an annual rate of the greater of
(a) %
above three month LIBOR on the related LIBOR determination date
or
(b) %.
Any such dividends will be distributed to holders of the
series A preferred shares in the manner described under
Description of the Series A Preferred
Shares Dividends. |
|
|
|
A dividend period is the period from and including a dividend
payment date to but excluding the next dividend payment date,
except that the initial dividend period will commence on and
include the original issue date of the series A preferred
shares and will end on and exclude the September ,
2005 dividend payment date. |
|
|
|
Dividends on the series A preferred shares are not
cumulative. Accordingly, in the event dividends are not declared
on the series A preferred shares for payment on any
dividend payment date, then any accrued dividends shall cease to
accrue and be payable. If MetLife, Inc.s board of
directors or a duly authorized committee of the board has not
declared a dividend before the dividend payment date for any
dividend period, MetLife, Inc. will have no obligation to pay
dividends accrued for such dividend period after the dividend
payment date for that dividend period, whether or not dividends
on the series A preferred shares are declared for any
future dividend period. |
|
Dividend Payment Dates |
|
The day
of March, June, September and December of each year, commencing
on September , 2005. If any date on which dividends
would otherwise be payable is not a business day, then the
dividend payment date will be the next succeeding business day
unless such day falls in the next calendar month, in which case
the dividend payment date will be the immediately preceding day
that is a business day. |
|
Redemption |
|
The series A preferred shares are not redeemable prior
to , 2010. On and after that date,
the series A preferred shares will be redeemable at
MetLife, Inc.s option and subject to the Federal Reserve
Boards prior approval, in whole or in part, at a redemption |
S-8
|
|
|
|
|
price equal to $25 per series A preferred share, plus
any declared and unpaid dividends, without accumulation of any
undeclared dividends. The series A preferred shares will
not be subject to any sinking fund or other obligation of
MetLife, Inc. to redeem, repurchase or retire the series A
preferred shares. |
|
|
|
MetLife, Inc. intends that, if it redeems the series A
preferred shares, it will redeem them only to the extent that
the aggregate liquidation preference of the series A
preferred shares redeemed is less than the amount, if any, of
net proceeds to MetLife, Inc. or its affiliates of shares
of certain types of junior stock or parity
stock (each as defined herein) or certain other securities
having sufficient equity characteristics, in each case that are
issued within six months before the redemption. See
Description of the Series A Preferred
Shares Redemption. |
|
Dividend Payment Restrictions |
|
The Certificate of Designation for the series A preferred
shares prohibits the declaration of dividends on the
series A preferred shares if we fail to meet specified
capital adequacy, net income and shareholders equity
levels. In addition, under Federal Reserve Board policy,
MetLife, Inc. may not be able to pay dividends if it does not
earn sufficient operating income. See Description of the
Series A Preferred Shares Restrictions on
Declaration and Payment of Dividends. |
|
Ranking |
|
The series A preferred shares: |
|
|
|
will rank senior to MetLife, Inc.s junior
stock with respect to the payment of dividends and distributions
upon liquidation, dissolution or winding-up. Junior stock
includes MetLife, Inc.s common stock, its Series A Junior
Participating Preferred Stock, any non-voting convertible
preferred stock that may be issued to Citigroup under the
Acquisition Agreement in lieu of common stock and any other
class of stock that ranks junior to the series A preferred
shares either as to the payment of dividends or as to the
distribution of assets upon any liquidation, dissolution or
winding-up of MetLife, Inc. |
|
|
|
will rank at least equally with each other series of
parity stock that MetLife, Inc. may issue with respect to the
payment of dividends and distributions upon liquidation,
dissolution or winding-up. As of the date of this prospectus
supplement, no other series of parity stock is outstanding. In
addition to the series A preferred shares offered hereby,
MetLife, Inc. plans to issue a series of fixed rate preferred
stock shortly after the completion of this offering of
series A preferred shares as part of the financing of the
Acquisition. This series of fixed rate preferred stock will rank
equally with the series A preferred shares offered hereby.
See Use of Proceeds and Capitalization. |
|
|
|
During any dividend period, so long as any series A
preferred shares remain outstanding, unless the full dividends
for the latest completed dividend period on all outstanding
series A preferred |
S-9
|
|
|
|
|
shares have been declared or paid, or declared and a sum
sufficient for the payment thereof has been set aside: |
|
|
|
No dividend shall be paid or declared on MetLife,
Inc.s common stock or other junior stock; and |
|
|
|
No common stock or other junior stock shall be
purchased, redeemed or otherwise acquired for consideration by
MetLife, Inc., directly or indirectly (other than as a result of
the reclassification of such junior stock for or into other
junior stock, or the exchange or conversion of one share of such
junior stock for or into another share of such junior stock). |
|
|
|
For any dividend period in which dividends are not paid in full
upon the series A preferred shares and any parity stock,
all dividends declared for such dividend period with respect to
the series A preferred shares and such parity stock shall
be declared on a pro rata basis. See Description of the
Series A Preferred Shares Dividends. |
|
Liquidation Rights |
|
Upon any voluntary or involuntary liquidation, dissolution or
winding up of MetLife, Inc., holders of the series A
preferred shares are entitled to receive out of the assets of
MetLife, Inc., available for distribution to stockholders,
before any distribution is made to holders of common stock or
other junior stock, a liquidating distribution in the amount of
$25 per preferred share plus any declared and unpaid dividends,
without accumulation of any undeclared dividends. Distributions
will be made pro rata as to the series A preferred shares
and any other parity stock and only to the extent of MetLife,
Inc.s assets, if any, that are available after
satisfaction of all liabilities to creditors. See
Description of the Series A Preferred
Shares Liquidation Rights. |
|
Voting Rights |
|
Holders of the series A preferred shares will have no
voting rights, except with respect to certain fundamental
changes in the terms of the series A preferred shares and
in the case of certain dividend non-payments. See
Description of the Series A Preferred
Shares Voting Rights. |
|
Maturity |
|
The series A preferred shares do not have any maturity
date, and MetLife, Inc. is not required to redeem the
series A preferred shares. Accordingly, the series A
preferred shares will remain outstanding indefinitely, unless
and until MetLife, Inc. decides to redeem them. |
|
Preemptive Rights |
|
Holders of the series A preferred shares will have no
preemptive rights. |
|
Listing |
|
MetLife, Inc. will apply for listing of the series A
preferred shares on the New York Stock Exchange under the symbol
METPrA. If approved for listing, MetLife, Inc.
expects trading of the series A preferred shares on the New
York Stock Exchange to commence on the date of initial delivery. |
|
Tax Consequences |
|
If you are a noncorporate United States holder, dividends paid
to you in taxable years beginning before January 1, 2009
will be taxable to you at a maximum rate of 15%, subject to
certain |
S-10
|
|
|
|
|
requirements described herein. If you are taxed as a
corporation, except as described below under Certain
United States Federal Income Tax Consequences United
States Holders Distributions on Series A
Preferred Shares, dividends generally would be eligible
for the 70% dividends-received deduction. If you are a United
States alien holder of series A preferred shares, dividends
paid to you are subject to withholding tax at a 30% rate or at a
lower rate if you are eligible for the benefits of an income tax
treaty that provides for a lower rate. For further discussion of
the tax consequences relating to the series A preferred
shares, see Certain United States Federal Income Tax
Consequences below. |
|
Ratings |
|
The series A preferred shares are expected to be
rated by
Standard & Poors Ratings
and by
Moodys Investors Service. The ratings of the series A
preferred shares should be evaluated independently from similar
ratings of other securities. A rating is not a recommendation to
buy, sell or hold securities and may be subject to review,
revision, suspension, reduction or withdrawal at any time by the
assigning rating agency. |
|
Use of Proceeds |
|
MetLife, Inc. expects to receive net proceeds from this offering
of approximately
$ ,
after expenses and underwriting discounts. |
|
|
|
MetLife, Inc. intends to use the net proceeds from this offering
to fund a portion of the purchase price for MetLife, Inc.s
acquisition of Citigroup L&A. In the event the Acquisition
is not consummated, MetLife, Inc. will use the net proceeds from
the sale of the series A preferred shares for general
corporate purposes. |
|
Transfer Agent and Registrar |
|
Mellon Investor Services L.L.C. |
|
Calculation Agent |
|
JPMorgan Chase Bank, N.A. |
S-11
RISK FACTORS
In considering whether to purchase series A preferred
shares, you should carefully consider all the information
included or incorporated by reference in this prospectus
supplement and in the accompanying prospectus. In particular,
you should carefully consider the following risk factors.
Risks Relating to the Acquisition of Citigroup L&A
|
|
|
We Do Not Expect Citigroup L&As Performance in
2004 and the First Quarter of 2005 to be Indicative of Its
Future Contribution to Our Net Income |
Citigroup L&A generated net income of $901 million in
2004 and $273 million in the first quarter of 2005. We
expect Citigroup L&As results in 2005 to be lower than
the $901 million generated in 2004 due to the impact of
certain items in 2004 that are unlikely to recur in 2005 and
trends in Citigroup L&As principal businesses. We also
do not believe Citigroup L&As net income for the first
quarter of 2005 is an accurate indicator of its full year
2005 net income.
Citigroup L&As 2004 net income of
$901 million was positively affected by tax recoveries,
releases of reserves, charges and other items and negatively
affected by other items, including a change in assumptions
relating to deferred policy acquisition costs (DAC) that, taken
together, contributed a net amount in excess of $60 million
to Citigroup L&As net income in 2004. We believe these
items are unlikely to recur in 2005. Similarly, Citigroup
L&As net income of $273 million in the first
quarter of 2005 was positively affected by unusually large
realized gains of $36 million and better than expected
results in Argentina due in part to a $16 million (after
tax) release of reserves.
We expect the following trends, which Citigroup L&A
management has reported to us, to affect the profitability of
Citigroup L&As various businesses in 2005:
|
|
|
|
|
Private Equity and Real Estate. According to Citigroup
L&A management, Citigroup L&A has experienced
significant declines in returns on its investments in arbitrage
funds in 2005. In addition, Citigroup L&As 2004 and
first quarter 2005 net income benefitted from the exceptionally
strong performance of its private equity and real estate
investments. Total private equity and real estate investment
income in 2004 was $193 million and $79 million,
respectively, which represented 6.5% and 2.7%, respectively, of
Citigroup L&As total net investment income for the
year. An adverse change in the private equity or real estate
markets or continuing poor returns on arbitrage investments
would have a negative impact on our returns from Citigroup
L&As investments. See Risks Relating to Our
Business The Performance of Our Investments Depends
on Conditions that Are Outside Our Control, and Our Net
Investment Income Can Vary from Period to Period below. |
|
|
|
Institutional Annuities. According to the Quarterly
Report on Form 10-Q filed by TIC for the first quarter of
2005, institutional annuities deposits were 30% lower in the
three months ended March 31, 2005 than in the comparable
period in 2004. The decline in volume was a result of lower
sales under TICs medium-term note program and GIC
customers assessing concentration risk associated with the
Acquisition. Structured settlement production also declined in
the first quarter of 2005 as a result of initial uncertainty
following the announcement of the Acquisition. Consistent with
industry trends, Citigroup L&A has also experienced a slower
group close-out market. The close-out business is characterized
by large, infrequent transactions that contribute to volatility
of quarterly premiums, benefits and losses. |
|
|
|
Retail Annuities. Although retail annuity sales have
shown some growth from 2004, they have been below expectations
in 2005. A slowdown in new product introductions by Citigroup
L&A has hampered the ability of Citigroup L&A to respond
to new offerings by competitors, and plans to expand
distribution in the financial planner market and in banks have
been cancelled. Also, uncertainty regarding long-term
integration plans has led to wholesaler turnover. |
|
|
|
Life Insurance. The life insurance industry is facing
numerous challenges that could have an impact in future periods.
Reserve requirements under NAIC Model Regulation AXXX for
universal life products with secondary guarantees are expected
to constrain capital, while higher cost and decreased |
S-12
|
|
|
|
|
availability of life reinsurance, in addition to heightened
competition from major U.S. life insurance market
participants, are expected to pressure profitability. |
|
|
|
International. Sales may be reduced in 2005 due to a
number of factors. In Japan, Citigroup L&A has experienced a
slowdown in sales of its variable annuity contracts and
increased competition, reflecting lower overall variable annuity
sales by Citigroup L&As distributors and a loss by
Citigroup L&A of market share within these channels. Sales
also may be reduced by a slowdown in the United Kingdom due to
reduced loan origination, changes in pension regulations in
Australia, and continuing uncertainty in Argentina due in part
to economic conditions and the potential for government and
judicial action. |
|
|
|
Citigroup L&As Business is Also Subject to
Risks |
Citigroup L&As business is affected by other market
risks and other categories of risk described elsewhere in this
section, in this prospectus supplement and in the documents
incorporated by reference herein. In particular, we note that:
|
|
|
|
|
Citigroup L&A has experienced continued spread compression
in 2005, as somewhat lower new money rates in 2005 were only
partially offset by lower crediting rates on annuity products.
Declining interest rates, continued low interest rates or
rapidly rising interest rates could exacerbate this trend. See
Risks Relating to Our Business Changes in
Market Interest Rates May Significantly Affect Our
Profitability. |
|
|
|
Citigroup L&As business is significantly affected by
movements in the U.S. equity and fixed income credit
markets. See Risks Relating to Our Business A
Decline in Equity Markets or an Increase in Volatility in Equity
Markets May Adversely Affect Sales of Our Investment Products
and Our Profitability. |
|
|
|
Citigroup L&A has experienced a sustained period of
favorable credit trends in 2004. Adverse changes in the credit
quality of issuers could have a negative effect on Citigroup
L&As investment portfolio and earnings. See
Risks Relating to Our Business Defaults,
Downgrades or Other Events Impairing the Value of Our
Fixed-Income Securities Portfolio May Reduce Our Earnings
below. |
|
|
|
Federal and state regulators have focused on, and continue to
devote substantial attention to, the mutual fund and variable
insurance product industries. See Risks Relating to Our
Business Legal and Regulatory Investigations and
Actions Are Increasingly Common in the Insurance Business and
May Result in Financial Losses and Harm our Reputation. |
|
|
|
Following the announcement of the Acquisition, the financial
strength rating of each of TIC and its subsidiary, The Travelers
Life and Annuity Company, was lowered one notch by certain
rating agencies. While we believe the negative impact of these
downgrades on Citigroup L&As financial results was
relatively modest, future downgrades, if any, could have a more
pronounced impact. See Risks Relating to Our
Business A Downgrade or a Potential Downgrade in Our
Financial Strength or Credit Ratings Could Result in a Loss of
Business and Adversely Affect Our Financial Condition and
Results of Operations. |
|
|
|
We May Experience Difficulties in Integrating the
Citigroup L&A Business |
Our ability to achieve the benefits we anticipate from the
Acquisition will depend in large part upon whether we are able
to integrate the businesses of MetLife and Citigroup L&A in
an efficient and effective manner. We may not be able to
integrate these businesses smoothly or successfully, and the
process may take longer than expected. The integration of
certain operations following the Acquisition will require the
dedication of significant management resources, which may
distract managements attention from day-to-day business.
Integration planning, which commenced on January 31, 2005,
has already required significant management resources. If we are
unable to successfully integrate the operations of MetLife and
Citigroup L&A, we may be unable to realize the cross-selling
and other distribution benefits, cost savings, revenue growth
and other anticipated benefits we expect to achieve as a result
of the Acquisition and our business and results of operations
could be adversely affected.
S-13
The success with which we are able to integrate the Citigroup
L&A business will depend on our ability to manage a variety
of issues, including the following:
|
|
|
|
|
Loss of key personnel or higher than expected employee attrition
rates could adversely affect the performance of the Citigroup
L&A business and our ability to integrate it successfully.
Citigroup L&A management has advised us that since the
announcement of the Acquisition, employee departures from the
Citigroup L&A business have been running at a significantly
higher rate than the historical average. |
|
|
|
Citigroup L&As customers may reduce, delay or defer
decisions concerning their use of Citigroup L&As
products and services as a result of the Acquisition or
uncertainties related to the consummation of the Acquisition. In
particular, we expect that some existing Citigroup L&A
customers that are also customers of MetLife will reduce their
purchases from Citigroup L&A and MetLife as they assess
concentration risk associated with the Acquisition. Citigroup
L&A experienced lower institutional annuities deposits in
the first quarter of 2005 following the announcement of the
Acquisition. |
|
|
|
The Citigroup L&A business relies in part upon independent
distributors to distribute its products. According to Citigroup
L&A management, financial professionals not affiliated with
Citigroup accounted for $1.8 billion of the
$5.7 billion total individual annuity premiums and
deposits, and $745 million of the $964 million total
individual life insurance sales, of the Citigroup L&A
business in 2004. Unaffiliated distributors typically distribute
products for many different financial institutions and may not
continue to generate the same volume of business for MetLife
after the Acquisition. Independent distributors may reexamine
the scope of their relationship with Citigroup L&A as a
result of the Acquisition and decide to curtail or eliminate
their distribution of Citigroup L&A products. |
|
|
|
Although we will enter into ten-year distribution arrangements
with the Citigroup-affiliated distributors at the closing of the
Acquisition, most of these distribution relationships will not
require the distributor to distribute MetLife or Citigroup
L&A products exclusively. We cannot assure you that the
volume of distribution through these channels will not decrease
after the Citigroup L&A business is no longer affiliated
with these channels. Distribution channels affiliated with
Citigroup account for significant volumes of the Citigroup
L&A business, including $3.9 billion of the
$5.7 billion total individual annuity premiums and deposits
of the Citigroup L&A business in 2004. |
|
|
|
Integrating the Citigroup L&A business with our existing
operations will require us to coordinate geographically
separated organizations, address possible differences in
corporate culture and management philosophies and combine
separate information technology platforms. |
We expect to incur significant one-time costs in connection with
the Acquisition and the related integration of approximately
$196 million, or $127 million after income taxes.
These costs have not been reflected in the accompanying
unaudited pro forma condensed consolidated financial information
because they are non-recurring. The costs and liabilities
actually incurred in connection with the Acquisition and
subsequent integration process may exceed those anticipated.
Although we expect that the realization of efficiencies related
to the Acquisition may offset additional expenses over time and
result in net cost savings, we cannot ensure that this net
benefit will be achieved soon or at all.
|
|
|
If the Citigroup L&A Business Does Not Perform Well or
We Do Not Integrate It Successfully, We May Incur Significant
Charges to Write Down the Goodwill Established in the
Acquisition |
As a result of the Acquisition, we expect to establish goodwill
of approximately $4.5 billion based upon the March 31,
2005 unaudited pro forma interim condensed consolidated balance
sheet included elsewhere in this prospectus supplement. Under
Statement of Financial Accounting Standards No. 142,
Goodwill and Other Intangible Assets, we must
test our goodwill annually for impairment and, if we determine
that the goodwill has been impaired, we must write down the
goodwill by the amount of the impairment, with a corresponding
charge to net income. If the Citigroup L&A business does not
perform well following the Acquisition or if we are unable to
integrate it successfully into our operations, we may incur
significant charges
S-14
to net income to write down the goodwill, which could have a
material adverse effect on our results of operations or
financial condition.
|
|
|
We Must Obtain Many Governmental and Other Consents to
Complete the Acquisition. If These Consents Are Delayed, Not
Granted or Granted with Unacceptable Conditions, It May
Jeopardize or Postpone the Completion of the Acquisition, Result
in Additional Expenditures of Money and Resources and/or Reduce
the Anticipated Benefits of the Acquisition |
We must obtain numerous approvals and consents in a timely
manner from federal, state and foreign agencies prior to the
completion of the Acquisition. If we do not receive these
approvals, or do not receive them on terms that satisfy the
conditions set forth in the Acquisition Agreement, then we will
not be obligated to complete the Acquisition. In such case, it
is possible that we may forego or postpone acquiring all of
Citigroup L&A and, instead, acquire only certain businesses
and/or assets of Citigroup L&A for which we have obtained
appropriate approvals, thereby reducing the anticipated benefits
of the Acquisition. The governmental agencies from which we will
seek these approvals have broad discretion in administering the
governing regulations. As a condition to approval of the
Acquisition, agencies may impose requirements, limitations or
costs that could negatively affect the way we conduct, or
Citigroup L&A conducts, business. These requirements,
limitations or costs could jeopardize or delay the completion of
the Acquisition. If we agree to any material requirements,
limitations or costs in order to obtain any approvals required
to complete the Acquisition, these requirements, limitations or
additional costs could adversely affect our ability to integrate
the Citigroup L&A operations or reduce the anticipated
benefits of the Acquisition. This could result in a material
adverse effect on our business and results of operations.
In the event the Acquisition is not consummated or we do not
acquire all of Citigroup L&A, we may incur significant costs
to redeem securities issued, or repay any drawdowns under the
bridge facility, in connection with the financing of the
Acquisition. See Use of Proceeds for our plans to
finance the Acquisition.
Risks Relating to Our Business
The Citigroup L&A business is similar to our own business in
many respects, and the Acquisition will increase our exposure to
many of the risks described below.
|
|
|
Changes in Market Interest Rates May Significantly Affect
Our Profitability |
Some of our products, principally traditional whole life
insurance, fixed annuities and guaranteed investment contracts,
expose us to the risk that changes in interest rates will reduce
our spread, or the difference between the amounts
that we are required to pay under the contracts in our general
account and the rate of return we are able to earn on general
account investments intended to support obligations under the
contracts. Our spread is a key component of our net income.
As interest rates decrease or remain at low levels, we may be
forced to reinvest proceeds from investments that have matured
or have been prepaid or sold at lower yields, reducing our
investment margin. Moreover, borrowers may prepay or redeem the
fixed-income securities, commercial mortgages and
mortgage-backed securities in our investment portfolio with
greater frequency in order to borrow at lower market rates,
which exacerbates this risk. Lowering interest crediting rates
can help offset decreases in investment margins on some
products. However, our ability to lower these rates could be
limited by competition or contractually guaranteed minimum rates
and might not match the timing or magnitude of changes in asset
yields. As a result, our spread could decrease or potentially
become negative. Our expectation for future spreads is an
important component in the amortization of DAC and significantly
lower spreads may cause us to accelerate amortization, thereby
reducing net income in the affected reporting period. In
addition, during periods of declining interest rates, life
insurance and annuity products may be relatively more attractive
investments to consumers, resulting in increased premium
payments on products with flexible premium features, repayment
of policy loans and increased persistency, or a higher
percentage of insurance policies remaining in force from year to
year, during a period when our new investments carry lower
returns. A decline in market interest rates
S-15
could also reduce our return on investments that do not support
particular policy obligations. Accordingly, declining interest
rates may materially adversely affect our results of operations
and financial condition and significantly reduce our
profitability.
Increases in market interest rates could also negatively affect
our profitability. In periods of rapidly increasing interest
rates, we may not be able to replace, in a timely manner, the
assets in our general account with higher yielding assets needed
to fund the higher crediting rates necessary to keep interest
sensitive products competitive. We therefore may have to accept
a lower spread and thus lower profitability or face a decline in
sales and greater loss of existing contracts and related assets.
In addition, policy loans, surrenders and withdrawals may tend
to increase as policyholders seek investments with higher
perceived returns as interest rates rise. This process may
result in cash outflows requiring that we sell invested assets
at a time when the prices of those assets are adversely affected
by the increase in market interest rates, which may result in
realized investment losses. Unanticipated withdrawals and
terminations may cause us to accelerate the amortization of DAC
unlocking, which would increase our current expenses and reduce
net income. An increase in market interest rates could also have
a material adverse effect on the value of our investment
portfolio, for example, by decreasing the fair values of the
fixed income securities that comprise a substantial majority of
our investment portfolio.
|
|
|
A Decline in Equity Markets or an Increase in Volatility
in Equity Markets May Adversely Affect Sales of Our Investment
Products and Our Profitability |
Significant downturns and volatility in equity markets could
have a material adverse effect on our financial condition and
results of operations in three principal ways.
First, market downturns and volatility may discourage purchases
of separate account products, such as variable annuities,
variable life insurance and mutual funds that have returns
linked to the performance of the equity markets and may cause
some existing customers to withdraw cash values or reduce
investments in those products.
Second, downturns and volatility in equity markets can have a
material adverse effect on the revenues and returns from our
savings and investment products and services. Because these
products and services depend on fees related primarily to the
value of assets under management, a decline in the equity
markets could reduce our revenues by reducing the value of the
investment assets we manage. The retail annuity business in
particular is highly equity market sensitive, and a sustained
weakness in the markets will decrease revenues and earnings in
variable annuity products.
Third, we provide certain guarantees within some of our products
that protect policyholders against significant downturns in the
equity markets. For example, we offer variable annuity products
with guaranteed features, such as minimum death and withdrawal
benefits. These guarantees may be more costly than expected in
volatile or declining equity market conditions, causing us to
increase reserves and negatively affecting net income.
|
|
|
The Performance of Our Investments Depends on Conditions
that Are Outside Our Control, and Our Net Investment Income Can
Vary from Period to Period |
The performance of our investment portfolio depends in part upon
the level of and changes in interest rates, equity prices, real
estate values, the performance of the economy generally, the
performance of the specific obligors included in our portfolio
and other factors that are beyond our control. Changes in these
factors can affect our net investment income in any period, and
such changes can be substantial.
We invest a portion of our invested assets in pooled investment
funds that make private equity investments. The amount and
timing of income from such investment funds tend to be uneven as
a result of the performance of the underlying private equity
investments, which can be difficult to predict, as well as the
timing of distributions from the funds, which depends on
particular events relating to the underlying investments as well
as the funds schedules for making distributions and their
needs for cash. As a result, the amount of income that we record
from these investments can vary substantially from quarter to
quarter.
S-16
|
|
|
Competitive Factors May Adversely Affect Our Market Share
and Profitability |
Our business segments are subject to intense competition. We
believe that this competition is based on a number of factors,
including service, product features, scale, price, commission
structure, financial strength, claims-paying ratings, credit
ratings, business capabilities and name recognition. We compete
with a large number of other insurers, as well as non-insurance
financial services companies, such as banks, broker-dealers and
asset managers, for individual consumers, employers and other
group customers and agents and other distributors of insurance
and investment products. Some of these companies offer a broader
array of products, are regulated differently, have more
competitive pricing or, with respect to other insurers, have
higher claims paying ability ratings. Some may also have greater
financial resources with which to compete and a greater market
share. National banks, which may sell annuity products of life
insurers in some circumstances, also have pre-existing customer
bases for financial services products.
Many of our insurance products, particularly those offered by
our Institutional segment, are underwritten annually, and,
accordingly, there is a risk that group purchasers may be able
to obtain more favorable terms from competitors rather than
renewing coverage with us. The effect of competition may, as a
result, adversely affect the persistency of these and other
products, as well as our ability to sell products in the future.
In addition, the investment management and securities brokerage
businesses have relatively few barriers to entry and continually
attract new entrants. Many of our competitors in these
businesses offer a broader array of investment products and
services and are better known than we are as sellers of
annuities and other investment products.
|
|
|
We May be Unable to Attract and Retain Sales
Representatives for Our Products |
We must attract and retain productive sales representatives to
sell our insurance, annuities and investment products. Strong
competition exists among insurers for sales representatives with
demonstrated ability. We compete with other insurers for sales
representatives primarily on the basis of our financial
position, product features, the marketing and support services
we provide to the representatives and compensation. We continue
to undertake initiatives to grow our career agency force while
continuing to enhance the efficiency and production of our
existing sales force. We cannot provide assurance that these
initiatives will succeed in attracting and retaining new agents.
Sales of individual insurance, annuities and investment products
and our results of operations and financial condition could be
materially adversely affected if we are unsuccessful in
attracting and retaining productive agents.
|
|
|
Differences Between Actual Claims Experience and
Underwriting and Reserving Assumptions May Adversely Affect Our
Financial Results |
Our earnings significantly depend upon the extent to which our
actual claims experience is consistent with the assumptions we
use in setting prices for our products and establishing
reserves. Our reserves for future policy benefits and claims are
established based on estimates by actuaries of how much we will
need to pay for future benefits and claims. For life insurance
and annuity products, we calculate these reserves based on many
assumptions and estimates, including estimated premiums to be
received over the assumed life of the policy, the timing of the
event covered by the insurance policy, the amount of benefits or
claims to be paid and the investment returns on the assets we
purchase with the premiums we receive. We establish property and
casualty reserves based on assumptions and estimates of damages
and liabilities incurred. To the extent that actual claims
experience is less favorable than our underlying assumptions
used in establishing such reserves, we could be required to
increase our reserves.
Due to the nature of the underlying risks and the high degree of
uncertainty associated with the determination of reserves, we
cannot determine precisely the amounts which we will ultimately
pay to settle our liabilities. Such amounts may vary from the
estimated amounts, particularly when those payments may not
occur until well into the future. We evaluate our reserves
periodically based on changes in the assumptions used to
establish the reserves, as well as our actual experience. We
charge or credit changes in our reserves to expenses in the
period the reserves are established or re-estimated. If the
reserves originally established for
S-17
future benefit payments prove inadequate, we must increase them.
Such increases could affect our earnings negatively and have a
material adverse effect on our business, results of operations
and financial condition.
|
|
|
Our Risk Management Policies and Procedures May Leave Us
Exposed to Unidentified or Unanticipated Risk, Which Could
Negatively Affect Our Business |
Management of operational, legal and regulatory risks requires,
among other things, policies and procedures to record properly
and verify a large number of transactions and events. We have
devoted significant resources to develop our risk management
policies and procedures and expect to continue to do so in the
future. Nonetheless, our policies and procedures may not be
fully effective. Many of our methods for managing risk and
exposures are based upon our use of observed historical market
behavior or statistics based on historical models. As a result,
these methods may not predict future exposures, which could be
significantly greater than our historical measures indicate.
Other risk management methods depend upon the evaluation of
information regarding markets, clients, catastrophe occurrence
or other matters that is publicly available or otherwise
accessible to us. This information may not always be accurate,
complete, up-to-date or properly evaluated.
|
|
|
Catastrophes May Adversely Impact Liabilities for
Policyholder Claims and Reinsurance Availability |
Our life insurance operations are exposed to the risk of
catastrophic mortality events, such as a pandemic or other
catastrophe that causes a large number of deaths. In our group
insurance operations, a localized event that affects the
workplace of one or more of our group insurance customers could
cause a significant loss due to mortality or morbidity claims.
These events could cause a material adverse effect on our
results of operations in any period and, depending on their
severity, could also materially and adversely affect our
financial condition.
Our Auto & Home business has experienced, and will
likely in the future experience, catastrophe losses that may
have a material adverse impact on the business, results of
operations and financial condition of the Auto & Home
segment. Although Auto & Home makes every effort to minimize
its exposure to catastrophic risks through volatility management
and reinsurance programs, these efforts may not succeed.
Catastrophes can be caused by various events, including
hurricanes, windstorms, earthquakes, hail, tornadoes,
explosions, severe winter weather (including snow, freezing
water, ice storms and blizzards), fires, as well as man-made
events such as terrorist attacks. Historically, substantially
all of our catastrophe-related claims have related to homeowners
coverages. However, catastrophes may also affect other Auto
& Home coverages. Due to their nature, we cannot predict the
incidence, timing and severity of catastrophes.
Hurricanes and earthquakes are of particular note for our
homeowners coverages. Areas of major hurricane exposure include
coastal sections of the northeastern United States (including
Long Island and the Connecticut, Rhode Island and Massachusetts
shorelines) and Florida. We also have some earthquake exposure,
primarily along the New Madrid fault line in the central United
States and in the Pacific Northwest. Losses incurred by Auto
& Home from all catastrophes, net of reinsurance but before
taxes, were $189 million, $77 million and
$55 million in 2004, 2003 and 2002, respectively.
Terrorism is a recently emerging risk. A major terrorist attack
not only could cost lives and destroy property, but could also
have a material adverse effect on the value of investments that
we hold, which could in turn have a material adverse impact on
investment income and on fees we earn that are based on the
value of investments we manage for others. It is possible that
both the frequency and severity of man-made catastrophic events
will increase.
The extent of losses from a catastrophe is a function of both
the total amount of insured exposure in the area affected by the
event and the severity of the event. Most catastrophes are
restricted to small geographic areas; however, hurricanes and
earthquakes may produce significant damage in larger areas,
especially those that are heavily populated. Claims resulting
from natural or man-made catastrophic events could cause
substantial volatility in our financial results for any fiscal
quarter or year and could materially reduce our profitability or
harm our financial condition. Our ability to write new business
could also be affected. It is
S-18
possible that increases in the value and geographic
concentration of insured property and the effects of inflation
could increase the severity of claims from catastrophic events
in the future.
Consistent with industry practices, we establish reserves for
claim liabilities arising from a catastrophe only after
assessing the probable losses arising from the event. We cannot
be certain that the reserves we have established will be
adequate to cover actual claim liabilities. From time to time,
states have passed legislation that has the effect of limiting
the ability of insurers to manage risk, such as legislation
restricting an insurers ability to withdraw from
catastrophe-prone areas. While we attempt to limit our exposure
to acceptable levels, subject to restrictions imposed by
insurance regulatory authorities, a catastrophic event or
multiple catastrophic events could have a material adverse
effect on our business, results of operations and financial
condition.
Our ability to manage this risk and the profitability of our
property and casualty and life insurance businesses depends in
part on our ability to obtain catastrophe reinsurance, which may
not be available at commercially acceptable rates in the future.
See Risks Relating to Our Business Reinsurance
May Not Be Available, Affordable or Adequate to Protect Us
Against Losses.
|
|
|
A Downgrade or a Potential Downgrade in Our Financial
Strength or Credit Ratings Could Result in a Loss of Business
and Adversely Affect Our Financial Condition and Results of
Operations |
Financial strength ratings, which various Nationally Recognized
Statistical Rating Organizations (NRSROs) publish as
indicators of an insurance companys ability to meet
contractholder and policyholder obligations, are important to
maintaining public confidence in our products, the ability to
market our products and our competitive position. Metropolitan
Life Insurance Company, our principal life insurance subsidiary,
has a financial strength rating of A+ from A.M. Best
Company, AA from Fitch Ratings, Aa2 from Moodys Investors
Service and AA from Standard & Poors.
A downgrade in our insurance subsidiaries financial
strength ratings, or an announced potential for a downgrade,
could have a material adverse effect on our financial condition
and results of operations in many ways, including:
|
|
|
|
|
reducing new sales of insurance products, annuities and other
investment products; |
|
|
|
adversely affecting our relationships with our sales force and
independent sales intermediaries; |
|
|
|
materially increasing the number or amount of policy surrenders
and withdrawals by contractholders and policyholders; |
|
|
|
requiring us to reduce prices for many of our products and
services to remain competitive; and |
|
|
|
adversely affecting our ability to obtain reinsurance at
reasonable prices or at all. |
In addition to the financial strength ratings of our insurance
subsidiaries, NRSROs also publish credit ratings for our
company. A downgrade in our credit ratings could increase our
cost of borrowing, which could have a material adverse effect on
our financial condition and results of operations.
Following the announcement of the Acquisition, a number of
NRSROs, including Moodys Investors Service, Standard &
Poors and A.M. Best Company, placed our ratings on
credit watch or changed our rating outlook from
stable to negative. We do not expect
these NRSROs to remove our ratings from credit watch
or return our outlook to stable until we have
established, to their satisfaction, a successful track record in
integrating the Citigroup L&A business and we have
reduced our financial leverage and increased our interest
coverage to levels closer to those which existed prior to the
Acquisition.
As a result of the additional securities that we plan to issue
to finance a portion of the purchase price for the Acquisition,
we estimate that our leverage ratio will increase moderately.
While we expect our leverage ratio to decrease over time as a
result of the accumulation of retained earnings, there is no
assurance that it will decrease as we expect. The increased
leverage will reduce our flexibility in managing our capital.
S-19
Rating agencies assign ratings based upon several factors, some
of which relate to general economic conditions and circumstances
outside of our control. In addition, rating agencies may employ
different models and formulas to assess our financial strength,
and may alter these models from time to time in their
discretion. We cannot predict what actions rating agencies may
take, or what actions we may be required to take in response to
the actions of rating agencies, which could adversely affect our
business.
|
|
|
Defaults, Downgrades or Other Events Impairing the Value
of Our Fixed Maturity Securities Portfolio May Reduce Our
Earnings |
We are subject to the risk that the issuers of the fixed
maturity securities we own may default on principal and interest
payments they owe us. At March 31, 2005, the fixed maturity
securities of $182.7 billion in our investment portfolio
represented 74.6% of our total cash and invested assets. The
occurrence of a major economic downturn, acts of corporate
malfeasance or other events that adversely affect the issuers of
these securities could cause the value of our fixed maturities
portfolio and our net earnings to decline and the default rate
of the fixed maturity securities in our investment portfolio to
increase. A ratings downgrade affecting particular issuers or
securities could also have a similar effect. With recent
downgrades in the automotive sector, as well as economic
uncertainty and increasing interest rates, credit quality of
issuers could be adversely affected. Any event reducing the
value of these securities other than on a temporary basis could
have a material adverse effect on our business, results of
operations and financial condition.
|
|
|
Defaults on Our Mortgage and Consumer Loans May Adversely
Affect Our Profitability |
Our mortgage and consumer loan investments face default risk.
Our mortgage and consumer loans are principally collateralized
by commercial, agricultural and residential properties, as well
as automobiles. At March 31, 2005, our mortgage and
consumer loan investments of $32.0 billion represented
13.1% of our total cash and invested assets. At March 31,
2005, loans that were either delinquent or in the process of
foreclosure totaled less than 1% of our mortgage and consumer
loan investments. The performance of our mortgage and consumer
loan investments, however, may fluctuate in the future. In
addition, substantially all of our mortgage loan investments
have balloon payment maturities. An increase in the default rate
of our mortgage and consumer loan investments could have a
material adverse effect on our business, results of operations
and financial condition.
|
|
|
Some of Our Investments Are Relatively Illiquid |
Our investments in private placement bonds, mortgage and
consumer loans, equity real estate, including real estate joint
ventures and other limited partnership interests, are relatively
illiquid. These asset classes represented 24.7% of the carrying
value of our total cash and invested assets as of March 31,
2005. If we require significant amounts of cash on short notice
in excess of our normal cash requirements, we may have
difficulty selling these investments in a timely manner, be
forced to sell them for less than we otherwise would have been
able to realize, or both.
|
|
|
Fluctuations in Foreign Currency Exchange Rates and
Foreign Securities Markets Could Negatively Affect Our
Profitability |
We are exposed to risks associated with fluctuations in foreign
currency exchange rates against the U.S. dollar resulting
from our holdings of non-U.S. dollar denominated securities
and investments in foreign subsidiaries. The principal
currencies which create foreign exchange rate risk in our
investment portfolios are Canadian dollars, Euros, British
pounds, Japanese yen and Chilean pesos. If the currencies of the
non-U.S. dollar denominated securities we hold in our
investment portfolios decline against the U.S. dollar, our
investment returns, and thus our profitability, may be adversely
affected. Although we use foreign currency swaps and forward
contracts to mitigate foreign currency exchange rate risk, there
is no assurance that these methods will be effective or that our
counterparties will perform their obligations.
From time to time, various emerging market countries have
experienced severe economic and financial disruptions, including
significant devaluations of their currencies. Our exposure to
foreign exchange rate risk is exacerbated by our investments in
emerging markets.
S-20
Through our investments in foreign subsidiaries, we are
primarily exposed to the Canadian dollar, the Mexican peso and
the Chilean peso. We have matched substantially all of our
foreign currency liabilities in our foreign subsidiaries with
their respective foreign currency assets, which limits the
effect of currency exchange rate fluctuation on local operating
results; however, fluctuations in such rates affect the
translation of these results into our consolidated financial
statements. Although we take certain actions to address this
risk, foreign currency exchange rate fluctuation could
materially adversely affect our reported results due to unhedged
positions or the failure of our hedges to effectively offset the
impact of the foreign currency exchange rate fluctuation.
|
|
|
Our International Operations Face Political, Legal,
Operational and Other Risks That Could Negatively Affect Those
Operations or Our Profitability |
Our international operations face political, legal, operational
and other risks that we do not face in our domestic operations.
We face the risk of discriminatory regulation, nationalization
or expropriation of assets, price controls and exchange controls
or other restrictions that prevent us from transferring funds
from these operations out of the countries in which they operate
or converting local currencies we hold into U.S. dollars or
other currencies. Some of our foreign insurance operations are,
and are likely to continue to be, in emerging markets where
these risks are heightened. In addition, we rely on local sales
forces in these countries and may encounter labor problems
resulting from workers associations and trade unions in
some countries. If our business model is not successful in a
particular country, we may lose all or most of our investment in
building and training the sales force in that country.
We are currently planning to expand our international operations
in markets where we operate and in selected new markets. This
may require considerable management time, as well as start-up
expenses for market development before any significant revenues
and earnings are generated. Operations in new foreign markets
may achieve low margins or may be unprofitable, and expansion in
existing markets may be affected by local economic and market
conditions. Therefore, as we expand internationally, we may not
achieve the operating margins we expect and our results of
operations may be negatively impacted.
The Citigroup L&A business includes operations in
several foreign countries, including Australia, Brazil,
Argentina, the United Kingdom, Belgium, Poland, Japan and
Hong Kong. Those operations, and operations in other new
markets, are subject to the risks described above, as well as
our unfamiliarity with the business, legal and regulatory
environment in any of those countries.
In recent years, the operating environment in Argentina has been
challenging. In Argentina, both we and Citigroup L&A
are principally engaged in the pension business. This business
has incurred significant losses in recent years as a result of
actions taken by the Argentinean government in response to a
sovereign debt crisis in December 2001. Further governmental or
legal actions related to pension reform could impact our
obligations to our customers and could result in future losses
in our combined Argentinean operations. The Acquisition will
increase our exposure to such potential losses. For certain
liabilities which will be established upon our acquisition of
the Citigroup L&A Argentina operations, see pro forma
adjustment 3(ff) in Unaudited Pro Forma Condensed
Consolidated Financial Information.
|
|
|
Reinsurance May Not Be Available, Affordable or Adequate
to Protect Us Against Losses |
As part of our overall risk and capacity management strategy, we
purchase reinsurance for certain risks underwritten by our
various business segments. For example, MetLife currently
reinsures up to 90% of the mortality risk for all new individual
life insurance policies that it writes through its various
insurance companies. Market conditions beyond our control
determine the availability and cost of the reinsurance
protection we purchase. Any decrease in the amount of our
reinsurance will increase our risk of loss and any increase in
the cost of our reinsurance will, absent a decrease in the
amount of reinsurance, reduce our earnings. Accordingly, we may
be forced to incur additional expenses for reinsurance or may
not be able to obtain sufficient reinsurance on acceptable
terms, which could adversely affect our ability to write future
business or result in our assuming more risk with respect to
those policies we issue.
S-21
As a result of consolidation of the life reinsurance market and
other market factors, capacity in the life reinsurance market
has decreased. Further, life reinsurance is currently available
at higher prices and on less favorable terms than those
prevailing between 1997 and 2003. It is likely that this trend
will continue, although we cannot predict to what extent.
Further consolidation, regulatory developments, catastrophic
events or other significant developments affecting the pricing
and availability of reinsurance could materially harm the
reinsurance market and our ability to enter into reinsurance
contracts.
|
|
|
If the Counterparties to Our Reinsurance Arrangements or
to the Derivative Instruments We Use to Hedge Our Business Risks
Default or Fail to Perform, We May Be Exposed to Risks We Had
Sought to Mitigate, Which Could Materially Adversely Affect Our
Financial Condition and Results of Operations |
We use reinsurance and derivative instruments to mitigate our
risks in various circumstances. Reinsurance does not relieve us
of our direct liability to our policyholders, even when the
reinsurer is liable to us. Accordingly, we bear credit risk with
respect to our reinsurers. We cannot assure you that our
reinsurers will pay the reinsurance recoverables owed to us now
or in the future or that they will pay these recoverables on a
timely basis. A reinsurers insolvency, inability or
unwillingness to make payments under the terms of its
reinsurance agreement with us could have a material adverse
effect on our financial condition and results of operations.
In addition, we use derivative instruments to hedge various
business risks. We enter into a variety of derivative
instruments, including options, forwards, interest rate and
currency swaps and options to enter into interest rate and
currency swaps with a number of counterparties. If our
counterparties fail or refuse to honor their obligations under
these derivative instruments, our hedges of the related risk
will be ineffective. Such failure could have a material adverse
effect on our financial condition and results of operations.
|
|
|
Our Insurance Businesses Are Heavily Regulated, and
Changes in Regulation May Reduce Our Profitability and
Limit Our Growth |
Our insurance operations are subject to a wide variety of
insurance and other laws and regulations. State insurance laws
regulate most aspects of our U.S. insurance businesses, and
our insurance subsidiaries are regulated by the insurance
departments of the states in which they are domiciled and the
states in which they are licensed. Our non-U.S. insurance
operations are principally regulated by insurance regulatory
authorities in the jurisdictions in which they are domiciled and
operate.
State laws in the United States grant insurance regulatory
authorities broad administrative powers with respect to, among
other things:
|
|
|
|
|
licensing companies and agents to transact business; |
|
|
|
calculating the value of assets to determine compliance with
statutory requirements; |
|
|
|
mandating certain insurance benefits; |
|
|
|
regulating certain premium rates; |
|
|
|
reviewing and approving policy forms; |
|
|
|
regulating unfair trade and claims practices, including through
the imposition of restrictions on marketing and sales practices,
distribution arrangements and payment of inducements; |
|
|
|
regulating advertising; |
|
|
|
protecting privacy; |
|
|
|
establishing statutory capital and reserve requirements and
solvency standards; |
|
|
|
fixing maximum interest rates on insurance policy loans and
minimum rates for guaranteed crediting rates on life insurance
policies and annuity contracts; |
|
|
|
approving changes in control of insurance companies; |
S-22
|
|
|
|
|
restricting the payment of dividends and other transactions
between affiliates; and |
|
|
|
regulating the types, amounts and valuation of investments. |
State insurance guaranty associations have the right to assess
insurance companies doing business in their state for funds to
help pay the obligations of insolvent insurance companies to
policyholders and claimants. Because the amount and timing of an
assessment is beyond our control, the reserves that we have
currently established for these potential liabilities may not be
adequate.
State insurance regulators and the National Association of
Insurance Commissioners, or NAIC, regularly re-examine existing
laws and regulations applicable to insurance companies and their
products. Changes in these laws and regulations, or in
interpretations thereof, are often made for the benefit of the
consumer at the expense of the insurer and, thus, could have a
material adverse effect on our financial condition and results
of operations.
The NAIC and several states have recently proposed regulations
and/or laws that would prohibit agent or broker practices that
have been the focus of recent investigations of broker
compensation in the State of New York and elsewhere. The NAIC
has adopted a Compensation Disclosure Amendment to its Producers
Licensing Model Act which, if adopted by the states, would
require disclosure by agents or brokers to customers that
insurers will compensate such agents or brokers for the
placement of insurance and documented acknowledgement of this
arrangement in cases where the customer also compensates the
agent or broker. Some larger states, including California and
New York, are considering additional provisions that would
require the disclosure of the amount of compensation and/or
require (where an agent or broker represents more than one
insurer) placement of the best coverage. We cannot
predict how many states, if any, may promulgate the NAIC
amendment or similar regulations or the extent to which these
regulations may have a material adverse impact on our business.
Currently, the U.S. federal government does not directly
regulate the business of insurance. However, federal legislation
and administrative policies in several areas can significantly
and adversely affect insurance companies. These areas include
financial services regulation, securities regulation, pension
regulation, privacy, tort reform legislation and taxation. In
addition, various forms of direct federal regulation of
insurance have been proposed. These proposals include The
State Modernization and Regulatory Transparency Act, which
would maintain state-based regulation of insurance, but would
affect state regulation of certain aspects of the business of
insurance, including rates, agent and company licensing and
market conduct examinations. We cannot predict whether this or
other proposals will be adopted, or what impact, if any, such
proposals or, if enacted, such laws, could have on our business,
financial condition or results of operations.
Our international operations are subject to regulation in the
jurisdictions in which they operate, which in many ways is
similar to that of the state regulation outlined above. Many of
our customers and independent sales intermediaries also operate
in regulated environments. Changes in the regulations that
affect their operations also may affect our business
relationships with them and their ability to purchase or
distribute our products. Accordingly, these changes could have a
material adverse effect on our financial condition and results
of operations. Compliance with applicable laws and regulations
is time consuming and personnel-intensive, and changes in these
laws and regulations may materially increase our direct and
indirect compliance and other expenses of doing business, thus
having a material adverse effect on our financial condition and
results of operations.
From time to time, regulators raise issues during examinations
or audits of our subsidiaries that could, if determined
adversely, have a material impact on us. We cannot predict
whether or when regulatory actions may be taken that could
adversely affect our operations. In addition, the
interpretations of regulations by regulators may change and
statutes may be enacted with retroactive impact, particularly in
areas such as accounting or reserve requirements.
S-23
|
|
|
Legal and Regulatory Investigations and Actions Are
Increasingly Common in the Insurance Business and May Result in
Financial Losses and Harm our Reputation |
We face a significant risk of litigation and regulatory
investigations and actions in the ordinary course of operating
our businesses, including the risk of class action lawsuits. Our
pending legal and regulatory actions include proceedings
specific to us and others generally applicable to business
practices in the industries in which we operate. In connection
with our insurance operations, plaintiffs lawyers may
bring or are bringing class actions and individual suits
alleging, among other things, issues relating to sales or
underwriting practices, claims payments and procedures, product
design, disclosure, administration, additional premium charges
for premiums paid on a periodic basis, denial or delay of
benefits and breaches of fiduciary or other duties to customers.
Plaintiffs in class action and other lawsuits against us may
seek very large or indeterminate amounts, including punitive and
treble damages, and the damages claimed and the amount of any
probable and estimable liability, if any, may remain unknown for
substantial periods of time.
Due to the vagaries of litigation, the outcome of a litigation
matter and the amount or range of potential loss at particular
points in time may normally be inherently impossible to
ascertain with any degree of certainty. Estimates of possible
additional losses or ranges of loss for particular matters
cannot in the ordinary course be made with a reasonable degree
of certainty. Liabilities are established when it is probable
that a loss has been incurred and the amount of the loss can be
reasonably estimated. It is possible that some of the matters
could require MetLife, Inc. to pay damages or make other
expenditures or establish accruals in amounts that could not be
estimated as of a balance sheet date.
Metropolitan Life and its affiliates are currently defendants in
approximately 450 lawsuits raising allegations of improper
marketing and sales of individual life insurance policies or
annuities. These lawsuits are generally referred to as
sales practices claims. Metropolitan Life is also a
defendant in numerous lawsuits seeking compensatory and punitive
damages for personal injuries allegedly caused by exposure to
asbestos or asbestos-containing products. These lawsuits are
principally based upon allegations relating to certain research,
publication and other activities of one or more of Metropolitan
Lifes employees during the period from the 1920s
through approximately the 1950s and have alleged that
Metropolitan Life learned or should have learned of certain
health risks posed by asbestos and, among other things,
improperly publicized or failed to disclose those health risks.
Additional litigation relating to these matters may be commenced
in the future. The ability of MetLife to estimate its ultimate
asbestos exposure is subject to considerable uncertainty due to
numerous factors. The availability of data is limited and it is
difficult to predict with any certainty numerous variables that
can affect liability estimates, including the number of future
claims, the cost to resolve claims, the disease mix and severity
of disease, the jurisdiction of claims filed, tort reform
efforts and the impact of any possible future adverse verdicts
and their amounts. The number of asbestos cases that may be
brought or the aggregate amount of any liability that MetLife
may ultimately incur is uncertain. Accordingly, it is reasonably
possible that MetLifes total exposure to asbestos claims
may be greater than the liability recorded by MetLife in its
financial statements and that future charges to income may be
necessary. The potential future charges could be material in
particular quarterly or annual periods in which they are
recorded. In addition, Metropolitan Life has been named as a
defendant in lawsuits relating to claims of possible
race-conscious underwriting of life insurance, and it and
MetLife, Inc. have been named as defendants in several lawsuits
brought in connection with Metropolitan Lifes
demutualization in 2000.
We are also subject to various regulatory inquiries, such as
information requests, subpoenas and books and record
examinations, from state and federal regulators and other
authorities. A substantial legal liability or a significant
regulatory action against us could have a material adverse
effect on our business, financial condition and results of
operations. Moreover, even if we ultimately prevail in the
litigation, regulatory action or investigation, we could suffer
significant reputational harm, which could have a material
adverse effect on our business, financial condition and results
of operations, including our ability to attract new customers,
retain our current customers and recruit and retain employees.
Regulatory inquiries may cause increased volatility in the price
of stocks of companies in our industry.
Recently, the insurance industry has become the focus of
increased scrutiny by regulatory and law enforcement authorities
concerning certain practices within the insurance industry. This
scrutiny includes the
S-24
commencement of investigations and other proceedings by the New
York State Attorney General and other governmental authorities
relating to allegations of improper conduct in connection with
the payment of, and disclosure with respect to, contingent
commissions paid by insurance companies to intermediaries, the
solicitation and provision of fictitious or inflated quotes, the
use of inducements to brokers or companies in the sale of
insurance products and the accounting treatment for finite
insurance and reinsurance or other non-traditional or loss
mitigation insurance and reinsurance products.
One possible result of these investigations and attendant
lawsuits is that many insurance industry practices and customs
may change, including, but not limited to, the manner in which
insurance is marketed and distributed through independent
brokers and agents. Our business strategy contemplates that we
will rely heavily on both intermediaries our internal sales
force to market and distribute insurance products. We cannot
predict how industry regulation with respect to the use of
intermediaries may change. Such changes, however, could
adversely affect our ability to implement our business strategy,
which could materially affect our growth and profitability.
Recent industry-wide inquiries also include those regarding
market timing and late trading in mutual funds and variable
annuity contracts, variable annuity sales practices/exchanges
and electronic communication document retention practices. The
Securities and Exchange Commission (the SEC) has
commenced an investigation with respect to market timing and
late trading in a limited number of privately-placed variable
insurance contracts that were sold through our subsidiary,
General American Life Insurance Company (General
American). In May 2004, General American received a so
called Wells Notice stating that the SEC staff is
considering recommending that the SEC bring a civil action
alleging violations of the U.S. securities laws against
General American. General American has responded to the Wells
Notice, and we are fully cooperating with the SEC with regard to
this investigation. TIC has also received inquiries regarding
market timing and other matters from the SEC. In addition, new
laws and regulations have been enacted affecting the mutual fund
industry generally, and it is difficult to predict at this time
whether changes resulting from those new laws and regulations
will affect our business and, if so, to what degree.
Other recent industry-wide inquiries include those relating to
finite insurance and reinsurance. On May 23, 2005, we
received a subpoena from the Office of the Attorney General of
the State of Connecticut requesting information regarding our
participation in any finite reinsurance transactions. We have
also received information requests relating to finite insurance
or reinsurance from other regulatory and governmental entities.
We believe we have appropriately accounted for these
transactions and intend to cooperate fully with these
information requests. We believe that a number of other industry
participants have received similar requests from various
regulatory and investigative authorities. It is reasonably
possible that we may receive additional requests. We will fully
cooperate with all such requests.
The Citigroup L&A business is also subject to risk of
litigation and regulatory investigations and actions in the
ordinary course of operations similar to the risks described
above. The legal and regulatory actions pending against the
Citigroup L&A business include proceedings, including those
specified below, specific to the Citigroup L&A business and
others generally applicable to business practices in the
industries in which the Citigroup L&A business operates,
many of which are the same industries in which we operate. TIC
and certain of its affiliates are defendants in a nationwide
class action which was certified by the Connecticut Superior
Court on May 26, 2004. The class action complaint claims
that TIC and certain of its affiliates are in violation of the
Connecticut Unfair Trade Practice Statute, and asserts unjust
enrichment and civil conspiracy claims. The complaint alleges
that Travelers Property Casualty Corporation, TICs former
affiliate and also a defendant in the class action, purchased a
lower amount of structured settlement annuities from TIC than
agreed with claimants, and that commissions paid to brokers of
structured settlement annuities, including a TIC affiliate, were
paid, in part, to Travelers Property Casualty Corporation. On
June 15, 2004, TIC and certain of its affiliates appealed
the Connecticut Superior Courts May 26, 2004 class
certification order. TIC has been sued in a number of asbestos
related claims, vigorously defends itself in these matters and
seeks indemnification with respect to these claims from its
former affiliates. Other claims may be brought against TIC with
respect to its historical business operations.
S-25
We cannot assure you that current claims, litigation, unasserted
claims probable of assertion, investigations and other
proceedings against us or the Citigroup L&A business will
not have a material adverse effect on our business, financial
condition or results of operations. It is also possible that
related or unrelated claims, litigation, unasserted claims
probable of assertion, investigations and proceedings may be
commenced in the future, and we could become subject to further
investigations and have lawsuits filed or enforcement actions
initiated against us. In addition, increased regulatory scrutiny
and any resulting investigations or proceedings could result in
new legal actions and precedents and industry-wide regulations
that could adversely affect our business, financial condition
and results of operation. For further details regarding the
litigation in which we are involved, see Note 5 to
MetLifes interim condensed consolidated financial
statements included in our Form 10-Q for the three months
ended March 31, 2005, filed on May 6, 2005, and our
Form 8-K filed on May 27, 2005, both incorporated by
reference in the accompanying prospectus. For further details
regarding the litigation in which the Citigroup L&A business
is involved, see our Form 8-K filed on May 13, 2005,
which is incorporated by reference in the accompanying
prospectus.
|
|
|
Changes in U.S. Federal and State Securities Laws May
Affect Our Operations and Our Profitability |
U.S. federal and state securities laws apply to investment
products that are also securities, including
variable annuities and variable life insurance policies. As a
result, some of our subsidiaries and the policies and contracts
they offer are subject to regulation under these federal and
state securities laws. Our insurance subsidiaries separate
accounts are registered as investment companies under the
Investment Company Act of 1940, as amended. Some variable
annuity contracts and variable life insurance policies issued by
our insurance subsidiaries also are registered under the
Securities Act of 1933, as amended (the Securities
Act). Other subsidiaries are registered as broker-dealers
under the Securities Exchange Act of 1934, as amended, and are
members of, and subject to, regulation by the National
Association of Securities Dealers, Inc. In addition, some of our
subsidiaries also are registered as investment advisers under
the Investment Advisers Act of 1940, as amended.
Securities laws and regulations are primarily intended to ensure
the integrity of the financial markets and to protect investors
in the securities markets or investment advisory or brokerage
clients. These laws and regulations generally grant supervisory
agencies broad administrative powers, including the power to
limit or restrict the conduct of business for failure to comply
with those laws and regulations. Changes to these laws or
regulations that restrict the conduct of our business could have
a material adverse effect on our financial condition and results
of operations.
|
|
|
Changes in Tax Laws Could Make Some of Our Products Less
Attractive to Consumers |
Changes in tax laws could make some of our products less
attractive to consumers. For example, reductions in the federal
income tax that investors are required to pay on long-term
capital gains and on some dividends paid on stock may provide an
incentive for some of our customers and potential customers to
shift assets into mutual funds and away from products, including
life insurance and annuities, designed to defer taxes payable on
investment returns. Because the income taxes payable on
long-term capital gains and some dividends paid on stock have
been reduced, investors may decide that the tax-deferral
benefits of annuity contracts are less advantageous than the
potential after-tax income benefits of mutual funds or other
investment products that provide dividends and long-term capital
gains. A shift away from life insurance and annuity contracts
and other tax-deferred products would reduce our income from
sales of these products, as well as the assets upon which we
earn investment income.
We cannot predict whether any other legislation will be enacted,
what the specific terms of any such legislation will be or how,
if at all, this legislation or any other legislation could have
a material adverse effect on our financial condition and results
of operations.
S-26
|
|
|
As a Holding Company, We Depend on the Ability of Our
Subsidiaries to Transfer Funds to Us to Pay Dividends and Meet
Our Obligations |
We are a holding company for our insurance and financial
subsidiaries and do not have any significant operations of our
own. Dividends from our subsidiaries and permitted payments to
us under our tax sharing arrangements with our subsidiaries are
our principal sources of cash to pay stockholder dividends and
to meet our obligations. If the cash we receive from our
subsidiaries is insufficient for us to fund our debt and other
holding company obligations, we may be required to raise cash
through the incurrence of debt, the issuance of additional
equity or the sale of assets.
The payment of dividends and other distributions to us by our
insurance subsidiaries is regulated by insurance laws and
regulations. In general, dividends in excess of prescribed
limits are deemed extraordinary and require
insurance regulatory approval. In addition, insurance regulators
may prohibit the payment of ordinary dividends or other payments
by our insurance subsidiaries to us if they determine that the
payment could be adverse to our policyholders or
contractholders. As a result of certain restructuring
transactions by Citigroup prior to the closing, all dividends
paid by TIC during the first year following the Acquisition
would be deemed extraordinary. It is possible that
TIC and its subsidiary, The Travelers Life and Annuity Company,
may be subject to additional restrictions imposed by Connecticut
law or the Connecticut Department of Insurance on their ability
to pay dividends to us after the Acquisition.
During the years ended December 31, 2004, 2003 and 2002, we
received dividends from our domestic insurance subsidiaries of
$1,162 million ($300 million of which were deemed
extraordinary), $1,721 million
($844 million of which were deemed
extraordinary) and $929 million
($369 million of which were deemed
extraordinary), respectively. Based on statutory
results as of December 31, 2004, our insurance subsidiaries
could pay dividends of approximately $1,186 million to us
in 2005 without obtaining regulatory approval. Metropolitan Life
and Metropolitan Tower Life Insurance Company recently paid
dividends to us in the aggregate amount of $4.1 billion
(approximately $3.2 billion of which were deemed
extraordinary). As a result of these dividends, any
further dividend from Metropolitan Life during 2005 will require
prior approval from the New York Insurance Department and any
further dividend from Metropolitan Tower Life Insurance Company
will require prior approval from the Delaware Department of
Insurance until the end of 2005 and may require prior approval
until the end of May 2006.
Any payment of interest, dividends, distributions, loans or
advances by our subsidiaries to us could be subject to taxation
or other restrictions on dividends or repatriation of earnings
under applicable law, monetary transfer restrictions and foreign
currency exchange regulations in the jurisdiction in which our
foreign subsidiaries operate.
|
|
|
We May Need to Fund Deficiencies in Our Closed Block;
Assets Allocated to the Closed Block Benefit Only the Holders of
Closed Block Policies |
The plan of reorganization entered into in connection with
MetLifes 2000 demutualization required that we
establish and operate an accounting mechanism, known as a closed
block, to ensure that the reasonable dividend expectations of
policyholders who own certain individual insurance policies of
MetLife are met. We allocated assets to the closed block in an
amount that will produce cash flows which, together with
anticipated revenue from the policies included in the closed
block, are reasonably expected to be sufficient to support
obligations and liabilities relating to these policies,
including, but not limited to, provisions for the payment of
claims and certain expenses and taxes, and to provide for the
continuation of the policyholder dividend scales in effect for
1999, if the experience underlying such scales continues, and
for appropriate adjustments in such scales if the experience
changes. We cannot assure that the closed block assets, the cash
flows generated by the closed block assets and the anticipated
revenue from the policies included in the closed block will be
sufficient to provide for the benefits guaranteed under these
policies. If they are not sufficient, we must fund the
shortfall. Even if they are sufficient, we may choose, for
competitive reasons, to support policyholder dividend payments
with our general account funds.
The closed block assets, the cash flows generated by the closed
block assets and the anticipated revenue from the policies in
the closed block will benefit only the holders of those
policies. In addition, to the extent
S-27
that these amounts are greater than the amounts estimated at the
time the closed block was funded, dividends payable in respect
of the policies included in the closed block may be greater than
they would be in the absence of a closed block. Any excess
earnings will be available for distribution over time only to
closed block policyholders.
|
|
|
The Continued Threat of Terrorism and Ongoing Military
Actions May Adversely Affect the Level of Claim Losses We Incur
and the Value of Our Investment Portfolio |
The continued threat of terrorism, both within the United States
and abroad, ongoing military and other actions and heightened
security measures in response to these types of threats may
cause significant volatility in global financial markets and
result in loss of life, property damage, additional disruptions
to commerce and reduced economic activity. Some of the assets in
our investment portfolio may be adversely affected by declines
in the equity markets and reduced economic activity caused by
the continued threat of terrorism. We cannot predict whether,
and the extent to which, companies in which we maintain
investments may suffer losses as a result of financial,
commercial or economic disruptions, or how any such disruptions
might affect the ability of those companies to pay interest or
principal on their securities. The continued threat of terrorism
also could result in increased reinsurance prices and reduced
insurance coverage and potentially cause us to retain more risk
than we otherwise would retain if we were able to obtain
reinsurance at lower prices. Terrorist actions also could
disrupt our operations centers in the United States or abroad.
In addition, the occurrence of terrorist actions could result in
higher claims under our insurance policies than we had
anticipated.
|
|
|
The Occurrence of Events Unanticipated In Our Disaster
Recovery Systems and Management Continuity Planning Could Impair
Our Ability to Conduct Business Effectively |
In the event of a disaster such as a natural catastrophe, an
industrial accident, a blackout, a computer virus, a terrorist
attack or war, unanticipated problems with our disaster recovery
systems could have a material adverse impact on our ability to
conduct business and on our results of operations and financial
condition, particularly if those problems affect our
computer-based data processing, transmission, storage and
retrieval systems and destroy valuable data. Despite our
implementation of network security measures, our servers could
be subject to physical and electronic break-ins, and similar
disruptions from unauthorized tampering with our computer
systems. In addition, in the event that a significant number of
our managers were unavailable in the event of a disaster, our
ability to effectively conduct our business could be severely
compromised.
|
|
|
We Face Unforeseen Liabilities Arising from Other Possible
Acquisitions and Dispositions of Businesses |
We have engaged in numerous dispositions and acquisitions of
businesses in the past, and expect to continue to do so in the
future. There could be unforeseen liabilities that arise in
connection with the businesses that we may sell or the
businesses that we may acquire in the future. In addition, there
may be liabilities that we fail, or are unable, to discover in
the course of performing due diligence investigations on each
business that we have acquired or may acquire.
Risks Relating to the Series A Preferred Shares
|
|
|
General Market Conditions and Unpredictable Factors Could
Adversely Affect Market Prices for the Series A Preferred
Shares |
There can be no assurance about the market prices for the
series A preferred shares. Several factors, many of which
are beyond MetLife, Inc.s control, will influence the
market value of the series A preferred shares. Factors that
might influence the market value of the series A preferred
shares include:
|
|
|
|
|
whether dividends have been declared and are likely to be
declared on the series A preferred shares from time to time; |
|
|
|
MetLife, Inc.s creditworthiness; |
|
|
|
the market for similar securities; and |
S-28
|
|
|
|
|
economic, financial, geopolitical, regulatory or judicial events
that affect MetLife, Inc. or the financial markets generally. |
Accordingly, if you purchase series A preferred shares,
whether in this offering or in the secondary market, the
series A preferred shares may trade at a discount to the
price that you paid for them.
|
|
|
The Series A Preferred Shares Are Equity and Are
Subordinate to MetLife, Inc.s Existing and Future
Indebtedness |
The series A preferred shares are equity interests in
MetLife, Inc. and do not constitute indebtedness. As such, the
series A preferred shares will rank junior to all
indebtedness and other non-equity claims on MetLife, Inc. with
respect to assets available to satisfy claims on MetLife, Inc.,
including in a liquidation of MetLife, Inc. MetLife, Inc.s
existing and future indebtedness may restrict payments of
dividends on the series A preferred shares. Additionally,
unlike indebtedness, where principal and interest would
customarily be payable on specified due dates, in the case of
preferred stock like the series A preferred shares
(1) dividends are payable only if declared by MetLife,
Inc.s board of directors (or a duly authorized committee
of the board) and (2) as a corporation, MetLife, Inc. is
subject to restrictions on payments of dividends and redemption
price out of lawfully available funds.
|
|
|
Dividends on the Series A Preferred Shares Are
Non-Cumulative |
Dividends on the series A preferred shares are
non-cumulative. Consequently, if MetLife, Inc.s board of
directors (or a duly authorized committee of the board) does not
authorize and declare a dividend for any dividend period,
holders of the series A preferred shares would not be
entitled to receive any such dividend, and such unpaid dividend
will cease to accrue and be payable. MetLife, Inc. will have no
obligation to pay dividends accrued for a dividend period after
the dividend payment date for such period if MetLife,
Inc.s board of directors (or a duly authorized committee
of the board) has not declared such dividend before the related
dividend payment date, whether or not dividends are declared for
any subsequent dividend period with respect to the series A
preferred shares or any other preferred stock MetLife, Inc. may
issue.
|
|
|
Banking Regulations May Restrict MetLife, Inc.s
Ability to Pay Dividends |
MetLife, Inc. may not be able to pay dividends in the future if
it does not earn sufficient operating income or meet specified
capital adequacy requirements.
MetLife, Inc. is a bank holding company registered with, and
subject to the examination of, the Federal Reserve Board as a
result of the companys ownership of MetLife Bank, N.A., a
subsidiary bank with total assets of approximately
$4.0 billion as of March 31, 2005. MetLife, Inc. is
also a financial holding company under the
Gramm-Leach-Bliley Act (GLB Act). This status is
important to MetLife, Inc., for it permits MetLife, Inc. to
engage in a broader range of insurance, securities and other
financial activities and investments than is otherwise permitted
to traditional bank holding companies. To maintain such status,
MetLife, Inc.s subsidiary bank must continue to be
well capitalized and well managed under
Federal Reserve Board regulations and must continue to hold a
Satisfactory or better rating under the Community Reinvestment
Act. If these requirements are not met in the future, MetLife,
Inc. would be required to take corrective measures and remedy
the matter, generally within six months, or could be required to
divest the bank.
As a bank holding company, MetLife, Inc. is subject to capital
adequacy requirements established by the Federal Reserve Board.
The companys banking, insurance and securities
subsidiaries are also subject to capital regulations of their
respective functional regulators. Under Federal Reserve Board
policy, a bank holding company is expected to act as a source of
strength to a subsidiary bank and to commit resources to its
support when necessary. It is also the Federal Reserve
Boards policy that dividends by a bank holding company
should be paid only out of current operating income. Both of
these policies may limit MetLife, Inc.s ability to declare
dividends under certain circumstances. Under the GLB Act,
however, the Federal Reserve Board generally cannot impose
capital requirements on regulated insurance and securities
subsidiaries or require them to contribute support to the
holding companys subsidiary bank.
S-29
|
|
|
MetLife, Inc.s Ability to Declare and Pay Dividends
on the Series A Preferred Shares Will Be Limited If It
Fails to Achieve Specified Net Income, Capital Adequacy and
Shareholders Equity Levels |
MetLife, Inc. is prohibited from declaring or paying dividends
on the series A preferred shares in excess of the amount of
net proceeds from an issuance of common stock taking place
within 90 days before a dividend declaration date, if, on
that dividend declaration date, either:
|
|
|
|
|
the risk-based capital ratio of our largest U.S. life
insurance subsidiaries that collectively account for 80% or more
of the general account admitted assets of all of our
U.S. life insurance subsidiaries was less than 175% of the
company action level as of the end of the most recent
year; or |
|
|
|
MetLife, Inc.s consolidated net income for the
four-quarter period ending on the preliminary quarter end test
date (the quarter that is two quarters prior to the most
recently completed quarter) is zero or negative and its
consolidated shareholders equity (minus accumulated other
comprehensive income, and subject to certain other adjustments
relating to changes in GAAP) as of each of the preliminary
quarter test date and the most recently completed quarter has
declined by 10% or more from its level as measured at the end of
the benchmark quarter (the date that is ten quarters prior to
the most recently completed quarter). |
If MetLife, Inc. fails to satisfy either of the above tests on
any dividend declaration date, the restrictions on dividends
will continue until MetLife, Inc. is able again to satisfy both
tests on a dividend declaration date. In addition, in the case
of a restriction arising under the second bullet point above,
the restrictions on dividends will continue until MetLife,
Inc.s consolidated shareholders equity (minus
accumulated other comprehensive income, and subject to certain
other adjustments relating to changes in GAAP) has increased, or
has declined by less than 10%, in either case as compared to its
level at the end of the benchmark quarter for each dividend
payment date as to which dividend restrictions were imposed
under the second bullet point above.
See Description of the Preferred Shares
Restrictions on Declaration and Payment of Dividends for
more information on these restrictions.
|
|
|
The Series A Preferred Shares May Not Have an Active
Trading Market |
The series A preferred shares are a new issue with no
established trading market. Although MetLife, Inc. plans to
apply to have the series A preferred shares listed on the
New York Stock Exchange, there is no guarantee that it will be
able to list the series A preferred shares. Even if the
series A preferred shares are listed, there may be little
or no secondary market for the series A preferred shares.
Even if a secondary market for the series A preferred
shares develops, it may not provide significant liquidity, and
transaction costs in any secondary market could be high. As a
result, the difference between bid and ask prices in any
secondary market could be substantial.
|
|
|
The Voting Rights of Holders of the Series A
Preferred Shares Will Be Limited |
Holders of the series A preferred shares have no voting
rights with respect to matters that generally require the
approval of voting shareholders. The limited voting rights of
holders of the series A preferred shares include the right
to vote as a class on certain fundamental matters that may
affect the preference or special rights of the series A
preferred shares, as described under Description of the
Series A Preferred Shares Voting Rights.
In addition, if dividends on the series A preferred shares
have not been declared or paid for the equivalent of six
dividend payments, whether or not for consecutive dividend
periods, holders of the outstanding series A preferred
shares, together with holders of any other series of MetLife,
Inc.s preferred stock ranking equal with the series A
preferred shares with similar voting rights, will be entitled to
vote for the election of two additional directors, subject to
the terms and to the limited extent described under
Description of the Series A Preferred
Shares Voting Rights.
If holders of the series A preferred shares become entitled
to vote for the election of directors, there is a risk that the
series A preferred shares could be deemed a class of
voting securities. In this instance, certain holders of
specified percentages of series A preferred shares could
then be subject to regulation under the Bank Holding Company Act
as described under Description of the Series A
Preferred Shares Certain Regulatory Issues Related
to Voting Rights.
S-30
SELECTED HISTORICAL CONSOLIDATED FINANCIAL INFORMATION
FOR METLIFE
The following table sets forth selected historical consolidated
financial information for MetLife. The selected historical
consolidated financial information as of and for the years ended
December 31, 2004 and 2003 has been derived from our
audited consolidated financial statements included in our Annual
Report on Form 10-K for the year ended December 31,
2004, the selected historical consolidated financial information
as of and for the year ended December 31, 2002 has been
derived from our audited consolidated financial statements
included in our Annual Report on Form 10-K for the year
ended December 31, 2002, and the selected historical
consolidated financial information as of and for the years ended
December 31, 2001 and 2000 has been derived from our
audited consolidated financial statements included in our Annual
Report on Form 10-K for the year ended December 31,
2001. This selected consolidated financial information should be
read in conjunction with and is qualified by reference to these
financial statements and the related notes. The selected
historical consolidated financial information at and for the
three months ended March 31, 2005 and 2004 has been derived
from the unaudited interim condensed consolidated financial
statements included in our Quarterly Report on Form 10-Q
for the three months ended March 31, 2005. The following
consolidated statements of income and consolidated balance sheet
data have been prepared in conformity with GAAP. Some previously
reported amounts have been reclassified to conform with the
presentation for the three months ended March 31, 2005.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three | |
|
|
|
|
|
|
|
|
|
|
|
|
Months Ended | |
|
|
|
|
March 31, | |
|
For the Year Ended December 31, | |
|
|
| |
|
| |
|
|
2005 | |
|
2004 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Statements of Income Data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$ |
6,002 |
|
|
$ |
5,386 |
|
|
$ |
22,204 |
|
|
$ |
20,576 |
|
|
$ |
19,021 |
|
|
$ |
16,963 |
|
|
$ |
15,999 |
|
|
Universal life and investment-type product policy fees
|
|
|
791 |
|
|
|
663 |
|
|
|
2,868 |
|
|
|
2,496 |
|
|
|
2,147 |
|
|
|
1,889 |
|
|
|
1,820 |
|
|
Net investment income(1)
|
|
|
3,217 |
|
|
|
2,939 |
|
|
|
12,367 |
|
|
|
11,484 |
|
|
|
11,139 |
|
|
|
11,127 |
|
|
|
10,926 |
|
|
Other revenues
|
|
|
299 |
|
|
|
313 |
|
|
|
1,198 |
|
|
|
1,199 |
|
|
|
1,166 |
|
|
|
1,340 |
|
|
|
2,070 |
|
|
Net investment gains (losses)(1)(2)(3)
|
|
|
(15 |
) |
|
|
116 |
|
|
|
175 |
|
|
|
(551 |
) |
|
|
(892 |
) |
|
|
(713 |
) |
|
|
(444 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues(4)(5)(6)
|
|
|
10,294 |
|
|
|
9,417 |
|
|
|
38,812 |
|
|
|
35,204 |
|
|
|
32,581 |
|
|
|
30,606 |
|
|
|
30,371 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
5,962 |
|
|
|
5,475 |
|
|
|
22,666 |
|
|
|
20,812 |
|
|
|
19,456 |
|
|
|
18,330 |
|
|
|
16,764 |
|
|
Interest credited to policyholder account balances
|
|
|
795 |
|
|
|
738 |
|
|
|
2,998 |
|
|
|
3,035 |
|
|
|
2,950 |
|
|
|
3,084 |
|
|
|
2,935 |
|
|
Policyholder dividends
|
|
|
415 |
|
|
|
425 |
|
|
|
1,666 |
|
|
|
1,731 |
|
|
|
1,803 |
|
|
|
1,802 |
|
|
|
1,771 |
|
|
Payments to former Canadian policyholders(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
327 |
|
|
Demutualization costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
230 |
|
|
Other expenses(1)
|
|
|
1,973 |
|
|
|
1,851 |
|
|
|
7,822 |
|
|
|
7,176 |
|
|
|
6,869 |
|
|
|
6,899 |
|
|
|
7,189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses(4)(5)(6)(7)
|
|
|
9,145 |
|
|
|
8,489 |
|
|
|
35,152 |
|
|
|
32,754 |
|
|
|
31,078 |
|
|
|
30,115 |
|
|
|
29,216 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income
taxes
|
|
|
1,149 |
|
|
|
928 |
|
|
|
3,660 |
|
|
|
2,450 |
|
|
|
1,503 |
|
|
|
491 |
|
|
|
1,155 |
|
Provision for income taxes(1)(4)(8)
|
|
|
350 |
|
|
|
290 |
|
|
|
1,030 |
|
|
|
620 |
|
|
|
454 |
|
|
|
177 |
|
|
|
363 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
799 |
|
|
|
638 |
|
|
|
2,630 |
|
|
|
1,830 |
|
|
|
1,049 |
|
|
|
314 |
|
|
|
792 |
|
Income from discontinued operations, net of income taxes(1)(4)
|
|
|
188 |
|
|
|
46 |
|
|
|
214 |
|
|
|
413 |
|
|
|
556 |
|
|
|
159 |
|
|
|
161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before cumulative effect of a change in accounting
|
|
|
987 |
|
|
|
684 |
|
|
|
2,844 |
|
|
|
2,243 |
|
|
|
1,605 |
|
|
|
473 |
|
|
|
953 |
|
Cumulative effect of a change in accounting, net of income taxes
|
|
|
|
|
|
|
(86 |
) |
|
|
(86 |
) |
|
|
(26 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
987 |
|
|
$ |
598 |
|
|
$ |
2,758 |
|
|
$ |
2,217 |
|
|
$ |
1,605 |
|
|
$ |
473 |
|
|
$ |
953 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income after April 7, 2000 (date of demutualization)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At March 31, | |
|
At December 31, | |
|
|
| |
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Balance Sheet Data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General account assets
|
|
$ |
276,885 |
|
|
$ |
270,039 |
|
|
$ |
251,085 |
|
|
$ |
217,733 |
|
|
$ |
194,256 |
|
|
$ |
183,912 |
|
|
Separate account assets
|
|
|
85,786 |
|
|
|
86,769 |
|
|
|
75,756 |
|
|
|
59,693 |
|
|
|
62,714 |
|
|
|
70,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets(4)
|
|
$ |
362,671 |
|
|
$ |
356,808 |
|
|
$ |
326,841 |
|
|
$ |
277,426 |
|
|
$ |
256,970 |
|
|
$ |
254,162 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life and health policyholder liabilities(9)
|
|
$ |
193,251 |
|
|
$ |
190,847 |
|
|
$ |
176,628 |
|
|
$ |
162,569 |
|
|
$ |
148,395 |
|
|
$ |
140,040 |
|
|
Property and casualty policyholder liabilities
|
|
|
3,192 |
|
|
|
3,180 |
|
|
|
2,943 |
|
|
|
2,673 |
|
|
|
2,610 |
|
|
|
2,559 |
|
|
Short-term debt
|
|
|
1,120 |
|
|
|
1,445 |
|
|
|
3,642 |
|
|
|
1,161 |
|
|
|
355 |
|
|
|
1,085 |
|
|
Long-term debt
|
|
|
7,414 |
|
|
|
7,412 |
|
|
|
5,703 |
|
|
|
4,411 |
|
|
|
3,614 |
|
|
|
2,353 |
|
|
Other liabilities
|
|
|
48,870 |
|
|
|
44,331 |
|
|
|
41,020 |
|
|
|
28,269 |
|
|
|
21,964 |
|
|
|
20,396 |
|
|
Separate account liabilities
|
|
|
85,786 |
|
|
|
86,769 |
|
|
|
75,756 |
|
|
|
59,693 |
|
|
|
62,714 |
|
|
|
70,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities(4)
|
|
|
339,633 |
|
|
|
333,984 |
|
|
|
305,692 |
|
|
|
258,776 |
|
|
|
239,652 |
|
|
|
236,683 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company-obligated mandatorily redeemable securities of
subsidiary trusts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,265 |
|
|
|
1,256 |
|
|
|
1,090 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, at par value(10)
|
|
|
8 |
|
|
|
8 |
|
|
|
8 |
|
|
|
8 |
|
|
|
8 |
|
|
|
8 |
|
|
Additional paid-in capital(10)
|
|
|
15,043 |
|
|
|
15,037 |
|
|
|
14,991 |
|
|
|
14,968 |
|
|
|
14,966 |
|
|
|
14,926 |
|
|
Retained earnings(10)
|
|
|
7,595 |
|
|
|
6,608 |
|
|
|
4,193 |
|
|
|
2,807 |
|
|
|
1,349 |
|
|
|
1,021 |
|
|
Treasury stock, at cost(10)
|
|
|
(1,764 |
) |
|
|
(1,785 |
) |
|
|
(835 |
) |
|
|
(2,405 |
) |
|
|
(1,934 |
) |
|
|
(613 |
) |
|
Accumulated other comprehensive income (loss)(10)
|
|
|
2,156 |
|
|
|
2,956 |
|
|
|
2,792 |
|
|
|
2,007 |
|
|
|
1,673 |
|
|
|
1,047 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
23,038 |
|
|
|
22,824 |
|
|
|
21,149 |
|
|
|
17,385 |
|
|
|
16,062 |
|
|
|
16,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$ |
362,671 |
|
|
$ |
356,808 |
|
|
$ |
326,841 |
|
|
$ |
277,426 |
|
|
$ |
256,970 |
|
|
$ |
254,162 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S-32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At or for the Three | |
|
|
|
|
|
|
|
|
|
|
|
|
Months Ended | |
|
|
|
|
March 31, | |
|
At or for the Year Ended December 31, | |
|
|
| |
|
| |
|
|
2005 | |
|
2004 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions, except per share data) | |
Other Data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
987 |
|
|
$ |
598 |
|
|
$ |
2,758 |
|
|
$ |
2,217 |
|
|
$ |
1,605 |
|
|
$ |
473 |
|
|
$ |
953 |
|
|
Return on equity(11)
|
|
|
N/A |
|
|
|
N/A |
|
|
|
12.5 |
% |
|
|
11.5 |
% |
|
|
9.6 |
% |
|
|
2.9 |
% |
|
|
6.3 |
% |
|
Return on equity, excluding accumulated other comprehensive
income
|
|
|
N/A |
|
|
|
N/A |
|
|
|
14.4 |
% |
|
|
13.1 |
% |
|
|
10.8 |
% |
|
|
3.2 |
% |
|
|
6.5 |
% |
|
Total assets under management
|
|
$ |
362,671 |
|
|
$ |
337,013 |
|
|
$ |
356,808 |
|
|
$ |
326,841 |
|
|
$ |
277,426 |
|
|
$ |
256,970 |
|
|
$ |
254,162 |
|
Income from Continuing Operations Available to Common
Shareholders Per Share(12)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
1.09 |
|
|
$ |
0.84 |
|
|
$ |
3.51 |
|
|
$ |
2.45 |
|
|
$ |
1.49 |
|
|
$ |
0.42 |
|
|
$ |
1.39 |
|
|
Diluted
|
|
$ |
1.08 |
|
|
$ |
0.84 |
|
|
$ |
3.48 |
|
|
$ |
2.42 |
|
|
$ |
1.44 |
|
|
$ |
0.41 |
|
|
$ |
1.37 |
|
Income from Discontinued Operations Per Share(12)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
0.25 |
|
|
$ |
0.06 |
|
|
$ |
0.28 |
|
|
$ |
0.57 |
|
|
$ |
0.79 |
|
|
$ |
0.22 |
|
|
$ |
0.13 |
|
|
Diluted
|
|
$ |
0.25 |
|
|
$ |
0.06 |
|
|
$ |
0.28 |
|
|
$ |
0.55 |
|
|
$ |
0.76 |
|
|
$ |
0.21 |
|
|
$ |
0.12 |
|
Cumulative Effect of a Change in Accounting Per Share(12)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
|
|
|
$ |
(0.11 |
) |
|
$ |
(0.11 |
) |
|
$ |
(0.04 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
Diluted
|
|
$ |
|
|
|
$ |
(0.11 |
) |
|
$ |
(0.11 |
) |
|
$ |
(0.03 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net Income Available to Common Shareholders Per Share(12)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
1.34 |
|
|
$ |
0.79 |
|
|
$ |
3.68 |
|
|
$ |
2.98 |
|
|
$ |
2.28 |
|
|
$ |
0.64 |
|
|
$ |
1.52 |
|
|
Diluted
|
|
$ |
1.33 |
|
|
$ |
0.79 |
|
|
$ |
3.65 |
|
|
$ |
2.94 |
|
|
$ |
2.20 |
|
|
$ |
0.62 |
|
|
$ |
1.49 |
|
Dividends Declared Per Share
|
|
|
N/A |
|
|
|
N/A |
|
|
$ |
0.46 |
|
|
$ |
0.23 |
|
|
$ |
0.21 |
|
|
$ |
0.20 |
|
|
$ |
0.20 |
|
|
|
|
|
(1) |
In accordance with Statement of Financial Accounting Standards
(SFAS) No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets
(SFAS 144), income related to real estate sold
or classified as held-for-sale for transactions initiated on or
after January 1, 2002 is presented as discontinued
operations. The following table presents the components of
income from discontinued real estate operations (see
footnote 4): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three | |
|
|
|
|
|
|
|
|
|
|
|
|
Months Ended | |
|
|
|
|
March 31, | |
|
For the Year Ended December 31, | |
|
|
| |
|
| |
|
|
2005 | |
|
2004 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Investment income
|
|
$ |
72 |
|
|
$ |
106 |
|
|
$ |
373 |
|
|
$ |
455 |
|
|
$ |
630 |
|
|
$ |
563 |
|
|
$ |
214 |
|
Investment expense
|
|
|
(33 |
) |
|
|
(58 |
) |
|
|
(207 |
) |
|
|
(253 |
) |
|
|
(351 |
) |
|
|
(338 |
) |
|
|
|
|
Net investment gains (losses)
|
|
|
18 |
|
|
|
20 |
|
|
|
146 |
|
|
|
420 |
|
|
|
582 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
57 |
|
|
|
68 |
|
|
|
312 |
|
|
|
622 |
|
|
|
861 |
|
|
|
225 |
|
|
|
214 |
|
Interest expense
|
|
|
|
|
|
|
2 |
|
|
|
13 |
|
|
|
4 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
Provision for income taxes
|
|
|
20 |
|
|
|
24 |
|
|
|
104 |
|
|
|
226 |
|
|
|
313 |
|
|
|
82 |
|
|
|
78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income taxes
|
|
$ |
37 |
|
|
$ |
42 |
|
|
$ |
195 |
|
|
$ |
392 |
|
|
$ |
548 |
|
|
$ |
142 |
|
|
$ |
136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) |
Net investment gains (losses) exclude amounts related to real
estate operations reported as discontinued operations in
accordance with SFAS 144. |
S-33
|
|
|
|
(3) |
Net investment gains (losses) presented include scheduled
periodic settlement payments on derivative instruments that do
not qualify for hedge accounting under SFAS No. 133,
Accounting for Derivative Instruments and Hedging
Activities, as amended, of $24 million and
$14 million for the three months ended March 31, 2005
and 2004, respectively, and $51 million, $84 million,
$32 million and $24 million for the years ended
December 31, 2004, 2003, 2002 and 2001, respectively. |
|
|
(4) |
During the third quarter of 2004, the Company entered into an
agreement to sell its wholly-owned subsidiary,
SSRM Holdings, Inc. (SSRM), to a third party,
which was sold on January 31, 2005. In accordance with
SFAS 144, the assets, liabilities and operations of SSRM
have been reclassified into discontinued operations for all
periods presented. The following tables present the operations
of SSRM: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the | |
|
|
|
|
|
|
|
|
|
|
|
|
Three | |
|
|
|
|
|
|
|
|
|
|
|
|
Months | |
|
|
|
|
|
|
|
|
|
|
|
|
Ended | |
|
|
|
|
March 31, | |
|
For the Year Ended December 31, | |
|
|
| |
|
| |
|
|
2005 | |
|
2004 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Revenues from discontinued operations
|
|
$ |
19 |
|
|
$ |
62 |
|
|
$ |
328 |
|
|
$ |
231 |
|
|
$ |
239 |
|
|
$ |
254 |
|
|
$ |
258 |
|
Expenses from discontinued operations
|
|
|
38 |
|
|
|
55 |
|
|
|
296 |
|
|
|
197 |
|
|
|
225 |
|
|
|
230 |
|
|
|
211 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, before provision for income
taxes
|
|
|
(19 |
) |
|
|
7 |
|
|
|
32 |
|
|
|
34 |
|
|
|
14 |
|
|
|
24 |
|
|
|
47 |
|
Provision for income taxes
|
|
|
(5 |
) |
|
|
3 |
|
|
|
13 |
|
|
|
13 |
|
|
|
6 |
|
|
|
7 |
|
|
|
22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income taxes
|
|
|
(14 |
) |
|
|
4 |
|
|
|
19 |
|
|
|
21 |
|
|
|
8 |
|
|
|
17 |
|
|
|
25 |
|
Net investment gains, net of income taxes
|
|
|
165 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income taxes
|
|
$ |
151 |
|
|
$ |
4 |
|
|
$ |
19 |
|
|
$ |
21 |
|
|
$ |
8 |
|
|
$ |
17 |
|
|
$ |
25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
General account assets
|
|
$ |
379 |
|
|
$ |
183 |
|
|
$ |
198 |
|
|
$ |
203 |
|
|
$ |
228 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
379 |
|
|
$ |
183 |
|
|
$ |
198 |
|
|
$ |
203 |
|
|
$ |
228 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt
|
|
$ |
19 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Long-term debt
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
14 |
|
|
|
47 |
|
Other liabilities
|
|
|
221 |
|
|
|
70 |
|
|
|
78 |
|
|
|
80 |
|
|
|
95 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$ |
240 |
|
|
$ |
70 |
|
|
$ |
92 |
|
|
$ |
94 |
|
|
$ |
142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5) |
Includes the following combined financial statement data of
Conning Corporation (Conning), which was sold in
2001, and MetLifes interest in Nvest Companies, L.P.
(Nvest) and its affiliates, which was sold in 2000: |
|
|
|
|
|
|
|
|
|
|
|
For the Year | |
|
|
Ended | |
|
|
December 31, | |
|
|
| |
|
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
|
(In millions) | |
Total revenues
|
|
$ |
32 |
|
|
$ |
605 |
|
|
|
|
|
|
|
|
Total expenses
|
|
$ |
33 |
|
|
$ |
580 |
|
|
|
|
|
|
|
|
|
|
|
|
|
As a result of these sales, investment gains of $25 million
and $663 million were recorded for the years ended
December 31, 2001 and 2000, respectively. |
|
|
|
|
(6) |
Included in total revenues and total expenses for the year ended
December 31, 2002 are $421 million and
$358 million, respectively, related to Aseguradora
Hidalgo S.A., which was acquired in June 2002. |
S-34
|
|
|
|
(7) |
In July 1998, Metropolitan Life sold a substantial portion
of its Canadian operations to Clarica Life Insurance Company
(Clarica Life). As part of that sale, a large
block of policies in effect with Metropolitan Life in Canada was
transferred to Clarica Life, and the holders of the transferred
Canadian policies became policyholders of Clarica Life. Those
transferred policyholders are no longer policyholders of
Metropolitan Life and, therefore, were not entitled to
compensation under the plan of reorganization. However, as a
result of a commitment made in connection with obtaining
Canadian regulatory approval of that sale and in connection with
the demutualization, Metropolitan Lifes Canadian branch
made cash payments to those who were, or were deemed to be,
holders of these transferred Canadian policies. The payments
were determined in a manner that is consistent with the
treatment of, and fair and equitable to, eligible policyholders
of Metropolitan Life. |
|
|
(8) |
Provision for income taxes includes a credit of
$145 million for surplus taxes for the year ended
December 31, 2000. Prior to its demutualization,
Metropolitan Life was subject to surplus tax imposed on mutual
life insurance companies under Section 809 of the Internal
Revenue Code. |
|
|
(9) |
Policyholder liabilities include future policy benefits and
other policyholder funds. Life and health policyholder
liabilities also include policyholder account balances,
policyholder dividends payable and the policyholder dividend
obligation. |
|
|
(10) |
For additional information regarding these items, see
Notes 1 and 12 to the Consolidated Financial Statements
contained in our Annual Report on Form 10-K for the year
ended December 31, 2004. |
|
(11) |
Return on equity is defined as net income divided by average
total equity. |
|
(12) |
Based on earnings subsequent to the date of demutualization. For
additional information regarding net income per share data, see
Note 14 to the Consolidated Financial Statements contained
in our Annual Report on Form 10-K for the year ended
December 31, 2004. |
S-35
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL
INFORMATION
On January 31, 2005, MetLife, Inc., and Citigroup, entered
into a definitive agreement, pursuant to which MetLife, Inc.
agreed to acquire Citigroup L&A for $11.5 billion in
consideration, subject to certain closing adjustments and
financing arrangements, and receipt of regulatory approvals. The
Acquisition Agreement provides for Citigroups execution of
specific transactions to exclude certain assets and liabilities
prior to the closing, and these transactions have been reflected
in the Citigroup L&A historical combined financial
statements as if completed. The Citigroup L&A historical
condensed combined financial statements as of and for the three
months ended March 31, 2005 and as of and for the year
ended December 31, 2004 are included as exhibits to the
Current Reports on Form 8-K filed by MetLife on
May 27, 2005 and May 13, 2005, respectively.
The following unaudited pro forma condensed consolidated
financial information consolidates the unaudited historical
interim condensed consolidated balance sheet at March 31,
2005, the unaudited historical interim condensed consolidated
statement of income for the three months ended March 31,
2005 and the historical consolidated statement of income for the
year ended December 31, 2004 of MetLife with the unaudited
historical interim condensed combined balance sheet at
March 31, 2005, the unaudited historical interim condensed
combined statement of income for the three months ended
March 31, 2005 and the historical combined statement of
income for the year ended December 31, 2004 of Citigroup
L&A. Those unaudited historical interim condensed financial
statements and historical financial statements were prepared in
conformity with accounting principles generally accepted in the
United States of America (GAAP). The unaudited pro forma
condensed consolidated financial information has been prepared
using the assumptions described in the notes thereto.
The unaudited pro forma condensed consolidated financial
information below should be read in conjunction with the notes
thereto and the unaudited historical interim condensed
consolidated financial statements as of and for the three months
ended March 31, 2005 of MetLife included in its Quarterly
Report on Form 10-Q as well as the historical consolidated
financial statements as of and for the year ended
December 31, 2004 of MetLife included in its Annual Report
on Form 10-K. The unaudited pro forma condensed
consolidated financial information below should also be read in
conjunction with the Current Reports on Form 8-K filed by
MetLife on May 27, 2005 and May 13, 2005 which include
as exhibits: 1) the unaudited historical interim condensed
combined financial statements of Citigroup L&A as of and for
the three months ended March 31, 2005, and 2) the
audited historical combined financial statements of Citigroup
L&A as of and for the year ended December 31, 2004,
respectively.
This unaudited pro forma condensed consolidated financial
information is presented for informational purposes only and is
not necessarily indicative of the financial position or results
of operations of the consolidated company that would have
actually occurred had the Acquisition been effective during the
periods presented or of the future financial position or future
results of operations of the consolidated company. The unaudited
condensed consolidated financial information as of and for the
periods presented may have been different had the companies
actually been consolidated as of or during those periods due to,
among other factors, possible revenue enhancements, expense
efficiencies and integration costs. Additionally, as discussed
in Note 1, the actual allocation of the purchase price to
the acquired assets and liabilities may vary materially from the
assumptions used in preparing the unaudited pro forma condensed
consolidated financial information.
S-36
MetLife, Inc.
Unaudited Pro Forma Condensed Consolidated Balance Sheet
March 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Historical | |
|
|
|
|
|
|
|
|
|
|
| |
|
Pro Forma | |
|
Pro Forma | |
|
|
|
|
|
|
|
|
Citigroup | |
|
Purchase | |
|
Financing | |
|
|
|
Pro Forma | |
|
|
MetLife | |
|
L&A | |
|
Adjustments | |
|
Adjustments | |
|
Notes | |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions, except per share data) | |
|
|
|
|
Increase/(decrease) | |
|
|
Assets |
Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities available-for-sale, at fair value
|
|
$ |
182,519 |
|
|
$ |
44,508 |
|
|
$ |
(88 |
) |
|
$ |
(1,404 |
) |
|
|
3(a), 3(b) |
|
|
$ |
225,535 |
|
|
Equity securities, at fair value
|
|
|
2,516 |
|
|
|
391 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,907 |
|
|
Mortgage and other loans
|
|
|
31,977 |
|
|
|
2,349 |
|
|
|
43 |
|
|
|
|
|
|
|
3(c) |
|
|
|
34,369 |
|
|
Policy loans
|
|
|
8,953 |
|
|
|
894 |
|
|
|
5 |
|
|
|
|
|
|
|
3(d) |
|
|
|
9,852 |
|
|
Real estate and real estate joint ventures held-for-investment
|
|
|
3,458 |
|
|
|
279 |
|
|
|
127 |
|
|
|
|
|
|
|
3(e) |
|
|
|
3,864 |
|
|
Real estate held-for-sale
|
|
|
848 |
|
|
|
29 |
|
|
|
13 |
|
|
|
(478 |
) |
|
|
3(f), 3(g) |
|
|
|
412 |
|
|
Other limited partnership interests
|
|
|
3,051 |
|
|
|
1,326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,377 |
|
|
Short-term investments
|
|
|
2,551 |
|
|
|
3,364 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,915 |
|
|
Trading securities
|
|
|
134 |
|
|
|
1,081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,215 |
|
|
Other invested assets
|
|
|
4,960 |
|
|
|
338 |
|
|
|
234 |
|
|
|
|
|
|
|
3(h) |
|
|
|
5,532 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
240,967 |
|
|
|
54,559 |
|
|
|
334 |
|
|
|
(1,882 |
) |
|
|
|
|
|
|
293,978 |
|
Cash and cash equivalents
|
|
|
3,925 |
|
|
|
648 |
|
|
|
(10,623 |
) |
|
|
10,623 |
|
|
|
3(i) |
|
|
|
4,573 |
|
Common stock issuance and distribution
|
|
|
|
|
|
|
|
|
|
|
(1,000 |
) |
|
|
1,000 |
|
|
|
3(i) |
|
|
|
|
|
Accrued investment income
|
|
|
2,433 |
|
|
|
560 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,993 |
|
Premiums and other receivables
|
|
|
7,515 |
|
|
|
4,146 |
|
|
|
1,137 |
|
|
|
|
|
|
|
3(j) |
|
|
|
12,798 |
|
Deferred policy acquisition costs
|
|
|
13,130 |
|
|
|
3,035 |
|
|
|
(3,035 |
) |
|
|
|
|
|
|
3(l) |
|
|
|
13,130 |
|
Value of business acquired
|
|
|
1,668 |
|
|
|
90 |
|
|
|
2,904 |
|
|
|
|
|
|
|
3(m), 3(n) |
|
|
|
4,662 |
|
Goodwill
|
|
|
611 |
|
|
|
226 |
|
|
|
4,292 |
|
|
|
|
|
|
|
3(o), 3(p) |
|
|
|
5,129 |
|
Other intangible assets
|
|
|
14 |
|
|
|
|
|
|
|
185 |
|
|
|
|
|
|
|
3(q) |
|
|
|
199 |
|
Other assets
|
|
|
6,622 |
|
|
|
1,617 |
|
|
|
1 |
|
|
|
74 |
|
|
|
3(r), 3(ff), 3(s) |
|
|
|
8,314 |
|
Separate account assets
|
|
|
85,786 |
|
|
|
31,052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
116,838 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
362,671 |
|
|
$ |
95,933 |
|
|
$ |
(5,805 |
) |
|
$ |
9,815 |
|
|
|
|
|
|
$ |
462,614 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders Equity |
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$ |
100,630 |
|
|
$ |
12,679 |
|
|
$ |
3,008 |
|
|
$ |
|
|
|
|
3(j), 3(ff) |
|
|
$ |
116,317 |
|
|
Policyholder account balances
|
|
|
85,802 |
|
|
|
35,633 |
|
|
|
1,831 |
|
|
|
|
|
|
|
3(k) |
|
|
|
123,266 |
|
|
Other policyholder funds
|
|
|
7,226 |
|
|
|
1,604 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,830 |
|
|
Policyholder dividends payable
|
|
|
1,048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,048 |
|
|
Policyholder dividend obligation
|
|
|
1,737 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,737 |
|
|
Short-term debt
|
|
|
1,120 |
|
|
|
|
|
|
|
|
|
|
|
1,000 |
|
|
|
3(t) |
|
|
|
2,120 |
|
|
Long-term debt
|
|
|
7,414 |
|
|
|
(23 |
) |
|
|
(87 |
) |
|
|
4,700 |
|
|
|
3(a), 3(t) |
|
|
|
12,004 |
|
|
Shares subject to mandatory redemption
|
|
|
278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
278 |
|
|
Current income taxes payable
|
|
|
31 |
|
|
|
8 |
|
|
|
50 |
|
|
|
460 |
|
|
|
3(ff), 3(g) |
|
|
|
549 |
|
|
Deferred income taxes payable
|
|
|
2,414 |
|
|
|
694 |
|
|
|
(1,709 |
) |
|
|
(51 |
) |
|
|
3(u), 3(g) |
|
|
|
1,348 |
|
|
Payables under securities loaned transactions
|
|
|
31,713 |
|
|
|
2,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,044 |
|
|
Trading securities sold not yet purchased
|
|
|
|
|
|
|
369 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
369 |
|
|
Other liabilities
|
|
|
14,434 |
|
|
|
2,915 |
|
|
|
(227 |
) |
|
|
111 |
|
|
|
3(v), 3(w) |
|
|
|
17,233 |
|
|
Separate account liabilities
|
|
|
85,786 |
|
|
|
31,052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
116,838 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
339,633 |
|
|
|
87,262 |
|
|
|
2,866 |
|
|
|
6,220 |
|
|
|
|
|
|
|
435,981 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value $0.01 per share;
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
|
|
Additional paid-in capital
|
|
|
15,043 |
|
|
|
|
|
|
|
|
|
|
|
889 |
|
|
|
3(t), 3(w) |
|
|
|
15,932 |
|
|
Preferred stock, par value $0.01 per share;
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,948 |
|
|
|
3(t) |
|
|
|
1,948 |
|
|
Common stock of Citigroup L&A
|
|
|
|
|
|
|
131 |
|
|
|
(131 |
) |
|
|
|
|
|
|
3(x) |
|
|
|
|
|
|
Additional paid-in capital
|
|
|
|
|
|
|
3,138 |
|
|
|
(3,138 |
) |
|
|
|
|
|
|
3(x) |
|
|
|
|
|
|
Retained earnings
|
|
|
7,595 |
|
|
|
4,238 |
|
|
|
(4,238 |
) |
|
|
758 |
|
|
|
3(x), 3(g) |
|
|
|
8,353 |
|
|
Treasury stock, at cost;
|
|
|
(1,764 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,764 |
) |
|
Accumulated other comprehensive income
|
|
|
2,156 |
|
|
|
1,164 |
|
|
|
(1,164 |
) |
|
|
|
|
|
|
3(x) |
|
|
|
2,156 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
23,038 |
|
|
|
8,671 |
|
|
|
(8,671 |
) |
|
|
3,595 |
|
|
|
|
|
|
|
26,633 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$ |
362,671 |
|
|
$ |
95,933 |
|
|
$ |
(5,805 |
) |
|
$ |
9,815 |
|
|
|
|
|
|
$ |
462,614 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to unaudited pro forma condensed
consolidated financial information.
S-37
MetLife, Inc.
Unaudited Pro Forma Interim Condensed Consolidated Statement
of Income
For the Three Months Ended March 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Historical | |
|
|
|
|
|
|
|
|
|
|
| |
|
Pro Forma | |
|
Pro Forma | |
|
|
|
|
|
|
|
|
Citigroup | |
|
Purchase | |
|
Financing | |
|
|
|
Pro Forma | |
|
|
MetLife | |
|
L&A | |
|
Adjustments | |
|
Adjustments | |
|
Notes |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
| |
|
|
|
| |
|
|
(In millions, except per share data) | |
|
|
|
|
Increase/(decrease) | |
|
|
Revenues |
Premiums
|
|
$ |
6,002 |
|
|
$ |
267 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
$ |
6,269 |
|
Universal life and investment-type product policy fees
|
|
|
791 |
|
|
|
232 |
|
|
|
(1 |
) |
|
|
|
|
|
3(y) |
|
|
1,022 |
|
Net investment income
|
|
|
3,217 |
|
|
|
759 |
|
|
|
(78 |
) |
|
|
(23 |
) |
|
3(z), 3(aa) |
|
|
3,875 |
|
Other revenues
|
|
|
299 |
|
|
|
50 |
|
|
|
(19 |
) |
|
|
|
|
|
3(bb) |
|
|
330 |
|
Net investment gains (losses)
|
|
|
(15 |
) |
|
|
54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
39 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
10,294 |
|
|
|
1,362 |
|
|
|
(98 |
) |
|
|
(23 |
) |
|
|
|
|
11,535 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses |
Policyholder benefits and claims
|
|
|
5,962 |
|
|
|
320 |
|
|
|
(10 |
) |
|
|
|
|
|
3(j) |
|
|
6,272 |
|
Interest credited to policyholder account balances
|
|
|
795 |
|
|
|
371 |
|
|
|
(62 |
) |
|
|
|
|
|
3(k) |
|
|
1,104 |
|
Policyholder dividends
|
|
|
415 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
415 |
|
Other expenses
|
|
|
1,973 |
|
|
|
274 |
|
|
|
(39 |
) |
|
|
70 |
|
|
3(cc), 3(dd) |
|
|
2,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
9,145 |
|
|
|
965 |
|
|
|
(111 |
) |
|
|
70 |
|
|
|
|
|
10,069 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income
taxes
|
|
|
1,149 |
|
|
|
397 |
|
|
|
13 |
|
|
|
(93 |
) |
|
|
|
|
1,466 |
|
Provision for income taxes
|
|
|
350 |
|
|
|
124 |
|
|
|
4 |
|
|
|
(32 |
) |
|
3(ee) |
|
|
446 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$ |
799 |
|
|
$ |
273 |
|
|
$ |
9 |
|
|
$ |
(61 |
) |
|
|
|
$ |
1,020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Per Share |
Income from continuing operations available to common
stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
1.09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1.31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$ |
1.08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1.30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
734.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
757.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
739.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
762.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to unaudited pro forma condensed
consolidated financial information.
S-38
MetLife, Inc.
Unaudited Pro Forma Condensed Consolidated Statement of
Income
For the Year Ended December 31, 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Historical | |
|
Pro Forma | |
|
Pro Forma | |
|
|
|
|
|
|
| |
|
Purchase | |
|
Financing | |
|
|
|
Pro Forma | |
|
|
MetLife | |
|
Citigroup L&A | |
|
Adjustments | |
|
Adjustments | |
|
Notes | |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions, except per share data) | |
|
|
|
|
Increase/(decrease) | |
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$ |
22,204 |
|
|
$ |
1,314 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
$ |
23,518 |
|
Universal life and investment-type product policy fees
|
|
|
2,868 |
|
|
|
711 |
|
|
|
34 |
|
|
|
|
|
|
|
3(y) |
|
|
|
3,613 |
|
Net investment income
|
|
|
12,367 |
|
|
|
2,973 |
|
|
|
(311 |
) |
|
|
(92 |
) |
|
|
3(z), 3(aa) |
|
|
|
14,937 |
|
Other revenues
|
|
|
1,198 |
|
|
|
161 |
|
|
|
(83 |
) |
|
|
|
|
|
|
3(bb) |
|
|
|
1,276 |
|
Net investment gains
|
|
|
175 |
|
|
|
14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
38,812 |
|
|
|
5,173 |
|
|
|
(360 |
) |
|
|
(92 |
) |
|
|
|
|
|
|
43,533 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
22,666 |
|
|
|
1,529 |
|
|
|
(36 |
) |
|
|
|
|
|
|
3(j) |
|
|
|
24,159 |
|
Interest credited to policyholder account balances
|
|
|
2,998 |
|
|
|
1,386 |
|
|
|
(227 |
) |
|
|
|
|
|
|
3(k) |
|
|
|
4,157 |
|
Policyholder dividends
|
|
|
1,666 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,666 |
|
Other expenses
|
|
|
7,822 |
|
|
|
1,014 |
|
|
|
(131 |
) |
|
|
279 |
|
|
|
3(cc), 3(dd) |
|
|
|
8,984 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
35,152 |
|
|
|
3,929 |
|
|
|
(394 |
) |
|
|
279 |
|
|
|
|
|
|
|
38,966 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income
taxes
|
|
|
3,660 |
|
|
|
1,244 |
|
|
|
34 |
|
|
|
(371 |
) |
|
|
|
|
|
|
4,567 |
|
Provision for income taxes
|
|
|
1,030 |
|
|
|
343 |
|
|
|
83 |
|
|
|
(130 |
) |
|
|
3(ee) |
|
|
|
1,326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$ |
2,630 |
|
|
$ |
901 |
|
|
$ |
(49 |
) |
|
$ |
(241 |
) |
|
|
|
|
|
$ |
3,241 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Per Share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to common
stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
3.51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
4.04 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$ |
3.48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
4.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
749.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
772.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
754.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
777.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to unaudited pro forma condensed
consolidated financial information.
S-39
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information
The unaudited pro forma condensed consolidated financial
information gives effect to the proposed acquisition as if it
had occurred at March 31, 2005 for the purposes of the
unaudited pro forma condensed consolidated balance sheet and at
January 1, 2004 for the purposes of the unaudited pro forma
condensed consolidated statements of income. The unaudited pro
forma condensed consolidated financial information has been
prepared by MetLifes management and is based on
MetLifes historical consolidated financial statements and
Citigroup L&As historical combined financial
statements, which have been prepared by Citigroup. Certain
amounts from Citigroup L&As historical combined
financial statements have been reclassified to conform to the
MetLife presentation. In accordance with Article 11 of
Regulation S-X, discontinued operations and cumulative
effects of changes in accounting and the related earnings per
share data have been excluded from the presentation of the
unaudited pro forma condensed consolidated statements of income.
This unaudited pro forma condensed consolidated financial
information is prepared in conformity with accounting principles
generally accepted in the United States of America. The
unaudited pro forma condensed consolidated balance sheet at
March 31, 2005 and the unaudited pro forma condensed
consolidated statements of income for the three months ended
March 31, 2005 and for the year ended December 31,
2004 have been prepared using the following information:
|
|
|
(a) Unaudited historical interim condensed consolidated
financial statements of MetLife as of and for the three months
ended March 31, 2005; |
|
|
(b) Unaudited historical interim combined financial
statements of Citigroup L&A as of and for the three months
ended March 31, 2005; |
|
|
(c) Audited historical consolidated financial statements of
MetLife as of and for the year ended December 31, 2004; |
|
|
(d) Audited historical combined financial statements of
Citigroup L&A as of and for the year ended December 31,
2004; and |
|
|
(e) Such other supplementary information as considered
necessary to reflect the Acquisition in the unaudited pro forma
condensed consolidated financial information. |
Some previously reported amounts have been reclassified to
conform with the presentation for the three months ended
March 31, 2005.
The pro forma adjustments reflecting the Acquisition of
Citigroup L&A under the purchase method of accounting are
based on certain estimates and assumptions. The pro forma
adjustments may be revised as additional information becomes
available. The actual adjustments upon consummation of the
Acquisition and the allocation of the purchase price of
Citigroup L&A will depend on a number of factors, including
additional financial information available at such time, changes
in values and changes in Citigroup L&As operating
results between the date of preparation of this unaudited pro
forma condensed consolidated financial information and the
effective date of the Acquisition. Therefore, it is likely that
the actual adjustments will differ from the pro forma
adjustments and it is possible the differences may be material.
MetLifes management believes that its assumptions provide
a reasonable basis for presenting all of the significant effects
of the transactions contemplated and that the pro forma
adjustments give appropriate effect to those assumptions and are
properly applied in the unaudited pro forma condensed
consolidated financial information.
The excess of the purchase price over the estimated fair value
of the net assets acquired, including identifiable intangible
assets, has been allocated to goodwill. The unaudited pro forma
condensed consolidated financial information does not include
the anticipated financial benefits or expenses from such items as
S-40
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
expense efficiencies or revenue enhancements arising from the
Acquisition nor does the unaudited pro forma condensed
consolidated financial information include the portion of
restructuring and integration costs to be incurred by MetLife.
The unaudited pro forma condensed consolidated financial
information is not intended to reflect the results of operations
or the financial position that would have resulted had the
Acquisition been effected on the dates indicated, or the results
that may be obtained by the consolidated company in the future.
The unaudited pro forma condensed consolidated financial
information should be read in conjunction with the notes thereto
and the unaudited historical interim condensed consolidated
financial statements as of and for three months ended
March 31, 2005 of MetLife included in its Quarterly Report
on Form 10-Q, as well as the historical consolidated
financial statements as of and for the year ended
December 31, 2004 of MetLife included in its Annual Report
on Form 10-K. The unaudited pro forma condensed
consolidated financial information should also be read in
conjunction with the Current Reports on Form 8-K filed by
MetLife on May 27, 2005 and May 13, 2005 which include
as exhibits: 1) the unaudited historical interim condensed
combined financial statements of Citigroup L&A as of and for
the three months ended March 31, 2005 and 2) the
audited historical combined financial statements of Citigroup
L&A as of and for the year ended December 31, 2004,
respectively.
|
|
2. |
Purchase Price and Financing Considerations |
Pursuant to the Acquisition Agreement, MetLife, Inc. will pay
Citigroup $11.5 billion in consideration for all of the
outstanding shares of capital stock held by Citigroup and its
affiliates, of certain of the domestic and international
insurance subsidiaries of Citigroup, constituting the Citigroup
L&A business. The Acquisition Agreement provides for
Citigroups execution of specific transactions to exclude
certain assets and liabilities prior to the closing, and these
transactions have been reflected in the Citigroup L&A
historical combined financial statements as if completed. The
closing is expected to occur during the summer of 2005. This
purchase price is subject to certain adjustments at closing,
including adjustments based on differences between estimated and
actual equity at closing and agreed-upon minimum risk based
capital (RBC) levels. The potential purchase price
adjustments are more fully described in the Acquisition
Agreement.
Under the terms of the Acquisition Agreement, MetLife, Inc. may,
at its discretion, issue up to $3 billion of its stock to
Citigroup as part of the funding of the purchase price. The
remainder of the purchase price must be paid in cash. The
financing related to the cash portion of the purchase price will
be finalized immediately prior to the closing of the transaction
and may include the use of short-term bridge financing.
The unaudited pro forma condensed consolidated financial
information included herein reflects managements best
estimate of the forms and amounts of financing at the time this
unaudited pro forma condensed consolidated financial information
was prepared. The actual form of financing of the Acquisition
may involve different forms of financing and/or different
amounts of the same financing vehicles. These differences in
form and amount of financing could result in materially
different pro forma adjustments than those presented in this
unaudited pro forma condensed consolidated financial
information. The actual financing forms and amounts of financing
will not be determined until shortly before the closing date of
the Acquisition. The unaudited pro forma condensed consolidated
financial information presented herein assumes the following:
|
|
|
(i) MetLife, Inc. will issue $1 billion,
23.0 million shares, of common stock to Citigroup in the
transaction. For purposes of computing the number of shares of
common stock to be issued to Citigroup, the price of the
MetLife, Inc.s common stock to be issued is assumed to be
$43.53 per common share, which represents the average
closing price of MetLife, Inc.s common stock on the New
York Stock Exchange for the ten-day period ending May 26,
2005. The impact on pro forma earnings per share of issuing the
maximum amount, $3 billion, of consideration in common
stock is described in Note 4. The number of shares to be
issued for purposes of that calculation was computed using the
same average closing price as described above. |
S-41
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
|
(ii) The remaining $10.5 billion of purchase price
will be paid to Citigroup in cash and will be funded by MetLife
in part through: |
|
|
|
a) The sale of a real estate property and fixed maturity
securities. The unaudited pro forma condensed consolidated
statements of income reflect the reduction in investment income
from the sale of fixed maturity securities but do not reflect a
reduction of investment income from the sale of real estate
property as such investment income is reported as discontinued
operations. The unaudited pro forma condensed consolidated
statements of income do not reflect the gains/(losses) on the
sale of real estate property or fixed maturity securities as
such gains/(losses) would be reported as discontinued operations
or are sales that would not be part of the normal course of
business. |
|
|
b) The issuance of commercial paper and various forms of
securities including senior debt, mandatorily convertible equity
units, and perpetual preferred stock. The unaudited pro forma
condensed consolidated statements of income reflect the impact
of these financing arrangements using MetLifes current
anticipated borrowing and dividend rates for such types of
securities. |
|
|
These assumptions are made based on the best information
available at the time the unaudited pro forma condensed
consolidated financial information was prepared. Changes in
risk-free interest rates and credit spreads could change the
assumed borrowing and dividend rates for such types of
securities. |
|
|
c) Bridge financing which would be a short-term
substitution for some or all of the longer term financing
alternatives may be considered. The amount and term of the
bridge financing will depend upon the timing of the closing of
the transaction in combination with market access and market
conditions at such time. |
S-42
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
For purposes of presentation in the unaudited pro forma
condensed consolidated financial information, the financing of
the Acquisition and allocation of purchase price is assumed to
be as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected | |
|
|
|
|
|
|
Range of | |
|
Annual | |
|
Expected Interest/ | |
|
|
Anticipated | |
|
Potential | |
|
Interest/ | |
|
Dividend(4)(5) | |
|
|
Financing | |
|
Financing | |
|
Dividend | |
|
| |
|
|
Amount | |
|
Amounts | |
|
Rate(4)(5) | |
|
Annual | |
|
Quarterly | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
|
(In millions) | |
|
(%) | |
|
(In millions) | |
|
(In millions) | |
Sources:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$ |
3,049 |
|
|
$ |
2,500 3,500 |
|
|
|
(1)(2) |
|
|
|
(1)(2) |
|
|
|
(1)(2) |
|
Debt
|
|
|
3,700 |
|
|
|
3,000 5,000 |
|
|
|
2.85 6.00% |
|
|
$ |
175 |
|
|
$ |
44 |
|
Mandatorily convertible equity units
|
|
|
2,000 |
|
|
|
2,000 3,000 |
|
|
|
3.50 4.50% |
|
|
$ |
80 |
|
|
$ |
20 |
|
Preferred stock
|
|
|
2,000 |
|
|
|
1,000 2,000 |
|
|
|
4.00 6.50% |
|
|
$ |
120 |
|
|
$ |
30 |
|
MetLife, Inc. common stock
|
|
|
1,000 |
|
|
|
1,000 3,000 |
|
|
|
(3) |
|
|
|
(3) |
|
|
|
(3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total sources of funds
|
|
$ |
11,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Uses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt and equity issuance costs See pro forma
adjustments 3(s) and 3(t) in Note 3
|
|
$ |
126 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other transaction costs See pro forma
adjustment 3(i) in Note 3
|
|
|
123 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price paid to Citigroup
|
|
|
11,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total purchase price
|
|
|
11,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total uses of funds
|
|
$ |
11,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Price Allocation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total purchase price
|
|
$ |
11,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net balance sheet assets acquired at March 31, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying value of net balance sheet assets prior to the
Acquisition
|
|
|
8,671 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated fair value adjustments
|
|
|
(1,566 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated fair value of net balance sheet assets acquired
|
|
|
7,105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
$ |
4,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
A real estate property with a carrying value of
$478 million was sold on May 4, 2005 for
$1,720 million, resulting in a gain of $758 million,
net of current income taxes payable of $460 million,
deferred income taxes of $(51) million and transaction
costs of $75 million. The real estate was sold to
facilitate the funding of the Acquisition. Net investment income
on such real estate property was $67 million for the year
ended December 31, 2004 and $16 million during the
three months ended March 31, 2005. The sale of the real
estate property is reflected as a pro forma adjustment in the
unaudited pro forma condensed consolidated balance sheet. The
unaudited pro forma condensed consolidated statements of income
have not been adjusted to reflect a reduction in the related net
investment income or to reflect the gain on the sale of such
real estate property as both would be reported as discontinued
operations. See pro forma adjustment 3(g). |
S-43
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
(2) |
Fixed maturities with a carrying value of $1,404 million
have been assumed sold to fund the purchase price. The net
investment income on such fixed maturities of $92 million
for the year ended December 31, 2004 was computed based
upon the average yield of fixed maturities of 6.55% during 2004.
The sale of the fixed maturities and the elimination of
one-fourth of the related annual investment income,
$23 million for the three months ended March 31, 2005,
are reflected as pro forma adjustments in the unaudited pro
forma condensed consolidated balance sheet and unaudited pro
forma condensed consolidated statements of income, respectively.
Any gains/(losses) realized on the sale of such investments
would not be part of the normal course of business and, as such,
has not been reflected in the accompanying unaudited pro forma
condensed consolidated statements of income for the three months
ended March 31, 2005. See pro forma adjustment 3(b).
The unaudited pro forma condensed consolidated statement of
income for the year ended December 31, 2004 reflects the
reduction of investment income related to the sale of the fixed
maturity securities but does not reflect the gains/(losses) on
the sale of such fixed maturity securities as such
gains/(losses) are on sales that would not be part of the normal
course of business. |
|
(3) |
Common stock dividend rates are set annually and are not
reflected in the unaudited pro forma condensed consolidated
financial information. |
|
(4) |
Debt and perpetual preferred stock may be issued in one or more
series. Debt securities are expected to consist of a combination
of instruments with varying maturities and interest rates, which
may be fixed or floating. The perpetual preferred stock is also
expected to consist of a mix of fixed and floating rate
issuances.
The ranges of interest and dividend rates noted above, which
have been used to calculate the impact of the financing on the
unaudited pro forma condensed consolidated financial
information, reflect the range associated with such potential
issuances and are based on MetLifes borrowing rates to the
date of this prospectus supplement. The actual interest and
dividend rates may differ from those estimated above.
The range of interest rates presented above relative to the
mandatorily convertible equity units (MCEUs) reflects only the
interest rate on the debt portion of such securities. The rate
on the MCEUs presented above does not reflect the contractual
payment rate on the forward share purchase contract associated
with such securities, which has been assumed to be 2%, and is
reflected on a discounted basis as a $111 million reduction
in additional paid-in capital. The discount of such contractual
payments is amortized into income over the estimated three year
term of such contracts.
MetLifes borrowing rates are sensitive to changes in
risk-free rates and credit spreads. An increase or decrease in
composite interest rates of one-quarter of a percent on debt
issuances would result in a change in annual interest expense of
$13 million ($3 million quarterly). Preferred
dividends would change by $5 million ($1 million
quarterly) as a result of a one-quarter of a percent change in
dividend rates and the related impact on earnings per share
would be minor. |
|
(5) |
In addition to the financing alternatives shown above, MetLife,
Inc. entered into a $7 billion senior bridge credit
facility with Bank of America N.A. Funding under the senior
bridge credit facility, if it occurs, may occur in up to two
parts, so long as the first funding relates to the acquisition
of not less than 80% of the value of the assets contemplated to
be acquired pursuant to the Acquisition Agreement. The net cash
proceeds of certain of the financing alternatives shown above
will be used to repay or reduce the amount available under the
senior bridge credit facility. Loans under the senior bridge
credit facility may be base rate loans or eurodollar rate loans.
Base rate loans bear interest at the higher of (i) the
Federal Funds Rate plus
1/2
of 1%, and (ii) the rate of interest in effect for such day
as publicly announced from time to time by Bank of America N.A.
as its prime rate. Eurodollar rate loans bear interest at LIBOR
divided by 1.00 minus the reserve percentage in effect under
regulations issued from time to time by the Board of Governors
of the Federal Reserve System of the United States for
determining the maximum reserve requirement with respect to
eurocurrency funding. Any amounts borrowed under the senior
bridge credit |
S-44
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
|
facility must be repaid by the 364th day after the earlier
of (i) the seventh day prior to the first closing date of
the Acquisition, and (ii) June 24, 2005. As the bridge
financing is expected to be temporary in nature, it would be a
substitute for certain of the aforementioned financing
alternatives, and would bear a short-term interest rate;
therefore, no additional interest expense has been reflected in
the accompanying unaudited pro forma condensed consolidated
financial information. |
The purchase price is allocated to balance sheet assets acquired
(including identifiable intangible assets arising from the
Acquisition) and liabilities assumed based on their estimated
fair value. The fair value adjustments to the Citigroup L&A
historical condensed combined balance sheet in connection with
the Acquisition are described below in Note 3. The excess
of the total purchase consideration over the estimated fair
value of the net assets acquired, together with capitalized
costs, is allocated to goodwill.
As discussed above, these pro forma adjustments are based on
certain estimates and assumptions made as of the date of the
unaudited pro forma condensed consolidated financial
information. The actual adjustments will depend on a number of
factors, including changes in the estimated fair value of net
balance sheet assets and operating results of Citigroup L&A
between the dates presented and the effective date of the
Acquisition. MetLife expects to make such adjustments at the
effective date of the Acquisition. These adjustments may be
different from the adjustments made to prepare the unaudited pro
forma condensed consolidated financial information and such
differences may be material.
|
|
|
|
(a) |
Elimination of the fair value of $88 million in fixed
maturities available-for-sale held by Citigroup and issued by
MetLife, Inc. and the related historical cost of the debt
securities issued by MetLife of $87 million at
March 31, 2005. The related interest expense to MetLife,
Inc. and interest income to Citigroup L&A of $2 million
and $8 million for the three months ended March 31,
2005 and for the year ended December 31, 2004,
respectively, has also been eliminated in the accompanying
unaudited pro forma condensed consolidated statements of income. |
|
|
(b) |
Sale by MetLife, Inc. of fixed maturities available-for-sale
with a carrying value of $1,404 million to fund the
Acquisition of Citigroup L&A. The unaudited pro forma
condensed consolidated statement of income reflects a reduction
in net investment income as a result of the assumption that the
sale of such fixed maturity securities would have occurred at
the beginning of 2004. The net investment income foregone is
computed based upon the average yield of fixed maturities of
6.55% in 2004. Net investment income of $23 million and
$92 million, respectively, has been eliminated from the
accompanying unaudited pro forma condensed consolidated
statements of income for the three months ended March 31,
2005 and for the year ended December 31, 2004. Any
gains/losses on the sale of such investments would not be part
of the normal course of business and, as such, have not been
reflected in the accompanying unaudited pro forma condensed
consolidated statements of income. |
|
|
(c) |
Fair value adjustment of $43 million for the difference
between the estimated fair value and carrying value of Citigroup
L&As investment in mortgage and other loans. Related
amortization of the fair value adjustment is estimated to be
$4 million and $15 million for the three months ended
March 31, 2005 and for the year ended December 31,
2004, respectively, in the unaudited pro forma condensed
consolidated statements of income. |
|
|
(d) |
Fair value adjustment of $5 million for the difference
between the estimated fair value and carrying value of Citigroup
L&As investment in policy loans. Related amortization
of the fair value adjustment is immaterial for the three months
ended March 31, 2005 and $1 million for the year ended
December 31, 2004 in the unaudited pro forma condensed
consolidated statements of income. |
S-45
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
|
|
(e) |
Fair value adjustment of $127 million relates to Citigroup
L&As investment in real estate and real estate joint
ventures held-for-investment. Related amortization of the fair
value adjustment resulting in a reduction in net investment
income is estimated at $1 million and $5 million for
the three months ended March 31, 2005 and for the year
ended December 31, 2004, respectively, in the unaudited pro
forma condensed consolidated statements of income. |
|
|
(f) |
Fair value adjustment of $13 million relates to Citigroup
L&As investment in real estate held-for-sale. No
related amortization of the fair value adjustment was estimated
to have occurred during the three months ended March 31,
2005 and the year ended December 31, 2004 as such
amortization was immaterial. |
|
|
(g) |
A real estate property with a carrying value of
$478 million was sold on May 4, 2005 for
$1,720 million, resulting in a gain of $758 million,
net of current income taxes payable of $460 million,
deferred income taxes of $(51) million and transaction
costs of $75 million. The real estate property was sold to
facilitate the funding of the Acquisition. The sale of the real
estate property is reflected as a pro forma adjustment in the
unaudited pro forma condensed consolidated balance sheet;
however, the unaudited pro forma condensed consolidated
statements of income have not been adjusted to reflect a
reduction in the related net investment income or to reflect the
gain on the sale of such real estate property as both would be
reported as discontinued operations. The gain has been reflected
as an increase in stockholders equity in the accompanying
unaudited pro forma condensed consolidated balance sheet. |
|
|
(h) |
Fair value adjustment of $234 million for the difference
between the estimated fair value and carrying value of
Citigroup L&As investment in other invested
assets principally the purchase accounting
adjustment related to the elimination of the historical deferred
policy acquisition costs and the establishment of value of
business acquired (VOBA) related to certain joint
ventures acquired. Related amortization of the fair value
adjustment is estimated at $3 million and $9 million,
for the three months ended March 31, 2005 and for the year
ended December 31, 2004, respectively, and is reflected as
a reduction in other revenues in the unaudited pro forma
condensed consolidated statements of income. |
|
|
(i) |
The pro forma financing adjustment represents the cash and cash
equivalent position of $10,623 million resulting from the
issuance of the commercial paper, senior debt, mandatorily
convertible equity units, and perpetual preferred stock, as well
as the sale of real estate and fixed maturity securities. The
common stock issuance of $1,000 million is reflected
separately from the cash financing sources in the pro forma
financing adjustments column. The remittance to Citigroup of
$10,500 million of cash and $1,000 million in common
stock to acquire Citigroup L&A, plus transaction costs to
other parties, is reflected in the pro forma purchase
adjustments column.
The transaction costs of $123 million represent an
estimate of the costs that the Company expects to incur over a
two year period. These costs consist primarily of investment
banker and legal fees, severance payments, relocation costs,
lease terminations, and closing of facilities of Citigroup
L&A and have been included in the purchase price. Actual
costs may vary from such estimates. |
|
|
(j) |
The pro forma purchase adjustment of $1,137 million is
comprised of an adjustment of $1,571 million to reinsurance
recoverable representing an increase in reinsurance recoverable
for benefits ceded to reinsurers and was computed using the same
assumptions that were used to determine the purchase accounting
adjustment to the liability for future policy benefits offset by
the elimination of the reinsurance recoverable on the liability
for future policy benefits of $434 million between MetLife
and TIC, related to a reinsurance agreement between the two
entities which will become an intercompany arrangement upon
acquisition. |
S-46
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
|
|
|
The pro forma purchase adjustment of $3,008 million is
comprised of an adjustment to the liability for future policy
benefits of $3,222 million representing the difference
between the Citigroup L&A carrying value of such liabilities
and the purchase accounting basis of such liabilities using
current assumptions, plus an adjustment of $212 million
related to Citigroup L&As Argentinean operations as
described in pro forma adjustments 3(ff)(i) and (ii), and
offset by the elimination of reinsurance recoverable on the
liability for future policy benefits of $426 million
between MetLife and TIC.
Amortization of the adjustment to the liability for future
policy benefits resulted in a decrease in policyholder benefits
and claims of $10 million and $36 million for the
three months ended March 31, 2005 and for the year ended
December 31, 2004, respectively. |
|
|
(k) |
The adjustment to policyholder account balances of
$1,831 million represents the adjustment of Citigroup
L&As carrying value to amounts based on expected
liability cash flows discounted at current crediting rates.
Interest credited to policyholder account balances for the
three months ended March 31, 2005 and for the year ended
December 31, 2004 decreased by $62 million and
$227 million, respectively, as a result of the revaluation
of policyholder account balances. |
|
|
(l) |
Elimination of Citigroup L&As historical deferred
policy acquisition costs of $3,035 million, and related
amortization of $108 million and $394 million for the
three months ended March 31, 2005 and the year ended
December 31, 2004, respectively. |
|
|
(m) |
Elimination of Citigroup L&As historical VOBA of
$90 million and related amortization of $2 million and
$10 million for the three months ended March 31, 2005
and for the year ended December 31, 2004, respectively. |
|
|
(n) |
The VOBA reflects the estimated fair value of in-force contracts
and represents the portion of the purchase price that is
allocated to the value of the right to receive future cash flows
from the life insurance and annuity contracts in force at the
Acquisition date. VOBA is based on actuarially determined
projections, by each block of business, of future policy and
contract charges, premiums, mortality and morbidity, separate
account performance, surrenders, operating expenses, investment
returns and other factors. Actual experience on the purchased
business may vary from these projections. An 11.5% discount rate
is used to value VOBA.
VOBA is amortized in relation to estimated gross profits or
premiums, depending on product type. If estimated gross profits
or premiums differ from expectations, the amortization of VOBA
is adjusted to reflect actual experience. At March 31,
2005, the VOBA balance is estimated at $2,994 million. The
estimated amortization for the three months ended March 31,
2005 and for the year ended December 31, 2004 is
$73 million and $283 million, respectively. |
The following table provides an estimated amortization of the
pro forma consolidated VOBA from 2005 to 2009:
|
|
|
|
|
|
|
(In millions) | |
Nine months ended December 31, 2005
|
|
$ |
233 |
|
2006
|
|
$ |
307 |
|
2007
|
|
$ |
292 |
|
2008
|
|
$ |
268 |
|
2009
|
|
$ |
242 |
|
(o) Elimination of Citigroup L&As
historical goodwill of $226 million.
|
|
|
|
(p) |
Represents the goodwill of $4,518 million arising from the
transaction. See computation in Note 2. |
S-47
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
|
|
(q) |
Represents the recognition of identifiable other intangible
assets, comprised of the Citigroup L&A distribution
agreements and customer relationships acquired as a part of the
purchase. The estimated fair value of the distribution
agreements and customer relationships are $173 million and
$12 million, respectively, for a total of
$185 million. The identifiable other intangibles will be
amortized in relation to the expected economic benefits of the
agreement. The estimated amortization for the three months ended
March 31, 2005 is immaterial and for the year ended
December 31, 2004 is $3 million. |
|
|
|
|
(r) |
Fair value adjustment of $1 million for the difference
between the estimated fair value and carrying value of Citigroup
L&As other assets of $24 million and a
recoverable from Citigroup of $25 million as described in
pro forma adjustment 3(ff)(iii).
The estimated amortization for the three months ended
March 31, 2005 is immaterial and for the year ended
December 31, 2004 is $5 million. |
|
|
|
|
(s) |
The pro forma financing adjustment represents the costs
associated with the issuance of commercial paper, senior debt
and mandatorily convertible equity units of $74 million.
For the three months ended March 31, 2005 and the year
ended December 31, 2004, approximately $5 million and
$20 million of such costs are assumed to be amortized,
respectively. |
|
|
|
|
(t) |
The pro forma financing adjustment to debt represents the
issuance of $1,000 million of commercial paper,
$2,700 million of senior debt, and $2,000 million of
mandatorily convertible equity units as described in
Note 2. Related interest expense is also described in
Note 2. Related debt issuance costs, and their
amortization, are described in pro forma adjustment 3(s).
The pro forma financing adjustment to equity represents the
issuance of $1,000 million of common stock to Citigroup and
$2,000 million of preferred shares as described in
Note 2. The estimated present value of the contractual
payments to be made under the variable share forward contract of
$111 million described in pro forma adjustment 3(w)
has been reflected as a reduction in the carrying value of the
common stock. Approximately $52 million in costs is
associated with the issuance of the perpetual preferred stock
and has been reflected as a reduction of their carrying value. |
|
|
|
|
(u) |
Deferred income taxes are adjusted to reflect the income tax
effects of the pro forma purchase adjustments and the adjustment
of the tax basis of the assets and liabilities acquired as a
result of an election under Internal Revenue Code
Section 338. The net effect of such adjustments is
$1,709 million. The deferred income tax asset is reduced by
a valuation allowance of $115 million related to operations
in Argentina. |
|
|
|
|
(v) |
The pro forma purchase adjustment of $227 million consists
of the fair value adjustment to decrease other liabilities for
the difference between the estimated fair value and carrying
value of Citigroup L&As other liabilities. |
|
|
|
|
(w) |
The pro forma financing adjustment of $111 million records
the estimated present value of the contractual payments to be
made under the terms of the variable share forward contract
component of the mandatorily convertible equity units. Also, a
pro forma financing adjustment of $1 million and
$4 million for the three months ended March 31, 2005
and the year ended December 31, 2004, respectively, has
been made to record accretion on the accrued balance. See
Note 2 for further discussion of the terms of the
mandatorily convertible equity units. |
|
|
|
|
(x) |
Elimination of Citigroup L&As historical equity
balances. |
|
|
|
|
(y) |
The pro forma purchase adjustment of $1 million for the
three months ended March 31, 2005 represents a
reclassification of $10 million in surrender fees from
other revenues to universal life and |
S-48
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
|
|
|
investment-type policy fees offset by the elimination of
$11 million in amortization of deferred policy fees
resulting from the elimination of such deferred revenue,
included within the other liabilities pro forma
adjustment 3(v). The pro forma purchase adjustment of
$34 million for the year ended December 31, 2004
represents a reclassification of $47 million in surrender
fees from other revenues to universal life and investment-type
policy fees offset by the elimination of $13 million in
amortization of deferred policy fees resulting from the
elimination of such deferred revenue. |
|
|
(z) |
Decrease in net investment income relates to pro forma purchase
adjustments for the three months ended March 31, 2005 and
the year ended December 31, 2004 as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three | |
|
|
|
|
|
|
|
|
months ended | |
|
For the year ended | |
|
|
|
|
|
|
March 31, 2005 | |
|
December 31, 2004 | |
|
|
|
|
|
|
| |
|
| |
|
|
|
|
|
|
(In millions) | |
1)
|
|
Amortization of the increase in fair value of fixed maturity
available-for-sale |
|
|
|
|
|
$ |
(71 |
) |
|
$ |
(282 |
) |
2)
|
|
Amortization of the increase in fair value of mortgage loans |
|
|
3(c) |
|
|
|
(4 |
) |
|
|
(15 |
) |
3)
|
|
Amortization of the increase in fair value of policy loans |
|
|
3(d) |
|
|
|
|
|
|
|
(1 |
) |
4)
|
|
Amortization of the increase in real estate held-for-investment |
|
|
3(e) |
|
|
|
(1 |
) |
|
|
(5 |
) |
5)
|
|
Elimination of investment income on the MetLife securities held
by Citigroup |
|
|
3(a) |
|
|
|
(2 |
) |
|
|
(8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(78 |
) |
|
$ |
(311 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(aa) |
Decrease in net investment income relating to the elimination of
the investment income on fixed maturity securities of
$23 million and $92 million for the three months ended
March 31, 2005 and for the year ended December 31,
2004, respectively, as described in pro forma
adjustment 3(b). |
|
|
|
|
(bb) |
The pro forma purchase adjustment of $19 million for the
three months ended March 31, 2005 represents a
reclassification of $10 million in surrender fees from
other revenues to universal life and investment-type policy
fees, plus the elimination of $6 million in amortization of
deferred ceding commission income resulting from the elimination
of such deferred revenue, included within the other liabilities
adjustment in pro forma purchase adjustment 3(v), and the
amortization of the fair value of other invested assets of
$3 million as described in pro forma adjustment 3(h). The
pro forma purchase adjustment of $83 million for the year
ended December 31, 2004 represents a reclassification of
$47 million in surrender fees from other revenues to
universal life and investment-type policy fees, plus the
elimination of $27 million in amortization of deferred
ceding commission income resulting from the elimination of such
deferred revenue, and the amortization of the fair value of
other invested assets of $9 million. |
S-49
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
|
|
(cc) |
Decrease in other expenses relates to pro forma purchase
adjustments for the three months ended March 31, 2005 and
the year ended December 31, 2004 is as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For | |
|
For | |
|
|
|
|
|
|
the three months ended | |
|
the year ended | |
|
|
|
|
|
|
March 31, 2005 | |
|
December 31, 2004 | |
|
|
|
|
|
|
| |
|
| |
|
|
|
|
|
|
(In millions) | |
1)
|
|
Elimination of intercompany interest expense |
|
|
3(a) |
|
|
$ |
(2 |
) |
|
$ |
(8 |
) |
2)
|
|
Elimination of amortization on historical deferred policy
acquisition costs |
|
|
3(l) |
|
|
|
(108 |
) |
|
|
(394 |
) |
3)
|
|
Elimination of historical amortization of VOBA |
|
|
3(m) |
|
|
|
(2 |
) |
|
|
(10 |
) |
4)
|
|
Amortization of VOBA |
|
|
3(n) |
|
|
|
73 |
|
|
|
283 |
|
5)
|
|
Amortization of other intangible assets |
|
|
3(q) |
|
|
|
|
|
|
|
3 |
|
6)
|
|
Amortization of other adjustments |
|
|
|
|
|
|
|
|
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(39 |
) |
|
$ |
(131 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dd) |
The pro forma financing adjustment of $70 million for the
three months ended March 31, 2005 represents interest
expense on financing of transaction of $64 million as
disclosed in Note 2, amortization of debt issuance costs of
$5 million in pro forma financing adjustment 3(s) and
$1 million in accretion on accrued contractual payments on
mandatorily convertible equity units in pro forma financing
adjustment 3(w). The pro forma financing adjustment of
$279 million for the year ended December 31, 2004
represents interest expense on financing of transaction of
$255 million as disclosed in Note 2, amortization of
debt issuance costs of $20 million in pro forma financing
adjustment 3(s) and $4 million in accretion on accrued
contractual payments on mandatorily convertible equity units. |
|
|
|
|
(ee) |
Represents the income tax effect of all unaudited pro forma
condensed consolidated statement of income adjustments using a
tax rate of 35% for the three months ended March 31, 2005
and for the year ended December 31, 2004. The year ended
December 31, 2004 also includes an adjustment of
$71 million to eliminate certain tax items which are not
relevant to that pro forma presentation. |
|
|
|
|
(ff) |
As a part of the Acquisition, MetLife will acquire Citigroup
L&As insurance operations in Argentina. The
Argentinean economic, regulatory and legal environment,
including interpretation of laws and regulations by regulators
and courts, is uncertain. Potential legal or governmental
actions related to pension reform, fiduciary responsibilities,
performance guarantees and tax rulings could adversely affect
the results of the combined company as reflected in the
accompanying unaudited pro forma interim condensed consolidated
financial information. |
|
|
|
Upon acquisition there are certain liabilities which will be
established in purchase accounting as follows (subject to any
adjustments to reflect changes in Citigroup L&As
closing balance sheet): |
|
|
|
|
(i) |
In order to conform to MetLifes interpretation of
applicable Argentine law, death and disability liabilities will
increase by an estimated $107 million in Citigroup
L&As managed pension business in Argentina. This
increase reflects additional death and disability claims that
have occurred through March 31, 2005 but had not yet been
approved by the Argentine regulator. MetLifes policy has
been to accrue a liability for incurred claims in excess of the |
S-50
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
|
|
|
claims-made amounts, reflecting managements belief that
applicable Argentine law does not relieve the managed pension
business from providing for such additional claims. The accrued
liability recorded by Citigroup L&A as of March 31,
2005 reflects Citigroups belief that the managed pension
business is only obligated under applicable Argentine law to
provide group claims-made coverage to the managed pension
business customers. |
|
|
(ii) |
An additional liability of $105 million will be established
related to litigation and an impending Supreme Court of Justice
of Argentina ruling in connection with the pesification of
certain policyholder liabilities from U.S.-dollar-denominated
insurance policies in January 2002 when the Argentina government
converted all foreign currency denominated financial contracts
to Argentinean pesos. |
|
|
|
The unaudited historical condensed combined financial statements
of Citigroup L&A reflect a liability for future policy
benefits for the affected insurance policies based on a
conversion ratio of one Argentine peso to one U.S. dollar
adjusted by CER (inflation index), which is the conversion ratio
specified by the conversion law and implementing regulations for
these policies. However, throughout the country and affecting
all insurance companies, policyholders have challenged the
legality of the conversion of their policies to pesos in various
court proceedings. When policyholders have brought similar
actions against MetLifes Argentinean insurance companies,
MetLife has accrued a liability, which it believes is both
probable and reasonably estimable, for the difference between
the value of the policy based on its original U.S. dollar
terms and current open market currency exchange rates. In
accordance with the requirements of Statement of Financial
Accounting Standards No. 141 Business
Combinations (SFAS No. 141), a
pro forma adjustment of $35 million has been recorded to
reflect MetLifes estimate of the present value of such
policy liabilities at March 31, 2005. |
|
|
The Supreme Court of Justice of Argentina is also currently
considering actions challenging the peso conversion as it was
applied to insurance policies and annuity contracts. The outcome
of the Supreme Court action is uncertain, but MetLife considers
it probable that some modification to the original peso
conversion will be required and that the most likely
modification will be to require a conversion ratio of 1.4
Argentinean pesos to one U.S. dollar, which is the
conversion ratio applied to bank deposits. MetLife has estimated
the fair value of the additional policy liability required for
Citigroup L&As insurance companies would be
approximately $70 million; accordingly, in accordance with
SFAS 141, MetLife has recorded an adjustment to record the
fair value of such liability. The maximum exposure for these
companies if the Supreme Court were to overturn entirely the
peso conversion is approximately $190 million. MetLife
considers the possibility that the Supreme Court will entirely
overturn the peso conversion as applied to insurance policies to
be remote because the Supreme Court has previously upheld the
peso conversion as applied to bank deposits at a conversion
ratio of 1.4 Argentinean pesos to one U.S. dollar. |
|
|
|
|
(iii) |
A pro forma purchase adjustment of $50 million at
March 31, 2005 has been recorded related to tax
contingencies generated upon pesification and the conversion of
Argentinean national debt obligations from U.S. dollars to pesos
at a conversion rate of 1.4 Argentinean pesos to one
U.S. dollar adjusted by CER (inflation index). Based on
statements from the Argentinean Undersecretary of Public
Revenues Ministry of Economy, MetLife believes a tax liability
exists on the conversion premium and the CER; accordingly, a
liability has been established for this potential tax
contingency. A receivable of $25 million from Citigroup has
also been established as Citigroup has indemnified MetLife for
50% of such tax contingencies. |
S-51
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
Merger-Related Costs
MetLifes preliminary integration plan includes merger
related costs of approximately $196 million,
$127 million net of income taxes. Such costs are not
included in the purchase price allocation but are period costs
which will be charged to the statement of income as incurred
over a two year period subsequent to the closing of the
Acquisition. As these costs are not a part of the normal
operations of MetLife, they have not been reflected in the
accompanying unaudited pro forma condensed consolidated
statements of income. These costs include expenses related to
the redeployment of MetLife staff, retention bonuses for
Citigroup L&A employees, MetLife employee-related
restructuring and integration expenses, system migration,
product integration and other infrastructure costs. As
integration plans are finalized and implemented, such costs will
be more precisely quantified. Actual costs may vary materially
from these preliminary estimates.
|
|
4. |
Earnings Per Common Share |
Pro forma earnings per common share for the three months ended
March 31, 2005 and for the year ended December 31,
2004 have been calculated based on the estimated weighted
average number of common shares on a pro forma basis, as
described below.
|
|
|
|
(a) |
The historical weighted average number of common shares of
MetLife, Inc. is 734.0 million and 739.6 million,
basic and diluted, respectively, for the three months ended
March 31, 2005. The historical weighted average number of
common shares of MetLife, Inc. is 749.7 million and
754.8 million, basic and diluted, respectively, for the
year ended December 31, 2004. |
|
|
(b) |
The pro forma weighted average number of common shares, after
giving effect to the Acquisition, is 757.0 million and
762.6 million, basic and diluted, respectively, for the
three months ended March 31, 2005. The pro forma weighted
average number of common shares reflects the issuance of
23.0 million MetLife, Inc. common shares to Citigroup in
the Acquisition. For purposes of calculating the number of
shares to be issued to Citigroup, the price of the MetLife, Inc.
common shares to be issued is assumed to be $43.53 per
common share, which represents the weighted average closing
price of MetLife, Inc.s common shares on the New York
Stock Exchange for the ten-day period ending May 26, 2005. |
|
|
|
The pro forma weighted average number of common shares, after
giving effect to the Acquisition, is 772.7 million and
777.8 million, basic and diluted, respectively, for the
year ended December 31, 2004. The pro forma weighted
average number of common shares reflects the issuance of
23.0 million MetLife, Inc. common shares to Citigroup in
the Acquisition. For purposes of calculating the number of
shares to be issued to Citigroup, the price of the MetLife, Inc.
common shares to be issued is assumed to be $43.53 per
common share, which represents the weighted average closing
price of MetLife, Inc.s common shares on the New York
Stock Exchange for the ten-day period ending May 26, 2005. |
|
|
|
|
(c) |
Estimated dividends of $30 million and $120 million on
the perpetual preferred stock to be issued in connection with
the Acquisition have been deducted from income available to
common stockholders for the three months ended March 31,
2005 and for the year ended December 31, 2004,
respectively, for purposes of the pro forma earnings per share
calculation. See Note 2 for discussion of the dividend rate
used in preparing the pro forma earnings per share. |
|
|
(d) |
As discussed in Note 2, the value of shares to be issued to
Citigroup by MetLife, Inc. under the Acquisition Agreement may
range up to $3 billion. This unaudited pro forma condensed
consolidated financial information assumes that $1 billion
of common shares will be issued. For the three months ended
March 31, 2005, the impact of issuing an additional
$2 billion of common shares, for a total of
$3 billion, to Citigroup would increase the basic and
diluted weighted average common shares by 45.9 million
shares and reduce both the basic and diluted pro forma earnings
per share |
S-52
MetLife, Inc.
Notes to the Unaudited Pro Forma Condensed Consolidated
Financial Information (Continued)
|
|
|
|
|
amounts by $0.06, to $1.25 and $1.24, respectively. The increase
in the number of common shares issued by $2 billion reduces
the amount of the mandatorily convertible equity units by
$2 billion which results in a decrease in interest expense
of $20 million, $13 million after income taxes. Debt
issuance costs on the mandatorily convertible equity units would
decline by $55 million, $36 million after income
taxes. The quarterly amortization of debt issuance costs and
amortization of the accretion on accrued contractual payments
related to the forward share contract component of the
mandatorily convertible equity units would also decline by
$5 million, $3 million after income taxes, and
$1 million, $1 million after income taxes,
respectively. |
|
|
|
For the year ended December 31, 2004, the impact of issuing
an additional $2 billion of common shares, for a total of
$3 billion, to Citigroup would increase the basic and
diluted weighted average common shares by 45.9 million
shares and reduce both the basic and diluted pro forma earnings
per share amounts by $0.14, to $3.90 and $3.87, respectively.
The increase in the number of common shares issued by
$2 billion reduces the amount of the mandatorily
convertible equity units by $2 billion which results in a
decrease in interest expense of $80 million,
$52 million after income taxes. Debt issuance costs on the
mandatorily convertible equity units would decline by
$55 million, $36 million after income taxes. The
amortization of debt issuance costs and amortization of the
accretion on accrued contractual payments related to the forward
share contract component of the mandatorily convertible equity
units would also decline by $18 million, $12 million
after income taxes, and $4 million, $3 million after
income taxes, respectively. |
S-53
RATIO OF EARNINGS TO FIXED CHARGES
The following table sets forth our historical ratio of earnings
to fixed charges for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the | |
|
|
|
|
|
|
|
|
|
|
|
|
Three Months | |
|
|
|
|
|
|
|
|
|
|
|
|
Ended | |
|
|
|
|
March 31, | |
|
For the Year Ended December 31, | |
|
|
| |
|
| |
|
|
2005 | |
|
2004 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Ratio of Earnings to Fixed Charges
|
|
|
2.16 |
|
|
|
2.16 |
|
|
|
2.06 |
|
|
|
1.75 |
|
|
|
1.50 |
|
|
|
1.13 |
|
|
|
1.31 |
|
For purposes of this computation, earnings are defined as income
before provision for income taxes and discontinued operations
and excluding undistributed income and losses from equity method
investments, minority interest and fixed charges, excluding
capitalized interest. Fixed charges are the sum of interest and
debt issue costs, interest credited to policyholder account
balances and an estimated interest component of rent expense.
S-54
USE OF PROCEEDS
MetLife, Inc. expects to receive net proceeds from this offering
of approximately
$ after
expenses and underwriting discounts.
MetLife, Inc. intends to use the net proceeds from this offering
to fund a portion of the purchase price for MetLife, Inc.s
acquisition of Citigroup L&A as described below. In the
event the Acquisition is not consummated, MetLife, Inc. will use
the net proceeds from the sale of the series A preferred
shares for general corporate purposes.
The Acquisition Agreement permits MetLife, Inc. to pay up to $3
billion of the $11.5 billion purchase price (with the
amount to be determined by us) to Citigroup in MetLife, Inc.
common stock (or, in the circumstances described below under
Proposed Acquisition of the Citigroup Life Insurance and
Annuities Business, non-voting convertible participating
preferred stock). MetLife, Inc. currently intends to issue
$1 billion of the purchase price in common stock. The
remainder of the purchase price must be paid in cash.
MetLife, Inc. intends to finance the cash portion of the
purchase price through a combination of cash on hand, dividends
from MetLife, Inc.s insurance subsidiaries, net proceeds
from the sale of a real estate property and available-for-sale
fixed maturity securities, and the net proceeds from the
issuance of commercial paper and various forms of securities
including:
|
|
|
|
|
the series A preferred shares offered hereby; |
|
|
|
an additional class of newly-issued fixed rate preferred stock; |
|
|
|
mandatorily convertible equity units; and |
|
|
|
senior debt. |
In the event that any of the proposed offerings of securities
cannot be completed on commercially acceptable terms, MetLife,
Inc. may borrow up to $7 billion under a bridge financing
facility. MetLife, Inc. currently expects to commence the
offerings of fixed-rate preferred stock, mandatorily convertible
equity units and senior debt shortly after the pricing of this
offering of series A preferred shares. The form, manner and
timing of the financing of the Acquisition is subject to change.
Please refer to Note 2 and pro forma adjustment
3(t) in Unaudited Pro Forma Condensed Consolidated
Financial Information for further discussion of the
financing transactions.
S-55
CAPITALIZATION
The following table sets forth our historical and unaudited pro
forma capitalization as of March 31, 2005, as adjusted to
give effect to (i) this offering of the series A
preferred shares and (ii) the Acquisition and related
financings:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At March 31, 2005 | |
|
|
| |
|
|
|
|
Adjusted for this | |
|
|
|
|
|
|
Offering of | |
|
|
|
|
|
|
Series A | |
|
Adjusted for the | |
|
|
|
|
Preferred | |
|
Acquisition and | |
|
|
Actual | |
|
Shares(1) | |
|
Related Financings(2) | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Short-term debt
|
|
$ |
1,120 |
|
|
$ |
1,120 |
|
|
$ |
2,120 |
|
Long-term debt
|
|
|
7,414 |
|
|
|
7,414 |
|
|
|
12,004 |
|
Shares subject to mandatory redemption
|
|
|
278 |
|
|
|
278 |
|
|
|
278 |
|
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
8,812 |
|
|
|
8,812 |
|
|
|
14,402 |
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, at par value
|
|
|
8 |
|
|
|
8 |
|
|
|
8 |
|
|
Additional paid-in capital
|
|
|
15,043 |
|
|
|
15,043 |
|
|
|
15,932 |
|
|
Preferred stock, at par value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital
|
|
|
|
|
|
|
487 |
|
|
|
1,948 |
|
|
Retained earnings
|
|
|
7,595 |
|
|
|
7,595 |
|
|
|
8,353 |
|
|
Treasury stock, at cost
|
|
|
(1,764 |
) |
|
|
(1,764 |
) |
|
|
(1,764 |
) |
|
Accumulated other comprehensive income
|
|
|
2,156 |
|
|
|
2,156 |
|
|
|
2,156 |
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
23,038 |
|
|
|
23,525 |
|
|
|
26,633 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total capitalization
|
|
$ |
31,850 |
|
|
$ |
32,337 |
|
|
$ |
41,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Adjusted for this offering of series A preferred shares,
assuming gross proceeds of $500 million, net of related
issuance costs of $13 million. |
|
(2) |
Adjusted for this offering of series A preferred shares, as well
as the Acquisition and the anticipated related financing
transactions, including the assumed issuance of
$1,000 million of commercial paper, $2,700 million of
senior debt, $2,000 million of mandatory convertible equity
units and $1,500 million of fixed-rate preferred
securities. Also adjusted for the anticipated issuance of
$1,000 million of common stock to Citigroup and the
elimination of $87 million of MetLife debt resulting from
the Acquisition. These adjustments reflect managements
best estimate of the forms and amounts of financing at the time
of this offering. The actual form of financing of the
Acquisition may involve different forms of financing and/or
different amounts of the same types of securities. Please refer
to Unaudited Pro Forma Condensed Consolidated Financial
Information for further discussion of the financing
transactions. |
S-56
PROPOSED ACQUISITION OF THE CITIGROUP LIFE
INSURANCE AND ANNUITIES BUSINESS
In this section we discuss the terms and provisions of the
Acquisition Agreement. This discussion does not purport to be
complete and is qualified in its entirety by reference to the
Acquisition Agreement attached as an exhibit to our Current
Report on Form 8-K, filed with the SEC on February 4,
2005, which is incorporated by reference in the accompanying
prospectus.
On January 31, 2005, MetLife, Inc. entered into the
Acquisition Agreement to acquire for $11.5 billion in
consideration, subject to certain closing adjustments, all of
the outstanding shares of Citigroup L&A. The closing is
expected to occur during the summer of 2005. As a condition to
closing, MetLife, Inc. will enter into ten-year distribution
agreements with Citigroup, under which we will expand our
distribution by making products available through certain
Citigroup distribution channels, subject to appropriate
suitability and other standards, including the competitiveness
of our products and the financial strength of our providers.
These channels include CitiStreet Retirement Services, Smith
Barney, Citibank branches and Primerica Financial Services in
the United States and various Citigroup consumer businesses
internationally.
Up to $3 billion (with the amount to be determined by us,
which we currently expect to be $1 billion) of the purchase
price will be paid in our common stock (or, in the circumstances
described below, non-voting convertible participating preferred
stock) with the remainder paid in cash. The amount of common
stock that we issue at the closing will be determined based on
the average daily closing price of our common stock for the 10
trading days prior to the closing date. If the common stock that
we issue at closing, taken together with existing shares of our
capital stock owned by Citigroup and its affiliates, would
exceed 4.9% of our outstanding capital stock, Citigroup may
require us to issue to Citigroup, in lieu of the shares of
common stock in excess of 4.9% of our outstanding capital stock,
shares of our non-voting convertible participating preferred
stock. Any such preferred stock, if issued as part of the
Acquisition, will rank junior to the series A preferred
shares. Under the terms of the Acquisition Agreement, in no
event may the common stock and any preferred stock we provide as
consideration exceed 9.4% of our issued and outstanding capital
stock. We intend to finance the cash portion of the purchase
price through a combination of cash on hand, dividends from our
insurance subsidiaries, net proceeds from the sale of a real
estate property and available-for-sale fixed maturity
securities, and the net proceeds from the issuance of commercial
paper and various other forms of securities, including the
series A preferred shares offered hereby, fixed rate
preferred securities, mandatorily convertible equity units and
senior debt. In the event that any of the proposed offerings of
securities cannot be completed on commercially acceptable terms,
we may borrow up to $7 billion under a bridge financing
facility. See Use of Proceeds,
Capitalization and the notes to our unaudited pro
forma condensed consolidated financial statements included
herein.
Overview of Citigroup L&A
Citigroup L&A provides insurance and other financial
services to a broad spectrum of individual and institutional
customers in the United States and select international markets.
Citigroup L&As U.S. business principally operates
through TIC, based in Hartford, Connecticut. Citigroup
L&As international business operates in several
countries with wholly owned subsidiaries in Australia, Brazil,
Argentina, the United Kingdom, Belgium and Poland and a joint
venture in each of Japan and Hong Kong. Citigroup L&A also
includes certain individual life and retail annuity business in
run-off status since 2003.
At December 31, 2004, Citigroup L&As total assets
were $97.3 billion, approximately 96% of which was
associated with domestic operations. Citigroup L&As
net income for the year ended December 31, 2004 was
$901 million, to which domestic and international
operations contributed 91% and 9%, respectively.
|
|
|
Citigroup L&A U.S. Operations |
Citigroup L&As principal U.S. product offerings
include:
|
|
|
|
|
Retail annuity products, including fixed and variable
deferred annuities and payout annuities. Citigroup L&A
distributes its individual annuity products through Citigroup
affiliated channels ($3.9 billion of |
S-57
|
|
|
|
|
individual retail annuity premium and deposits in 2004) and
non-affiliated channels ($1.8 billion of individual annuity
premium and deposits in 2004). The Citigroup affiliated channels
include CitiStreet Retirement Services, Smith Barney, Primerica
Financial Services and Citibank branches. Non-affiliated
channels include a nationwide network of independent financial
professionals and independent broker-dealers, including Morgan
Stanley, Merrill Lynch & Co., Fidelity, AXA and
Wachovia Securities. |
|
|
|
Individual life insurance products, including term,
universal and variable life insurance. Citigroup L&As
individual life insurance products are primarily marketed by
independent financial professionals, who accounted for
$745 million of the $964 million total life insurance
sales for 2004. |
|
|
|
Institutional annuity products, including institutional
pensions, GICs, payout annuities, group annuities sold to
employer-sponsored retirement and savings plans, structured
settlements and funding agreements. Citigroup L&As
institutional annuity products are sold through direct sales and
various intermediaries. |
|
|
|
Citigroup L&A International Operations |
Citigroup L&As international operations offer a
variety of insurance products, including credit insurance, basic
indemnity policies (such as accident and health products),
traditional term life, group life, whole life, endowment, fixed
and variable annuities, pension annuities and unit-linked
policies. Citigroup L&A distributes its products in
international markets primarily through Citigroups
consumer businesses, including its retail banking, credit card
and consumer finance franchises, as well as through
non-proprietary channels. International sales are also conducted
through direct mail and telemarketing, branch sales, wholesaling
networks, agencies and direct sales agents.
Non-Competition Covenant
For a period of seven years following the closing date,
Citigroup and its affiliates are prohibited under the
Acquisition Agreement from issuing or reinsuring life insurance
and annuity contracts in the United States and internationally
(with the exception of Argentina and Mexico) and from issuing or
reinsuring accident and health insurance in Australia, Belgium,
Brazil, China, Hong Kong, Japan, Poland and the United Kingdom,
subject to a number of exceptions, including without limitation:
(i) the issuance and distribution of term life insurance
products by Primerica Life Insurance Company and its
subsidiaries in specified countries, including the United
States, (ii) issuing credit protection and related
insurance products, (iii) for certain other insurance
company affiliates of Citigroup not acquired as part of the
Acquisition, issuing, distributing or administering any
insurance products, which business in the aggregate, for all
such insurance companies, may account for no more than
$80 million in net revenues on an annual basis in the
United States and $20 million in net revenues on an annual
basis outside the United States and (iv) acquiring
companies with life insurance, annuity and accident and health
insurance operations whose net revenues and net earnings derived
from these operations do not exceed certain contractually
specified thresholds.
Distribution Agreements
As a condition to closing, MetLife, Inc. and Citigroup will
enter into ten-year distribution agreements pursuant to which
Citigroup will provide MetLife with access to certain Citigroup
distribution channels, subject to appropriate suitability and
other standards, including the competitiveness of MetLifes
products and the financial strength of its providers. MetLife
will have rights to continue the existing distribution
arrangements between the life insurance companies acquired by
MetLife under the Acquisition Agreement and distributors
affiliated with Citigroup with respect to the acquired life
insurers existing products, and in certain circumstances,
to substitute MetLife products for the acquired life
insurers products. In addition, for the first seven years
of the distribution agreements, MetLife will have the right to
have its bid considered in the event that distributors
affiliated with Citigroup seek to distribute new
Citigroup-branded life insurance products (other than term life
insurance). This right does not apply to cases where
distributors are approached on an unsolicited basis with
proposals for Citigroup-branded life insurance products.
S-58
Investor Rights Agreement
In connection with the issuance of MetLife, Inc.s common
stock to Citigroup as part of the Acquisition purchase price, we
will enter into an investor rights agreement with Citigroup.
Under the investor rights agreement, at Citigroups request
we will use our best efforts to promptly file a shelf
registration statement providing for the resale of such number
of shares of MetLife, Inc.s common stock held by Citigroup
as Citigroup requests on a delayed or continuous basis pursuant
to Rule 415 under the Securities Act. Citigroup will be
entitled to effect between two and four fully marketed
underwritten takedowns (but in any event no more than two
underwritten takedowns in any 12 month period) under the
shelf registration statement depending on the amount of MetLife,
Inc.s common stock issued to Citigroup as part of the
Acquisition purchase price. Citigroup may also demand that
MetLife, Inc. file registration statements with the SEC
providing for one-off offerings of all or a portion
of MetLife, Inc.s common stock issued to Citigroup as part
of the Acquisition purchase price. Citigroup will be permitted
to effect between two and four demand registrations less any
underwritten takedowns previously completed off of the shelf
registration statement described above. Citigroup may transfer
all or a portion of its then-remaining demand registration
rights to a third party who acquires at least 20% of the total
amount of stock consideration paid to Citigroup as part of the
Acquisition purchase price, provided that such third party
agrees to be bound by the terms of the investor rights
agreement. Subject to customary exceptions, Citigroup may not
(i) transfer more than 5% of MetLife, Inc.s
outstanding common stock to a competitor of ours; or
(ii) transfer more than $1 billion in the aggregate of
MetLife, Inc.s stock consideration paid to Citigroup as
part of the Acquisition purchase price to any one person. These
restrictions on transfer will not apply to any transfer pursuant
to Rule 144 under the Securities Act or offerings made
under a shelf registration statement, demand registrations or
piggyback registrations.
If we issue stock consideration to Citigroup in connection with
the Acquisition for $1 billion or less of the purchase
price, Citigroup may not sell any of the stock consideration for
12 months following the closing of the Acquisition. If we
issue stock consideration to Citigroup for more than
$1 billion of the purchase price, Citigroup may not sell
$1 billion of the stock consideration for 12 months
following the closing of the Acquisition and any additional
amount in excess of $1 billion for six months
following the closing of the Acquisition. These restrictions
will not prohibit private offerings by Citigroup of the stock
consideration that do not require registration under the
Securities Act at any time after six months following the
closing.
Citigroup has also agreed that until such time as it holds less
than 5% of MetLife, Inc.s outstanding common stock, it
will agree to a number of standstill provisions, including
(i) not to propose to acquire, or to acquire any securities
or other property of MetLife, Inc. or make any statement about
any merger or other corporate transaction of MetLife, Inc.,
(ii) not to seek representation on
MetLife, Inc.s board of directors or the removal of
any directors from MetLife, Inc.s board of directors,
(iii) not to make any solicitation of proxies to vote
MetLife, Inc.s securities, (iv) not to form or
join a group with respect to any of
MetLife, Inc.s voting securities, (v) not to
seek to control MetLife, Inc.s management or
MetLife, Inc.s board of directors, (vi) not to
deposit any of MetLife, Inc.s securities in a voting
trust and (vii) not to make a public request, or advise or
otherwise assist others, to do any of the foregoing.
Other Ancillary Agreements
In addition to the distribution agreements and the investor
rights agreement described above, we will also enter into
several other agreements with Citigroup in connection with the
Acquisition. These agreements include an investment management
agreement, pursuant to which affiliates of Citigroup will
continue to provide certain management and advisory services to
Citigroup L&A, and Citigroup L&A will continue to
include funds advised or sub-advised by Citigroup affiliates as
investment alternatives under variable life insurance policies
and variable annuity contracts, following the closing of the
Acquisition, a license agreement governing certain of the
parties intellectual property rights and a transition
services agreement, pursuant to which Citigroup L&A and
Citigroup, following the closing of the Acquisition, will
continue to provide each other services that they provided to
each other prior to the closing, in each case for a specified
term.
S-59
Conditions to Closing
The respective obligations of each of MetLife and Citigroup to
effect the Acquisition are conditioned upon the satisfaction of
the following conditions:
|
|
|
|
|
expiration or termination of the applicable waiting period under
the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended; |
|
|
|
completion of required filings with, and receipt of required
authorizations, consents and approvals of, insurance regulatory
authorities; |
|
|
|
completion of required filings with, and receipt of required
authorizations, consents and approvals of other governmental or
regulatory bodies, agencies, court or authorities, except to the
extent that the failure to make or obtain such filings,
authorizations, consents and approvals would not, individually
or in the aggregate, reasonably be expected to have a material
adverse effect on the condition (financial or otherwise),
business or operating results of MetLife or the Citigroup
L&A business, a material adverse effect on Citigroup, or a
material adverse change or effect on the ability of Citigroup or
MetLife to timely perform their obligations under the
Acquisition Agreement or the transactions contemplated
thereunder; |
|
|
|
absence of legal or regulatory conditions, restrictions,
undertakings or limitations with respect to any authorizations,
consents or approvals by insurance regulatory authorities or any
other governmental or regulatory body, agency, court or
authority in connection with the Acquisition which would,
individually or in the aggregate, reasonably be expected to have
a material adverse effect on the condition (financial or
otherwise), business or operating results of MetLife or the
Citigroup L&A business, a material adverse effect on
Citigroup, or a material adverse change or effect on the ability
of Citigroup or MetLife to timely perform their obligations
under the Acquisition Agreement or the transactions contemplated
thereunder; and |
|
|
|
absence of any statute, rule, regulation, judgment or order
being in effect by any governmental or regulatory body, agency,
court or authority that restrains, enjoins or otherwise
prohibits the consummation of the Acquisition or that makes the
consummation of the Acquisition illegal. |
MetLifes obligation to effect the Acquisition is also
subject to, among other things, the satisfaction or waiver by
MetLife, at or prior to the closing of the Acquisition, of the
following conditions:
|
|
|
|
|
the representations and warranties of Citigroup set forth in the
Acquisition Agreement are true and correct as of the date of
execution of the Acquisition Agreement and as of the closing
date of the Acquisition (subject to certain exceptions), except
where any failure of the representations and warranties to be
true and correct would not reasonably be expected to have,
individually or in the aggregate, a material adverse effect on
the condition (financial or otherwise), business or operating
results of the Citigroup L&A business or a material adverse
change or effect on the ability of Citigroup to perform timely
its obligations under the Acquisition Agreement or the
transactions contemplated thereunder; and |
|
|
|
Citigroup has performed in all material respects all obligations
required to be performed by it under the Acquisition Agreement. |
Citigroups obligation to effect the Acquisition is also
subject to, among other things, the satisfaction or waiver by
Citigroup, at or prior to the closing of the Acquisition, of the
following conditions:
|
|
|
|
|
the representations and warranties of MetLife set forth in the
Acquisition Agreement are true and correct as of the date of
execution of the Acquisition Agreement and as of the closing
date of the Acquisition (subject to certain exceptions), except
where any failure of the representations and warranties to be
true and correct would not reasonably be expected to have,
individually or in the aggregate, a material adverse effect on
the condition (financial or otherwise), business or operating
results of MetLife or a material adverse change or effect on the
ability of MetLife to perform timely its obligations under the
Acquisition Agreement or the transactions contemplated
thereunder; |
S-60
|
|
|
|
|
MetLife has performed in all material respects all requirements
required to be performed by it under the Acquisition
Agreement; and |
|
|
|
approval for the listing on the New York Stock Exchange of the
MetLife, Inc. common stock issued to Citigroup in the
Acquisition (including any shares issuable upon conversion of
any non-voting convertible participating preferred stock issued
to Citigroup in the Acquisition). |
The closing of the Acquisition is also subject to the execution
and delivery of the various agreements described above.
The closing of the Acquisition will take place on the first
business day of the month following the date on which the last
of the conditions to closing under the Acquisition Agreement is
either satisfied or waived, unless the closing is delayed.
MetLife, Inc., for example, may delay closing for a period not
to exceed three months following the date on which the SEC has
confirmed that it is not undertaking a review of a registration
statement of MetLife, Inc. to be used to offer and sell
securities as part of the financing by MetLife, Inc. of the
Acquisition purchase price. We received confirmation on
May 12, 2005 that this registration statement would not be
reviewed by the SEC.
Termination
MetLife and Citigroup may terminate the Acquisition Agreement by
mutual consent. Also, either party may terminate the Acquisition
Agreement if:
|
|
|
|
|
the Acquisition has not been consummated before January 31,
2006, unless the party seeking to terminate the Acquisition
Agreement has materially breached any representation, warranty,
covenant or obligation under the Acquisition Agreement and the
failure of the Acquisition to occur on or before that date has
arisen out of, or resulted from, the material breach; or |
|
|
|
the other party breaches any of its representations, warranties,
covenants or obligations in the Acquisition Agreement, which
breach would prevent satisfaction of a closing condition and the
breach is incapable of being cured, or is not cured, within
60 days after receipt of written notice of the breach. |
For further information on the pro forma effect of the
Acquisition on MetLifes financial statements, see
Unaudited Pro Forma Condensed Consolidated Financial
Information.
S-61
DESCRIPTION OF THE SERIES A PREFERRED SHARES
The following description of the particular terms of the
series A preferred shares supplements the description of
the general terms and provisions of the preferred stock set
forth under Description of Capital Stock
Preferred Stock beginning on page 15 in the
accompanying prospectus. The following summary of the terms and
provisions of the series A preferred shares does not
purport to be complete and is qualified in its entirety by
reference to the pertinent sections of our amended and restated
certificate of incorporation, which we have previously filed
with the SEC, and the certificate of designations creating the
series A preferred shares, which will be included as an
exhibit to documents that MetLife, Inc. files with the SEC.
Terms used in this prospectus supplement that are otherwise not
defined will have the meanings given to them in the accompanying
prospectus. As used in this section, we,
us, our and MetLife mean
MetLife, Inc. and do not include its subsidiaries.
General
MetLife, Inc.s authorized capital stock includes
200,000,000 shares of preferred stock, par value
$0.01 per share, which includes 10,000,000 shares of
our Series A Junior Participating Preferred Stock, par
value $0.01 per share. MetLife, Inc. does not have any
preferred stock or Series A Junior Participating Preferred
Stock outstanding as of the date of this prospectus supplement.
The series A preferred shares are part of a single series
of authorized preferred stock consisting
of shares. series A
preferred shares
( shares,
if the underwriters exercise their overallotment option to
purchase additional series A preferred shares in full) are
being initially offered hereby. We may from time to time,
without notice to or the consent of holders of the series A
preferred shares, issue additional series A preferred
shares.
The series A preferred shares will rank senior to our
junior stock (as defined herein) and at least equally with each
other series of our preferred stock that we may issue (except
for any senior series that may be issued with the requisite
consent of the holders of the series A preferred shares),
with respect to the payment of dividends and distributions of
assets upon liquidation, dissolution or winding up. In addition,
we will generally be able to pay dividends and distributions
upon liquidation, dissolution or winding up only out of lawfully
available funds for such payment (i.e., after taking account of
all indebtedness and other non-equity claims). The series A
preferred shares will be fully paid and nonassessable when
issued, which means that holders will have paid their purchase
price in full and that we may not ask them to surrender
additional funds. Holders of the series A preferred shares
will not have preemptive or subscription rights to acquire more
stock of MetLife, Inc.
The series A preferred shares will not be convertible into,
or exchangeable for, shares of any other class or series of
stock or other securities of MetLife, Inc. The series A
preferred shares have no stated maturity and will not be subject
to any sinking fund, retirement fund or purchase fund or other
obligation of MetLife, Inc. to redeem, repurchase or retire the
series A preferred shares.
Dividends
Dividends on the series A preferred shares will not be
mandatory. Holders of series A preferred shares will be
entitled to receive, when, as and if declared by our board of
directors or a duly authorized committee of the board, out of
funds legally available for the payment of dividends under
Delaware law, non-cumulative cash dividends from the original
issue date, quarterly in arrears on
the day of March, June, September
and December of each year, commencing on September ,
2005. These dividends will accrue, with respect to each dividend
period, on the liquidation preference amount of $25 per
share at an annual rate of the greater of:
|
|
|
|
|
%
above three month LIBOR on the related LIBOR determination date
(as described below); or |
|
|
|
%. |
In the event that we issue additional series A preferred
shares after the original issue date, dividends on such
additional shares may accrue from the original issue date or any
other date we specify at the time such additional shares are
issued.
S-62
Dividends will be payable to holders of record of the
series A preferred shares as they appear on our books on
the applicable record date, which shall be the 15th calendar day
before that dividend payment date or such other record date
fixed by our board of directors (or a duly authorized committee
of the board) that is not more than 60 nor less than
10 days prior to such dividend payment date (each, a
dividend record date). These dividend record dates
will apply regardless of whether a particular dividend record
date is a business day.
A dividend period is the period from and including a dividend
payment date to but excluding the next dividend payment date,
except that the initial dividend period will commence on and
include the original issue date of the series A preferred
shares and will end on and exclude the September ,
2005 dividend payment date. Dividends payable on the
series A preferred shares will be computed on the basis of
a 360-day year and the actual number of days elapsed in the
dividend period, except that dividends for the initial period
will be calculated from the original issue date. If any date on
which dividends would otherwise be payable is not a business
day, then the dividend payment date will be the next succeeding
business day unless such day falls in the next calendar month,
in which case the dividend payment date will be the first
preceding day that is a business day.
For any dividend period, three month LIBOR shall be determined
by the calculation agent on the second London business day
immediately preceding the first day of such dividend period in
the following manner:
|
|
|
|
|
LIBOR will be the annual offered rate for three-month deposits
in U.S. dollars, beginning on the first day of such period,
as that rate appears on Moneyline Telerate Page 3750 as of
11:00 a.m., London time, on the second London business day
immediately preceding the first day of such dividend period. |
|
|
|
If the rate described above does not appear on Moneyline
Telerate page 3750, LIBOR will be determined on the basis
of the rates, at approximately 11:00 a.m., London time, on
the second London business day immediately preceding the first
day of such dividend period, at which deposits of the following
kind are offered to prime banks in the London interbank market
by four major banks in that market selected by the calculation
agent: three-month deposits in U.S. dollars, beginning on
the first day of such dividend period, and in a Representative
Amount. The calculation agent will request the principal London
office of each of these banks to provide a quotation of its
rate. If at least two quotations are provided, LIBOR for the
second London business day immediately preceding the first day
of such dividend period will be the arithmetic mean of the
quotations. |
|
|
|
If fewer than two quotations are provided as described above,
LIBOR for the second London business day immediately preceding
the first day of such dividend period will be the arithmetic
mean of the rates for loans of the following kind to leading
European banks quoted, at approximately 11:00 a.m. New York
City time on the second London business day immediately
preceding the first day of such dividend period, by three major
banks in New York City selected by the calculation agent:
three-month loans of U.S. dollars, beginning on the first
day of such dividend period, and in a Representative Amount. |
|
|
|
If fewer than three banks selected by the calculation agent are
quoting as described above, LIBOR for the new dividend period
will be LIBOR in effect for the prior dividend period |
The calculation agents determination of any dividend rate,
and its calculation of the amount of dividends for any dividend
period, will be on file at our principal offices, will be made
available to any stockholder upon request and will be final and
binding in the absence of manifest error.
In this subsection, we use several terms that have special
meanings relevant to calculating LIBOR. MetLife, Inc. defines
these terms as follows:
|
|
|
|
|
The term Representative Amount means an amount that,
in the calculation agents judgment, is representative of a
single transaction in the relevant market at the relevant time. |
|
|
|
The term Moneyline Telerate Page means the display
on Moneyline Telerate, Inc., or any successor service, on the
page or pages specified in this prospectus supplement or any
replacement page or pages on that service. |
S-63
|
|
|
|
|
The term business day, when used in this prospectus
supplement, means a day that is a Monday, Tuesday, Wednesday,
Thursday or Friday and is not a day on which banking
institutions in New York City generally are authorized or
obligated by law or executive order to close. |
|
|
|
The term London business day means a day that is a
Monday, Tuesday, Wednesday, Thursday or Friday and is a day on
which dealings in U.S. dollars are transacted in the London
interbank market. |
Dividends on the series A preferred shares will not be
cumulative. Accordingly, if the board of directors of MetLife,
Inc., or a duly authorized committee of the board, does not
declare a dividend on the series A preferred shares payable
in respect of any dividend period before the related dividend
payment date, such dividend will not accrue and we will have no
obligation to pay a dividend for that dividend period on the
dividend payment date or at any future time, whether or not
dividends on the series A preferred shares are declared for
any future dividend period.
So long as any series A preferred shares remain outstanding
for any dividend period, unless the full dividends for the
latest completed dividend period on all outstanding
series A preferred shares and parity stock have been
declared and paid (or declared and a sum sufficient for the
payment thereof has been set aside):
|
|
|
|
|
no dividend shall be paid or declared on our Series A
Junior Participating Preferred Stock, our common stock or any
other shares of our junior stock (as defined below) (other than
a dividend payable solely in junior stock); and |
|
|
|
no Series A Junior Participating Preferred Stock or common
stock or other junior stock shall be purchased, redeemed or
otherwise acquired for consideration by us, directly or
indirectly (other than as a result of a reclassification of
junior stock for or into other junior stock, or the exchange or
conversion of one share of junior stock for or into another
share of junior stock and other than through the use of the
proceeds of a substantially contemporaneous sale of junior
stock). |
As used in this prospectus supplement, junior stock
means any class or series of stock of MetLife, Inc. that ranks
junior to the series A preferred shares either as to the
payment of dividends or as to the distribution of assets upon
any liquidation, dissolution or winding up of MetLife, Inc.
Junior stock includes our common stock and the Series A
Junior Participating Preferred Stock and any non-voting
convertible participating preferred stock that may be issued to
Citigroup under the Acquisition Agreement in lieu of common
stock.
When dividends are not paid in full (or duly provided for) on
any dividend payment date (or, in the case of parity stock (as
defined below) having dividend payment dates different from the
dividend payment dates pertaining to the series A preferred
shares, on a dividend payment date falling within the related
dividend period for the series A preferred shares) upon the
series A preferred shares and any shares of parity stock,
all dividends declared upon the series A preferred shares
and all such parity stock payable on such dividend payment date
(or, in the case of parity stock having dividend payment dates
different from the dividend payment dates pertaining to the
series A preferred shares, on a dividend payment date
falling within the related dividend period for the series A
preferred shares) shall be declared pro rata so that the
respective amounts of such dividends shall bear the same ratio
to each other as all accrued but unpaid dividends per preferred
share and all parity stock payable on such dividend payment date
(or, in the case of parity stock having dividend payment dates
different from the dividend payment dates pertaining to the
series A preferred shares, on a dividend payment date
falling within the related dividend period for the series A
preferred shares) bear to each other.
As used in this prospectus supplement, parity stock
means any other class or series of stock of MetLife, Inc. that
ranks equally with the series A preferred shares in the
payment of dividends and in the distribution of assets on any
liquidation, dissolution or winding up of MetLife, Inc.
Restrictions on Declaration and Payment of Dividends
MetLife, Inc. is prohibited from paying dividends on the
series A preferred shares under certain circumstances.
S-64
Federal Reserve Board policy provides that a bank holding
company should pay dividends only out of current operating
earnings. MetLife, Inc. may not be able to pay dividends if it
does not earn sufficient operating income.
In addition, the terms of the series A preferred shares
limit MetLife, Inc.s ability to declare dividends for
payment on any dividend payment date if, on that declaration
date, either:
|
|
|
|
(i) |
the covered insurance subsidiaries risk-based capital
ratio was less than 175% of the company action level for such
subsidiaries, in the case of each covered insurance subsidiary
based on the most recent annual financial statements for the
year ended prior to such dividend payment date for which such
subsidiary has filed its annual statement with the applicable
state insurance commissioners (annual statements for a year are
generally required to be filed on or before March 1 of the
following year); |
OR
|
|
|
|
(ii) |
(x) the Trailing Four Quarters Consolidated Net Income
Amount for the period ending on the quarter that is two quarters
prior to the most recently completed quarter is zero or a
negative amount and (y) the Adjusted Shareholders
Equity Amount as of the most recently completed quarter and as
of the end of the quarter that is two quarters before the most
recently completed quarter has declined by 10% or more as
compared to the Adjusted Shareholders Equity Amount at the
end of the benchmark quarter (the date that is ten quarters
prior to the most recently completed quarter). |
If MetLife, Inc. fails to satisfy either of the above tests for
any dividend payment date, the restrictions on dividends will
continue until MetLife, Inc. is able again to satisfy both tests
for a dividend payment date. In addition, in the case of a
restriction arising under clause (ii) above, the
restrictions on dividends will continue until MetLife, Inc.
satisfies the two tests in clauses (i) and (ii) above
for a dividend payment date and MetLife, Inc.s Adjusted
Shareholders Equity Amount has increased, or has declined
by less than 10%, in either case as compared to the Adjusted
Shareholders Equity Amount at the end of the benchmark
quarter for each dividend payment date as to which dividend
restrictions were imposed under clause (ii) above. For
example, if MetLife, Inc. failed to satisfy the test in
clause (ii) above for three consecutive dividend payment
dates, MetLife would be able to declare dividends on the
series A preferred shares on the fourth dividend payment
date only if, as of the related dividend declaration date:
|
|
|
|
|
MetLife, Inc. satisfied the tests in each of clauses (i)
and (ii) above for that fourth dividend payment date, and |
|
|
|
MetLife, Inc.s Adjusted Shareholders Equity Amount
as of the last completed quarter for that dividend payment date
had increased from, or was less than 10% below, its level at the
end of the benchmark quarter for each of the prior three
dividend payment dates for which dividends were restricted under
clause (ii) above. In effect, MetLife, Inc.s Adjusted
Shareholders Equity Amount as of the most recently
completed quarter for that dividend payment date would have to
be greater than, or less than 10% below, its level as of the end
of not only the tenth quarter, but also each of the eleventh,
twelfth and thirteenth quarters, preceding the most recently
completed quarter. |
In this subsection, we use several terms that have special
meanings relevant to the mandatory dividend suspension tests.
MetLife, Inc. defines these terms as follows:
|
|
|
|
|
The term Adjusted Shareholders Equity Amount
means, as of any quarter end and subject to certain adjustments,
the shareholders equity of MetLife, Inc. as reflected on
its consolidated GAAP balance sheet as of such quarter end
minus accumulated other comprehensive income as reflected
on such consolidated balance sheet. |
|
|
|
The term covered insurance subsidiaries means our
largest U.S. life insurance subsidiaries (in terms of general
account admitted assets) that collectively account for 80% or
more of the general account admitted assets of all of our U.S.
life insurance subsidiaries. For purposes of this definition,
life insurance subsidiaries does not include life
insurance companies that are subsidiaries of other life
insurance companies. |
S-65
|
|
|
|
|
The term GAAP means, at any date or for any period,
U.S. generally accepted accounting principles as in effect
on such date or for such period. |
|
|
|
The term risk-based capital ratio in clause (i)
above refers to a ratio that insurance companies are required to
calculate and report to their regulators as of the end of each
year in accordance with prescribed procedures. The ratio
measures the relationship of the insurance companys
total adjusted capital, calculated in accordance
with those prescribed procedures, relative to a standard that is
determined based on the magnitude of various risks present in
the insurers operations. The NAICs model risk-based
capital (RBC) law sets forth the RBC levels, ranging
from the company action level to the mandatory control level, at
which certain corrective actions are required and at which a
state insurance regulator is authorized and expected to take
regulatory action. |
The highest RBC level is known as the company action level. If
an insurance companys total adjusted capital is higher
than the company action level, no corrective action is required
to be taken. At progressively lower levels of total adjusted
capital, an insurance company faces increasingly rigorous levels
of corrective action, including the submission of a
comprehensive financial plan to the insurance regulator in its
state of domicile, a mandatory examination or analysis of the
insurers business and operations by the regulator and the
issuance of appropriate corrective orders to address the
insurance companys financial problems, and, at the lowest
levels, either voluntary or mandatory action by the regulator to
place the insurer under regulatory control. The company action
level is twice the level (known as the authorized control
level) below which the regulator is authorized (but not
yet required) to place the insurance company under regulatory
control.
|
|
|
|
|
The term Trailing Four Quarters Consolidated Net Income
Amount means, for any fiscal quarter, the sum of the
consolidated GAAP net income of MetLife Inc. for the four fiscal
quarters ending as of the last day of such fiscal quarter. |
With the exception of statutory accounting terms such as
general account admitted assets and terms that have
specific insurance regulatory meanings such as risk-based
capital, all financial terms used in this caption
Restrictions on Declaration and Payment of
Dividends will be determined in accordance with GAAP as
applied to and reflected in the related financial statements of
MetLife, Inc. as of the relevant dates, except as provided in
the next sentence. If because of a change in GAAP that results
in a cumulative effect of a change in accounting principle or a
restatement, either:
|
|
|
|
|
Consolidated net income of MetLife, Inc. is higher or lower than
it would have been absent such change, then, for purposes of
calculating the calculations described in clause (ii) of
the third paragraph of this caption,
Restrictions on Declaration and Payment of
Dividends, commencing with the fiscal quarter for which
such changes in GAAP becomes effective, such consolidated net
income will be calculated on a pro forma basis as if such change
had not occurred; or |
|
|
|
the Adjusted Shareholders Equity Amount as of a quarter
end is higher or lower than it would have been absent such
change, then, for purposes of the calculations described in
clause (ii) of the third paragraph of this caption,
Restrictions on Declaration and Payment of
Dividends, the Adjusted Shareholders Equity Amount
will be calculated on a pro forma basis as if such change had
not occurred, subject to certain limitations described in the
certificate of designations for the series A preferred
shares. |
If at any relevant time or for any relevant period MetLife, Inc.
is not a reporting company under the Securities Exchange Act of
1934, then for any such relevant dates and periods MetLife, Inc.
shall prepare and post on its website the financial statements
that it would have been required to file with the SEC had it
continued to be a reporting company under the Securities
Exchange Act, in each case on or before the dates that MetLife,
Inc. would have been required to file such financial statements
had it continued to be an accelerated filer within
the meaning of Rule 12b-2 under the Securities Exchange Act.
If MetLife, Inc. fails either of these tests on a dividend
payment date, dividends declared on such dividend payment date
may not exceed the net proceeds MetLife, Inc. has received
within the prior 90 days from issuances of common stock.
S-66
Notices Related to Potential or Actual Mandatory Suspension
of Dividends
MetLife, Inc. is required to give notice to preferred
stockholders of a potential mandatory suspension of dividends
that could take effect for a subsequent dividend payment date
two quarters in the future if:
|
|
|
|
|
the Trailing Four Quarters Consolidated Net Income Amount for
the most recently completed quarter is zero or a negative
amount; and |
|
|
|
the Adjusted Shareholders Equity Amount as of the most
recently completed quarter has declined by 10% or more as
compared to the Adjusted Shareholders Equity Amount as of
the date that is eight quarters prior to the most recently
completed quarter. |
MetLife, Inc. shall send such notice no later than the first
dividend payment date following the end of the most recently
completed quarter as of which the above tests indicate that a
potential mandatory suspension of dividends could occur. Such
notice shall be sent by first class mail, postage prepaid,
addressed to the holders of record of the shares of
series A preferred shares at their respective last
addresses appearing on the books of MetLife, Inc., and shall
file a copy of such notice on Form 8-K with the SEC. Such
notice shall (x) set forth the results of the Trailing Four
Quarters Consolidated Net Income Amount and Adjusted
Shareholders Equity Amounts for the relevant period and
dates, and (y) state that MetLife, Inc. may be precluded by
the terms of the series A preferred shares from declaring
and paying dividends on such dividend payment date unless it,
through the generation of earnings or issuance of new common
equity, increases its Adjusted Shareholders Equity Amount
by an amount specified in such notice by the second dividend
payment date after the date of such notice.
By not later than the 15th day prior to each dividend payment
date for which dividends are being suspended by reason of the
tests set forth in clauses (i) or (ii) of the third
paragraph under Restrictions on Declaration
and Payment of Dividends, MetLife, Inc. shall give notice
of such suspension by first class mail, postage prepaid,
addressed to the holders of record of the preferred shares, and
shall file a copy of such notice on Form 8-K with the SEC.
Such notice, in addition to stating that dividends will be
suspended, shall set forth the fact that the covered insurance
subsidiaries risk-based capital ratio is less than 175% of
such subsidiaries company action level if dividends are
suspended by reason of failing to satisfy the test in clause
(i) of that paragraph and the applicable Adjusted
Shareholders Equity Amount (and the amount by which the
Adjusted Shareholders Equity Amount must increase in order
for declaration and payment of dividends to be resumed) if
dividends are suspended by reason of failing to satisfy the test
in clause (ii) of that paragraph.
Liquidation Rights
Upon any voluntary or involuntary liquidation, dissolution or
winding up of MetLife, Inc., holders of the series A
preferred shares are entitled to receive out of assets of
MetLife, Inc. available for distribution to stockholders, after
satisfaction of liabilities to creditors, if any, before any
distribution of assets is made to holders of Series A
Junior Participating Preferred Stock, common stock or any of our
other shares of stock ranking junior as to such a distribution
to the series A preferred shares, a liquidating
distribution in the amount of $25 per preferred share plus
declared and unpaid dividends, without accumulation of any
undeclared dividends. Holders of the series A preferred
shares will not be entitled to any other amounts from us after
they have received their full liquidation preference.
In any such distribution, if the assets of MetLife, Inc. are not
sufficient to pay the liquidation preferences in full to all
holders of the series A preferred shares and all holders of
any other shares of our stock ranking equally as to such
distribution with the series A preferred shares, the
amounts paid to the holders of series A preferred shares
and to the holders of all such other stock will be paid pro rata
in accordance with the respective aggregate liquidation
preferences of those holders. In any such distribution, the
liquidation preference of any holder of preferred
stock means the amount payable to such holder in such
distribution, including any declared but unpaid dividends (and
any unpaid, accrued cumulative dividends in the case of any
holder of stock on which dividends accrue on a cumulative
basis). If the liquidation preference has been paid in full to
all holders of the series A preferred shares, the holders
of our other stock shall be entitled to receive all remaining
assets of MetLife, Inc. according to their respective rights and
preferences.
S-67
For purposes of this section, the merger or consolidation of
MetLife, Inc. with any other entity, including a merger or
consolidation in which the holders of the series A
preferred shares receive cash, securities or property for their
shares, or the sale, lease or exchange of all or substantially
all of the assets of MetLife, Inc., for cash, securities or
other property shall not constitute a liquidation, dissolution
or winding up of MetLife, Inc.
Redemption
The series A preferred shares are not subject to any
mandatory redemption, sinking fund, retirement fund, purchase
fund or other similar provisions. The series A preferred
shares are not redeemable prior
to 2010.
On and after that date, the series A preferred shares will
be redeemable at our option and subject to the prior approval of
the Federal Reserve Board, as described below, in whole or in
part, upon not less than 30 nor more than 60 days notice,
at a redemption price equal to $25 per preferred share,
plus declared and unpaid dividends, without accumulation of any
undeclared dividends. Holders of the series A preferred
shares will have no right to require the redemption or
repurchase of the series A preferred shares.
If the series A preferred shares are to be redeemed, the
notice of redemption shall be given by first class mail to the
holders of record of the series A preferred shares to be
redeemed, mailed not less than 30 days nor more than
60 days prior to the date fixed for redemption thereof
(provided that, if the series A preferred shares are held
in book-entry form through The Depository Trust Company, or
DTC, we may give such notice in any manner permitted
by the DTC). Each notice of redemption will include a statement
setting forth:
|
|
|
|
|
the redemption date; |
|
|
|
the number of series A preferred shares to be redeemed and,
if less than all the series A preferred shares held by such
holder are to be redeemed, the number of such series A
preferred shares to be redeemed from such holder; |
|
|
|
the redemption price; and |
|
|
|
the place or places where holders may surrender certificates
evidencing the series A preferred shares for payment of the
redemption price. |
If notice of redemption of any series A preferred shares
has been given and if the funds necessary for such redemption
have been set aside by us for the benefit of the holders of any
series A preferred shares so called for redemption, then,
from and after the redemption date, dividends will cease to
accrue on such series A preferred shares, such
series A preferred shares shall no longer be deemed
outstanding and all rights of the holders of such series A
preferred shares will terminate, except the right to receive the
redemption price.
In case of any redemption of only part of the series A
preferred shares at the time outstanding, the series A
preferred shares to be redeemed shall be selected either pro
rata or in such other manner as we may determine to be fair and
equitable.
We may not redeem the series A preferred shares without the
prior approval of the Federal Reserve Board, if such approval is
then required under applicable law or capital regulations. Under
current regulations, the Federal Reserve Board generally can be
expected to permit a redemption only if (1) the
series A preferred shares are redeemed with the proceeds of
a sale of common stock, perpetual preferred stock or other
tier 1 capital instruments of equal or higher quality, or
(2) the Federal Reserve Board determines that our
condition, circumstances and resulting capital levels are
consistent with the proposed reduction of permanent capital.
MetLife intends that, if it redeems the series A preferred
shares, it will redeem such series A preferred shares only
to the extent the aggregate liquidation preference of the shares
redeemed is less than the New Equity Amount as of the date of
redemption, if any. This intention also applies to any
series A preferred shares that any regulatory authority
requires MetLife to redeem, unless such regulatory authority
directs MetLife, Inc. otherwise.
S-68
New Equity Amount means at any date the amount, if
any, of the net proceeds to MetLife or its affiliates of shares
of junior stock or parity stock or Other Qualifying Securities
of MetLife or its affiliates newly-issued during the six months
prior to such date to purchasers other than to MetLifes
affiliates.
Other Qualifying Security means, at any time, a
security or instrument that is of a type that has equal or
greater equity characteristics than the series A preferred
shares, as evidenced by a certificate or a letter of a
nationally recognized investment bank reasonably satisfactory to
MetLife.
Voting Rights
Except as provided below, the holders of the series A
preferred shares will have no voting rights.
Whenever dividends on any series A preferred shares shall
have not been declared and paid for the equivalent of six or
more dividend payments, whether or not for consecutive dividend
periods (a Nonpayment), the holders of such
series A preferred shares, voting together as a single
class with holders of any and all other series of voting
preferred stock (as defined below) then outstanding, will be
entitled to vote for the election of a total of two additional
members of our board of directors (the Preferred Stock
Directors), provided that the election of any such
directors shall not cause us to violate the corporate governance
requirement of the New York Stock Exchange (or any other
exchange on which our securities may be listed) that listed
companies must have a majority of independent directors. In that
event, the number of directors on our board of directors shall
automatically increase by two, and the new directors shall be
elected at a special meeting called at the request of the
holders of record of at least 20% of the series A preferred
shares or of any other series of voting preferred stock (unless
such request is received less than 90 days before the date
fixed for the next annual or special meeting of the
stockholders, in which event such election shall be held at such
next annual or special meeting of stockholders), and at each
subsequent annual meeting. These voting rights will continue
until dividends on the series A preferred shares and any
such series of voting preferred stock for at least four dividend
periods, whether or not consecutive, following the Nonpayment
shall have been fully paid (or declared and a sum sufficient for
the payment of such dividends shall have been set aside for
payment).
As used in this prospectus supplement, voting preferred
stock means any other class or series of preferred stock
of MetLife, Inc. ranking equally with the series A
preferred shares either as to dividends or the distribution of
assets upon liquidation, dissolution or winding up and upon
which like voting rights have been conferred and are
exercisable. Whether a plurality, majority or other portion of
the series A preferred shares and any other voting
preferred stock have been voted in favor of any matter shall be
determined by reference to the liquidation amounts of the
series A preferred shares voted.
If and when dividends for at least four dividend periods,
whether or not consecutive, following a Nonpayment have been
paid in full (or declared and a sum sufficient for such payment
shall have been set aside), the holders of the series A
preferred shares shall be divested of the foregoing voting
rights (subject to revesting in the event of each subsequent
Nonpayment) and, if such voting rights for all other holders of
voting preferred stock have terminated, the term of office of
each Preferred Stock Director so elected shall terminate and the
number of directors on the board of directors shall
automatically decrease by two. In determining whether dividends
have been paid for four dividend periods following a Nonpayment,
we may take account of any dividend we elect to pay for such a
dividend period after the regular dividend date for that period
has passed. Any Preferred Stock Director may be removed at any
time without cause by the holders of record of a majority of the
outstanding series A preferred shares and any other shares
of voting preferred stock then outstanding (voting together as a
class) when they have the voting rights described above. So long
as a Nonpayment shall continue, any vacancy in the office of a
Preferred Stock Director (other than prior to the initial
election after a Nonpayment) may be filled by the written
consent of the Preferred Stock Director remaining in office, or
if none remains in office, by a vote of the holders of record of
a majority of the outstanding series A preferred shares and
any other shares of voting preferred stock then outstanding
(voting together as a class) when they have the voting rights
described above. The Preferred Stock Directors shall each be
entitled to one vote per director on any matter.
S-69
So long as any series A preferred shares remain
outstanding, we will not, without the affirmative vote or
consent of the holders of at least two-thirds of the outstanding
series A preferred shares and all other series of voting
preferred stock entitled to vote thereon, voting together as a
single class, given in person or by proxy, either in writing or
at a meeting:
|
|
|
|
|
amend or alter the provisions of MetLife, Inc.s amended
and restated certificate of incorporation or the certificate of
designations of the series A preferred shares so as to
authorize or create, or increase the authorized amount of, any
class or series of stock ranking senior to the series A
preferred shares with respect to payment of dividends or the
distribution of assets upon liquidation, dissolution or winding
up of MetLife, Inc.; |
|
|
|
amend, alter or repeal the provisions of MetLife, Inc.s
amended and restated certificate of incorporation or the
certificate of designations of the series A preferred
shares so as to materially and adversely affect the special
rights, preferences, privileges and voting powers of the
series A preferred shares, taken as a whole; or |
|
|
|
consummate a binding share exchange or reclassification
involving the series A preferred shares or a merger or
consolidation of MetLife, Inc. with another entity, unless in
each case (i) the series A preferred shares remain
outstanding or, in the case of any such merger or consolidation
with respect to which we are not the surviving or resulting
entity, are converted into or exchanged for preference
securities of the surviving or resulting entity or its ultimate
parent, and (ii) such series A preferred shares
remaining outstanding or such preference securities, as the case
may be, have such rights, preferences, privileges and voting
powers, taken as a whole, as are not materially less favorable
to the holders thereof than the rights, preferences, privileges
and voting powers of the series A preferred shares, taken
as a whole; |
provided, however, that any increase in the amount of the
authorized or issued series A preferred shares or
authorized preferred stock or the creation and issuance, or an
increase in the authorized or issued amount, of other series of
preferred stock ranking equally with and/or junior to the
series A preferred shares with respect to the payment of
dividends (whether such dividends are cumulative or
non-cumulative) and/or the distribution of assets upon
liquidation, dissolution or winding up of MetLife, Inc. will not
be deemed to adversely affect the special rights, preferences,
privileges or voting powers of the series A preferred
shares.
If an amendment, alteration, repeal, share exchange,
reclassification, merger or consolidation described above would
adversely affect one or more but not all series of voting
preferred stock (including the series A preferred shares
for this purpose), then only the series affected and entitled to
vote shall vote as a class in lieu of all such series of
preferred stock.
Without the consent of the holders of the series A
preferred shares, so long as such action does not adversely
affect the special rights, preferences, privileges and voting
powers of the series A preferred shares, taken as a whole,
we may amend, alter, supplement or repeal any terms of the
series A preferred shares:
|
|
|
|
|
to cure any ambiguity, or to cure, correct or supplement any
provision contained in the certificate of designation for the
series A preferred shares that may be defective or
inconsistent; or |
|
|
|
to make any provision with respect to matters or questions
arising with respect to the series A preferred shares that
is not inconsistent with the provisions of the certificate of
designations. |
The foregoing voting provisions will not apply if, at or prior
to the time when the act with respect to which such vote would
otherwise be required shall be effected, all outstanding
series A preferred shares shall have been redeemed or
called for redemption upon proper notice and sufficient funds
shall have been set aside by us for the benefit of the holders
of series A preferred shares to effect such redemption.
Certain Regulatory Issues Related to Voting Rights
Under regulations adopted by the Federal Reserve Board, if the
holders of series A preferred shares become entitled to
vote for the election of directors as described above, the
series A preferred shares could be deemed a class of
voting securities, together with any other series of
voting preferred stock then outstanding
S-70
entitled to vote for the election of directors as a single class
with the series A preferred shares. In this instance, a
holder, other than a natural person, of 25% or more of the
series A preferred shares (measured together with any other
series of voting preferred stock) could then be subject to
regulation as a bank holding company in accordance with the Bank
Holding Company Act. A holder, other than a natural person, of
5% that otherwise exercises a controlling influence
over MetLife, Inc. could also be subject to regulation under the
Bank Holding Company Act. In addition, at any time the
series A preferred shares are deemed a class of voting
securities, (1) any other bank holding company may be
required to obtain the approval of the Federal Reserve Board to
acquire or retain 5% or more of the outstanding series A
preferred shares and other series of voting preferred stock, and
(2) any person other than a bank holding company may be
required to file with the Federal Reserve Board under the Change
in Bank Control Act to acquire or retain 10% or more of such
shares.
Listing of the Series A Preferred Shares
MetLife, Inc. will apply for listing of the series A
preferred shares on the New York Stock Exchange under the symbol
METPrA. If approved for listing, MetLife, Inc.
expects trading of the series A preferred shares on the New
York Stock Exchange to commence on the date of initial delivery.
Transfer Agent, Registrar and Calculation Agent
Mellon Investor Services L.L.C. will be the transfer agent,
registrar, dividend disbursing agent and redemption agent for
the series A preferred shares.
JPMorgan Chase Bank, N.A. will be the calculation agent for the
series A preferred shares.
Book-Entry; Delivery and Form
Each series A preferred share will be deposited with, or on
behalf of, DTC or any successor thereto (the
Depositary), as depositary, and registered in the
name of Cede & Co. (DTCs partnership nominee).
DTC advises that it is a limited-purpose trust company organized
under the New York Banking Law, a banking
organization within the meaning of the New York Banking
Law, a member of the Federal Reserve System, a clearing
corporation within the meaning of the New York Uniform
Commercial Code, and a clearing agency registered
pursuant to the provisions of Section 17A of the Securities
Exchange Act of 1934, as amended. DTC holds and provides asset
servicing for over 2 million issues of U.S. and
non-U.S. equity issues, corporate and municipal debt
issues, and money market instruments from over 85 countries that
DTCs participants (Participants) deposit with
DTC. DTC also facilitates the post-trade settlement among
Participants of sales and other securities transactions in
deposited securities, through electronic computerized book-entry
transfers and pledges between Participants accounts. This
eliminates the need for physical movement of securities
certificates.
Direct Participants in DTC include both U.S. and
non-U.S. securities brokers and dealers, banks, trust
companies, clearing corporations, and certain other
organizations. DTC is a wholly-owned subsidiary of The
Depository Trust & Clearing Corporation
(DTCC). DTCC, in turn, is owned by a number of
Direct Participants of DTC and members of the National
Securities Clearing Corporation, Government Securities Clearing
Corporation, MBS Clearing Corporation, and Emerging Markets
Clearing Corporation, each of which is a subsidiary of DTCC, as
well as by the New York Stock Exchange, Inc., the American Stock
Exchange LLC, and the National Association of Securities
Dealers, Inc. Access to DTCs book-entry system is also
available to others such as both U.S. and
non-U.S. securities brokers and dealers, banks, trust
companies, and clearing corporations that clear through or
maintain a custodial relationship with a Direct Participant,
either directly or indirectly (Indirect
Participants).
Purchases of the series A preferred shares under DTCs
book-entry system must be made by or through Direct
Participants, which will receive a credit for the series A
preferred shares on the records of DTC. The ownership interest
of each actual purchaser of the series A preferred shares,
which we refer to as the beneficial owner, is in
turn to be recorded on the Participants records.
Beneficial owners will not receive written confirmation from DTC
of their purchase, but beneficial owners are expected to receive
written
S-71
confirmations providing details of the transactions, as well as
periodic statements of their holdings from the Direct
Participant or Indirect Participant through which the beneficial
owner entered into the transaction. Transfers of ownership
interests in the series A preferred shares will be effected
only through entries made on the books of Participants acting on
behalf of beneficial owners. Beneficial owners will not receive
certificates representing their ownership interests in the
series A preferred shares, except in the event that use of
the book-entry system for the series A preferred shares is
discontinued. The laws of some states require that certain
purchasers of securities take physical delivery of such
securities in definitive form. Such limits and such laws may
impair the ability to own, transfer or pledge beneficial
interests in the series A preferred shares.
To facilitate subsequent transfers, all series A preferred
shares deposited by Participants with DTC are registered in the
name of DTCs partnership nominee, Cede & Co. The
deposit of the series A preferred shares with DTC and their
registration in the name of Cede & Co. effect no change
in beneficial ownership. DTC has no knowledge of the actual
beneficial owners of the series A preferred shares;
DTCs records reflect only the identity of the Direct
Participants to whose accounts such series A preferred
shares are credited, which may or may not be the beneficial
owners. The Participants will remain responsible for keeping
account of their holdings on behalf of their customers.
So long as DTC or its nominee is the registered owner and holder
of the series A preferred shares, DTC or its nominee, as
the case may be, will be considered the sole owner or holder of
the series A preferred shares represented by the
series A preferred shares for all purposes under the
indenture. Except as provided below, beneficial owners of
interests in the series A preferred shares will not be
entitled to have book-entry shares represented by the
series A preferred shares registered in their names, will
not receive or be entitled to receive physical delivery of
series A preferred shares in definitive form and will not
be considered the owners or holders thereof under the indenture.
Accordingly, each beneficial owner must rely on the procedures
of DTC and, if the person is not a Participant, on the
procedures of the Participants through which such person owns
its interest, to exercise any rights of a holder under the
indenture. MetLife Inc. understands that under existing industry
practices, in the event that we request any action of holders of
series A preferred shares or that an owner of a beneficial
interest in the series A preferred shares desires to give
or take any action which a holder is entitled to give or take
under the indenture, DTC would authorize the Participants
holding the relevant beneficial interests to give or take the
action, and the Participants would authorize beneficial owners
owning through the Participants to give or to take the action or
would otherwise act upon the instructions of beneficial owners.
Conveyance of notices and other communications by DTC to
Participants, by Direct Participants to Indirect Participants,
and by Direct Participants and Indirect Participants to
beneficial owners, will be governed by arrangements among them,
subject to any statutory or regulatory requirements as may be in
effect from time to time.
Although voting with respect to the series A preferred
shares is limited, in those cases where a vote is required,
neither DTC nor Cede & Co. (nor any other DTC nominee)
will itself consent or vote with respect to series A
preferred shares, unless authorized by a Direct Participant in
accordance with DTCs procedures. Under its usual
procedures, DTC mails an Omnibus Proxy to us as soon as possible
after the record date. The Omnibus Proxy assigns Cede &
Co.s consenting or voting rights to those Direct
Participants to whose accounts the series A preferred
shares are credited on the record date (identified in a listing
attached to the Omnibus Proxy).
Payments on the series A preferred shares will be made to
DTC. MetLife, Inc. will send all required reports and notices
solely to DTC as long as DTC is the registered holder of the
series A preferred shares. Neither we, the trustee, nor any
other agent of ours or agent of the trustee will have any
responsibility or liability for any aspect of the records
relating to, or payments made on account of, beneficial
ownership interests in series A preferred shares or for
maintaining, supervising or reviewing any records relating to
the beneficial ownership interests. DTCs practice is to
credit the accounts of the Direct Participants with payment in
amounts proportionate to their respective holdings in principal
amount of beneficial interest in a security as shown on the
records of DTC, unless DTC has reason to believe that it will
not receive payment on the payment date. Payments by
Participants to beneficial owners will be governed by standing
instructions and customary practices, as is the case with
securities held for the accounts of customers in bearer form or
registered in street name, and will be the
responsibility of the Participants.
S-72
CERTAIN UNITED STATES FEDERAL INCOME TAX CONSEQUENCES
This section describes the material United States federal income
tax consequences of purchase, ownership and disposition of the
series A preferred shares. It applies to you only if you
hold your series A preferred shares as capital assets for
tax purposes. This section does not apply to you if you are a
member of a class of holders subject to special rules, such as:
|
|
|
|
|
a dealer in securities or currencies; |
|
|
|
a trader in securities that elects to use a market-to-market
method of accounting for your securities holdings; |
|
|
|
a bank; |
|
|
|
an insurance company; |
|
|
|
a thrift institution; |
|
|
|
a regulated investment company; |
|
|
|
a tax-exempt organization; |
|
|
|
a person that owns securities that are part of a hedge or that
are hedged against currency risks; |
|
|
|
a person that owns securities as part of a straddle, a
constructive sale or conversion transaction for tax
purposes; |
|
|
|
a partnership, or |
|
|
|
a person whose functional currency for tax purposes is not the
U.S. dollar. |
This section is based on the U.S. Internal Revenue Code of
1986, as amended (the Code), its legislative
history, existing and proposed regulations under the Internal
Revenue Code, published rulings and court decisions, all as
currently in effect. These laws are subject to change, possibly
on a retroactive basis. If a partnership holds the series A
preferred shares, the United States federal income tax treatment
of a partner will generally depend on the status of the partner
and the tax treatment of the partnership. The discussion that
follows will not address the tax consequences to the partners of
a partnership that owns series A preferred shares. A
partner in a partnership holding the series A preferred
shares should consult its tax advisor with regard to the United
States tax treatment of an investment in the series A
preferred shares.
THE DISCUSSION OF THE MATERIAL UNITED STATES FEDERAL INCOME TAX
CONSEQUENCES OF THE OWNERSHIP, SALE OR OTHER DISPOSITION OF THE
SERIES A PREFERRED SHARES IS NOT INTENDED TO BE, NOR SHOULD
IT BE CONSTRUED TO BE, LEGAL OR TAX ADVICE TO ANY PARTICULAR
PERSON. ACCORDINGLY, ALL PROSPECTIVE INVESTORS ARE URGED TO
CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE UNITED STATES
FEDERAL INCOME TAX CONSEQUENCES RELATING TO THE OWNERSHIP, SALE
OR OTHER DISPOSITION OF THE SERIES A PREFERRED SHARES,
INCLUDING THE APPLICATION AND EFFECT OF THE LAWS OF ANY STATE,
LOCAL, FOREIGN OR OTHER TAX JURISDICTION, AS TAX CONSEQUENCES
MAY VARY WITH RESPECT TO A SHAREHOLDERS PARTICULAR
CIRCUMSTANCES.
United States Holders
This subsection describes the tax consequences to a United
States Holder. You are a United States Holder if you are a
beneficial owner of series A preferred shares and you are:
|
|
|
|
|
a citizen or resident of the United States; |
|
|
|
a domestic corporation; |
|
|
|
an estate whose income is subject to United States federal
income tax regardless of its source; or |
|
|
|
a trust if a United States court has the authority to exercise
primary supervision over the trusts administration and one
or more United States persons are authorized to control all
substantial decisions of the trust. |
S-73
If you are not a United States Holder, this subsection does not
apply to you and you should refer to
Non-U.S. Holders below.
Distributions on the Series A Preferred shares.
United States Holders will be taxed on distributions on the
series A preferred shares as dividend income to the extent
the distribution is paid out of our current or accumulated
earnings and profits for United States federal income tax
purposes. If you are a noncorporate United States Holder,
dividends paid to you in taxable years beginning before
January 1, 2009 will constitute qualified dividend income
taxable to you at a maximum rate of 15%, provided that you hold
your series A preferred shares for more than 60 days
during the 121-day period beginning 60 days before the
ex-dividend date or, if the dividend is attributable to a period
or periods aggregating over 366 days, provided that you
hold your series A preferred shares for more than
90 days during the 181-day period beginning 90 days
before the ex-dividend date.
Corporate holders of the series A preferred shares may be
eligible for the 70% dividends received deduction
with respect to dividend distributions that are paid on the
series A preferred shares, provided certain holding period
requirements are satisfied. The full amount of such dividends
(including the otherwise deductible amount) is included by the
corporate shareholder in determining the excess (if any) of a
corporate shareholders adjusted current earnings over its
alternative minimum taxable income, which may increase its
alternative minimum tax liability.
With respect to distributions not paid out of our current or
accumulated earnings and profits, you generally will not be
taxed on any portion of such distribution if your tax basis in
the series A preferred shares is greater than or equal to
the amount of the distribution. However, you would be required
to reduce your tax basis (but not below zero) in the
series A preferred shares by the amount of the
distribution, and would recognize capital gain to the extent
that the distribution exceeds your tax basis in the
series A preferred shares. Corporate shareholders will not
be entitled to a dividends-received deduction on this portion of
a distribution.
Further, United States Holders should be aware that dividends
that exceed certain thresholds in relation to such holders
tax basis in their series A preferred shares could be
characterized as extraordinary dividends (as defined
in section 1059 of the Code). Generally, a corporate holder
that receives an extraordinary dividend is required to reduce
its stock basis by the portion of such dividend that is not
taxed because of the dividends received deduction and is
required to recognize taxable gain to the extent such portion of
the dividend exceeds the holders tax basis in such
series A preferred shares. United States Holders who are
individuals and who receive an extraordinary
dividend would be required to treat any losses on the sale
of the series A preferred shares as long-term capital
losses to the extent such dividends received by them qualify for
the reduced 15% tax rate. Investors should consult their
own tax advisers with respect to the potential application of
the extraordinary dividend rules to an investment in
MetLife, Inc.s series A preferred shares.
Sale or Exchange of the Series A Preferred Shares.
If you sell or otherwise dispose of your series A preferred
shares (other than by redemption), you will generally recognize
capital gain or loss equal to the difference between the amount
realized upon the disposition and your adjusted tax basis in the
preferred stock. Capital gain of a non-corporate United States
holder that is recognized before January 1, 2009 is
generally taxed at a maximum rate of 15% where the holder has a
holding period greater than one year.
Redemption of the Series A Preferred Shares. If we
redeem your series A preferred shares, it generally will be
a taxable event. You will generally recognize capital gain or
loss on the redemption of MetLife, Inc.s series A
preferred shares provided that the redemption meets at least one
of the following requirements as determined under federal income
tax principles:
|
|
|
|
|
results in a complete termination of your stock interest in
MetLife, Inc.; |
|
|
|
is substantially disproportionate with respect to you; or |
|
|
|
is not essentially equivalent to a dividend with respect to you. |
In determining whether any of these tests has been met, shares
of stock considered to be owned by you by reason of certain
constructive ownership rules set forth in Section 318 of
the Code, as well as shares actually owned by you, must be taken
into account. It may be more difficult for a person who owns,
actually or
S-74
constructively by operation of the attribution rules, any of our
voting stock to satisfy any of the above requirements.
Conversely, the redemption of our series A preferred shares
from an investor who does not own any of our voting stock
(either actually or constructively) will be treated as a taxable
sale of the series A preferred shares.
If we redeem your series A preferred shares in a redemption
that meets one of the tests described above, you generally would
recognize taxable gain or loss equal to the sum of the amount of
cash and fair market value of property (other than MetLife,
Inc.s stock or the stock of MetLife, Inc.s
successor) received by you less your tax basis in the
series A preferred shares redeemed. This gain or loss would
be long-term capital gain or capital loss if you have held the
series A preferred shares for more than one year. If the
redemption does not satisfy any of the above requirements, then
the entire amount received (without offset for your tax basis in
your series A preferred shares) in redemption of your
series A preferred shares will be treated as a distribution as
described under Distributions on the series A
Preferred Shares above. If a redemption of the
series A preferred shares is treated as a distribution that
is taxable as a dividend and subsequent to the redemption for
United States federal income tax purposes you continue to own
(either actually or constructively) our stock, your tax basis in
the redeemed series A preferred shares would be transferred
to your remaining shares of our stock. Prospective investors
should consult their own tax advisors for purposes of
determining the tax consequences resulting from redemption of
our series A preferred shares.
Non-U.S. Holders
This section summarizes certain United States federal income and
estate tax consequences of the ownership and disposition of
series A preferred shares by a Non-U.S. Holder. You
are a Non-U.S. Holder if you are, for United States federal
income tax purposes:
|
|
|
|
|
a nonresident alien individual; |
|
|
|
a foreign corporation; or |
|
|
|
an estate or trust that in either case is not subject to United
States federal income tax on a net income basis on income or
gain from the series A preferred shares. |
Dividends. Except as described below, if you are a
Non-U.S. Holder of series A preferred shares,
dividends paid to you are subject to withholding of United
States federal income tax at a 30% rate or at a lower rate if
you are eligible for the benefits of an income tax treaty that
provides for a lower rate. Even if you are eligible for a lower
treaty rate, we and other payors will generally be required to
withhold at a 30% rate (rather than the lower treaty rate) on
dividend payments to you, unless you have furnished to the payor:
|
|
|
|
|
a valid Internal Revenue Service Form W-8BEN or an
acceptable substitute form upon which you certify, under
penalties of perjury, that you are (or, in the case of a
Non-U.S. Holder that is a partnership or an estate or
trust, such forms certifying that each partner in the
partnership or beneficiary of the estate or trust is) not a
United States person and are entitled to the lower treaty rate
with respect to such payments; or |
|
|
|
in the case of payments made outside the United States to an
offshore account (generally, an account maintained by you at an
office or branch of a bank or other financial institution at any
location outside the United States), other documentary evidence
establishing your entitlement to the lower treaty rate in
accordance with U.S. Treasury regulations. |
If you are eligible for a reduced rate of United States
withholding tax under a tax treaty, you may obtain a refund of
any amounts withheld in excess of that rate by filing a refund
claim with the United States Internal Revenue Service.
If dividends paid to you are effectively connected
with your conduct of a trade or business within the United
States, and, if required by a tax treaty, the dividends are
attributable to a permanent establishment that you maintain in
the United States, we and other payors generally are not
required to withhold tax from the
S-75
dividends, provided that you have furnished to us or another
payor a valid Internal Revenue Service Form W-8ECI or an
acceptable substitute form upon which you represent, under
penalties of perjury, that:
|
|
|
|
|
you are (or, in the case of a Non-U.S. Holder that is a
partnership or an estate or trust, such forms certifying that
each partner in the partnership or beneficiary of the estate or
trust is) not a United States person; and |
|
|
|
the dividends are effectively connected with your conduct of a
trade or business within the United States and are includible in
your gross income. |
Effectively connected dividends are taxed at rates
applicable to United States citizens, resident aliens and
domestic United States corporations. If you are a corporate
Non-U.S. Holder, effectively connected
dividends that you receive may, under certain circumstances, be
subject to an additional branch profits tax at a 30%
rate or at a lower rate if you are eligible for the benefits of
an income tax treaty that provides for a lower rate.
Gain on Disposition of the Series A Preferred Shares.
If you are a Non-U.S. Holder, you generally will not be
subject to United States federal income tax on gain that you
recognize on a disposition of series A preferred shares
unless:
|
|
|
|
|
the gain is effectively connected with your conduct
of a trade or business in the United States, and with respect to
shareholders that are entitled to claim the benefits under
certain tax treaties, the gain is attributable to a permanent
establishment that you maintain in the United States; |
|
|
|
you are an individual, you hold the series A preferred
shares as a capital asset, you are present in the United States
for 183 or more days in the taxable year of the sale and certain
other conditions exist; or |
|
|
|
we are or have been a United States real property holding
corporation for federal income tax purposes and you held,
directly or indirectly, at any time during the five-year period
ending on the date of disposition, more than 5% of the
series A preferred shares and you are not eligible for any
treaty exemption. |
If you are a corporate Non-U.S. Holder, effectively
connected gains that you recognize may also, under certain
circumstances, be subject to an additional branch profits
tax at a 30% rate or at a lower rate if you are eligible
for the benefits of an income tax treaty that provides for a
lower rate.
We have not been, are not and do not anticipate becoming a
United States real property holding corporation for United
States federal income tax purposes.
Federal Estate Taxes. Series A preferred shares held
by a Non-U.S. Holder at the time of death will be included
in the holders gross estate for United States federal
estate tax purposes, unless an applicable estate tax treaty
provides otherwise.
Backup Withholding and Information Reporting
United States Holders. In general, if you are a
non-corporate U.S. Holder you will be subject to
information reporting requirements and will be subject to backup
withholding tax on dividend payments, or other taxable
distributions, made within the United States if:
|
|
|
|
|
you fail to provide an accurate taxpayer identification number
to the payor; |
|
|
|
you are notified by the United States Internal Revenue Service
that you have failed to report all interest or dividends
required to be shown on your federal income tax returns; or |
|
|
|
in certain circumstances, you fail to comply with applicable
certification requirements. |
If you sell your series A preferred shares outside the
United States through a non-U.S. office of a
non-U.S. broker, and the sales proceeds are paid to you
outside the United States, then U.S. backup withholding and
information reporting requirements generally will not apply to
that payment. However, U.S. information reporting, but not
backup withholding, will apply to a payment of sales proceeds,
even if that
S-76
payment is made outside the United States, if you sell your
series A preferred shares through a non-U.S. office of a
broker that is:
|
|
|
|
|
a United States person; |
|
|
|
a controlled foreign corporation for United States tax purposes; |
|
|
|
a foreign person 50% or more of whose gross income is
effectively connected with the conduct of a United States trade
or business for a specified three-year period; or |
|
|
|
a foreign partnership, if at any time during its tax year:
(1) one or more of its partners are
U.S. persons, as defined in U.S. Treasury
regulations, who in the aggregate hold more than 50% of the
income or capital interest in the partnership; or (2) such
foreign partnership is engaged in the conduct of a United States
trade or business. |
Any amounts withheld under the backup withholding rules will be
allowed as a refund or a credit against your United States
federal income tax liability provided the required information
is furnished to the Internal Revenue Service on a timely basis.
Non-U.S. Holders. A non-U.S. Holder will be
subject to backup withholding for dividends paid to such holder
unless such holder certifies under penalty of perjury that it is
a non-U.S. Holder (and the payor does not have actual
knowledge or reason to know that such holder is a United States
person as defined under the Code), or such holder otherwise
establishes an exemption. Information reporting and, depending
on the circumstances, backup withholding will apply to the
proceeds of a sale of the series A preferred shares that are
effected within the United States or conducted through certain
United States-related financial intermediaries, unless the
beneficial owner certifies under penalty of perjury that it is a
non-U.S. Holder (and the payor does not have actual
knowledge or reason to know that the beneficial owner is a
United States person as defined under the Code) or such owner of
Metlife, Inc.s series A preferred shares otherwise
establishes an exemption.
Any amounts withheld under the backup withholding rules will be
allowed as a refund or a credit against your United States
federal income tax liability provided the required information
is furnished to the Internal Revenue Service on a timely basis.
S-77
UNDERWRITING
Subject to the terms and conditions of the underwriting
agreement and pricing agreements dated the date of this
prospectus supplement, MetLife, Inc. has agreed to sell to each
of the underwriters named below, severally, and each of the
underwriters has severally agreed to purchase, the number of
series A preferred shares set forth opposite its name
below. Banc of America Securities LLC, Goldman, Sachs
& Co. and Merrill Lynch, Pierce, Fenner & Smith
Incorporated will act as joint global coordinators and, together
with Citigroup Global Markets Inc., Lehman Brothers Inc., Morgan
Stanley & Co. Incorporated, UBS Securities LLC and Wachovia
Capital Markets, LLC, will act as joint book-running managers
for the offering. Banc of America Securities LLC, Goldman,
Sachs & Co. and Merrill Lynch, Pierce,
Fenner & Smith Incorporated are the representatives of
the underwriters.
|
|
|
|
|
|
|
|
Number of | |
|
|
Series A | |
Underwriters |
|
Preferred Shares | |
|
|
| |
Banc of America Securities LLC
|
|
|
|
|
Goldman, Sachs & Co.
|
|
|
|
|
Merrill Lynch, Pierce, Fenner & Smith
Incorporated
|
|
|
|
|
Citigroup Global Markets Inc.
|
|
|
|
|
Lehman Brothers Inc.
|
|
|
|
|
Morgan Stanley & Co. Incorporated
|
|
|
|
|
UBS Securities LLC
|
|
|
|
|
Wachovia Capital Markets, LLC
|
|
|
|
|
Advest, Inc.
|
|
|
|
|
A.G. Edwards & Sons, Inc.
|
|
|
|
|
HSBC Securities (USA) Inc.
|
|
|
|
|
J.P. Morgan Securities Inc.
|
|
|
|
|
Janney Montgomery Scott LLC
|
|
|
|
|
KeyBanc Capital Markets, a division of McDonald Investments
Inc.
|
|
|
|
|
Morgan Keegan & Company, Inc.
|
|
|
|
|
Piper Jaffray & Co.
|
|
|
|
|
RBC Capital Markets Corporation
|
|
|
|
|
Raymond James & Associates, Inc.
|
|
|
|
|
SunTrust Capital Markets, Inc.
|
|
|
|
|
Wells Fargo Securities, LLC
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
|
|
|
|
|
|
The underwriters are committed to take and pay for all of the
series A preferred shares being offered, if any are taken,
other than the series A preferred shares covered by the
option described below unless and until this option is exercised.
If the underwriters sell more series A preferred shares
than the total number set forth in the table above, the
underwriters have an option to buy up to an
additional series A
preferred shares from MetLife, Inc. to cover such sales. They
may exercise that option for 30 days. If series A
preferred shares are purchased pursuant to this option, the
underwriters will severally purchase the series A preferred
shares in approximately the same proportion as set forth in the
table above.
The following table shows the per preferred share and total
underwriting discounts and commissions to be paid to the
underwriters by MetLife, Inc. Such amounts are shown assuming
both no exercise and full exercise of the underwriters
option to
purchase additional
series A preferred shares.
S-78
Paid by the Company
|
|
|
|
|
|
|
|
|
|
|
No Exercise | |
|
Full Exercise | |
|
|
| |
|
| |
Per Preferred Share
|
|
$ |
|
|
|
$ |
|
|
Total
|
|
$ |
|
|
|
$ |
|
|
The underwriting discount will be
$ per
series A preferred share offered hereby with respect to any
series A preferred shares sold in an aggregate liquidation
preference of $500,000 or more to a single purchaser, which
decreases the total underwriting discount by
$ .
If the underwriters exercise their option to buy up to an
additional series A preferred shares, as described
above, the total underwriting discount will also decrease to the
extent that any of the additional series A preferred shares
are sold in an aggregate liquidation preference of $500,000 or
more to a single purchaser.
The series A preferred shares sold by the underwriters to
the public will initially be offered at the initial public
offering price set forth on the cover of this prospectus
supplement. Any series A preferred shares sold by the
underwriters to securities dealers may be sold at a discount
from the initial public offering price of up to
$ per
preferred share
($ per
preferred share sold to certain institutions) from the initial
public offering price. Any such securities dealers may resell
any series A preferred shares purchased from the
underwriters to certain other brokers or dealers at a discount
from the initial public offering price of up to
$ per
preferred share from the initial public offering price. If all
the series A preferred shares are not sold at the initial
public offering price, the underwriters may change the offering
price and the other selling terms.
Prior to this offering, there has been no public market for the
series A preferred shares. MetLife, Inc. will apply to list
the series A preferred shares on the New York Stock
Exchange under the symbol METPrA. If approved, we
expect trading of the series A preferred shares on the New
York Stock Exchange to begin on the date of initial delivery. In
order to meet one of the requirements for listing the
series A preferred shares on the New York Stock Exchange,
the underwriters have undertaken to sell lots
of or
more series A preferred shares to a minimum
of beneficial
owners.
MetLife, Inc. and certain of its executive officers have agreed
with the underwriters, subject to certain limited exceptions,
not to issue, offer, sell, contract to sell, or otherwise
dispose of, directly or indirectly, any shares of common stock
or securities convertible into or exchangeable for shares of
common stock, or publicly announce an intention to do any of the
foregoing, during the period beginning on the date of this
preliminary prospectus supplement and continuing to and
including September 18, 2005, except with the prior written
consent of the global coordinators. This agreement shall not
prohibit MetLife, Inc. from issuing up to $3 billion in
mandatorily convertible equity securities as part of the
financing of the Acquisition or from issuing shares of common
stock or non-voting convertible participating preferred stock to
Citigroup in an aggregate amount not to exceed $3 billion
as contemplated in the Acquisition Agreement.
In addition, MetLife, Inc. has agreed with the underwriters not
to issue, offer, sell, contract to sell, or otherwise dispose
of, directly or indirectly, any shares of U.S. dollar
denominated preferred stock or any securities substantially
similar to U.S. dollar denominated preferred stock, or
publicly announce an intention to do any of the foregoing,
during the period beginning on the date of the underwriting
agreement and continuing to and including the date that is
60 days after delivery of the series A preferred shares,
except with the prior written consent of the global
coordinators. This agreement shall not prohibit MetLife, Inc.
from issuing the series A preferred shares offered hereby or
issuing additional preferred securities in an amount not to
exceed, when taken together with the series A preferred shares
issued hereby, $2.5 billion in aggregate liquidation
preference as part of the financing of the Acquisition.
The underwriters have advised us that they intend to make a
market for the series A preferred shares, but they have no
obligation to do so and may discontinue market making at any
time without providing any notice. No assurance can be given as
to the liquidity of any trading market for the series A
preferred shares. MetLife Inc. estimates that our expenses for
this offering will be approximately
$ .
S-79
MetLife Inc. has agreed to indemnify the underwriters against
certain liabilities, including liabilities under the Securities
Act of 1933, as amended, or to contribute to payments which the
underwriters may be required to make in respect of any such
liabilities.
In connection with the offering of the series A preferred
shares, the representatives may engage in transactions that
stabilize, maintain or otherwise affect the price of the
series A preferred shares. Specifically, the
representatives may overallot in connection with the offering of
the series A preferred shares, creating a syndicate short
position. In addition, the representatives may bid for, and
purchase, series A preferred shares in the open market to
cover syndicate short positions or to stabilize the price of the
series A preferred shares. Finally, the representatives may
reclaim selling concessions allowed for distributing the
series A preferred shares in the offering of the
series A preferred shares, if the representatives
repurchase previously distributed series A preferred shares
in syndicate covering transactions, stabilization transactions
or otherwise. Any of these activities may stabilize or maintain
the market price of the series A preferred shares above
independent market levels. The representatives are not required
to engage in any of these activities, may end any of them at any
time, and must bring them to an end after a limited period.
In the ordinary course of their respective businesses, the
underwriters and their affiliates have engaged, and may in the
future engage, in commercial banking and/or investment banking
transactions with us and our affiliates for which they have in
the past received, and may in the future receive, customary
fees. Affiliates of some of the lenders under MetLife,
Inc.s credit agreements are acting as underwriters for
this offering. Banc of America Securities LLC and Goldman, Sachs
& Co. have advised MetLife, Inc. with respect to the
Acquisition and are acting as underwriters for this offering of
series A preferred shares. In addition, Citigroup Global
Markets Inc. is an affiliate of Citigroup, from whom MetLife,
Inc. is acquiring Citigroup L&A, and has advised Citigroup
with respect to the Acquisition. The proceeds received by
MetLife, Inc. from this offering are expected to be used to
finance a portion of the Acquisition purchase price. This
offering will be conducted in accordance with NASD Conduct
Rule 2710(h).
LEGAL OPINIONS
The validity of the series A preferred shares offered
hereby will be passed upon for MetLife, Inc. by Richard S.
Collins, Chief Counsel General Corporate of MetLife
and by LeBoeuf, Lamb, Greene & MacRae, L.L.P., New
York, New York, which has also acted as special tax counsel for
MetLife, Inc. Mr. Collins is paid a salary by MetLife,
Inc., is a participant in various employee benefit plans offered
by MetLife, Inc. to employees generally and has options to
purchase shares of MetLife, Inc. common stock. Cleary Gottlieb
Steen & Hamilton LLP, New York, New York, will pass
upon certain legal matters for the underwriters. LeBoeuf, Lamb,
Greene & MacRae, L.L.P. maintains various group and
other insurance policies with Metropolitan Life.
EXPERTS
The consolidated financial statements of Citigroup L&A as of
December 31, 2004, and the related combined statements of
income, shareholders equity and cash flows for the year
then ended December 31, 2004, included in MetLife,
Inc.s Current Report on Form 8-K filed by MetLife, Inc. on
May 13, 2005, and incorporated by reference herein, have
been audited by KPMG L.L.P., independent auditors, as stated in
their report, which is also incorporated by reference herein.
The consolidated financial statements of Citigroup L&A
referred to above are incorporated by reference herein in
reliance upon such report given upon the authority of said firm
as experts in accounting and auditing.
S-80
PROSPECTUS
$14,876,994,500
METLIFE, INC.
DEBT SECURITIES, PREFERRED STOCK, DEPOSITARY SHARES,
COMMON STOCK, WARRANTS, PURCHASE CONTRACTS AND UNITS
METLIFE CAPITAL TRUST II
METLIFE CAPITAL TRUST III
TRUST PREFERRED SECURITIES
Fully and Unconditionally Guaranteed by MetLife, Inc.,
As Set Forth Herein
MetLife, Inc., MetLife Capital Trust II and MetLife Capital
Trust III will provide the specific terms of these
securities in supplements to this prospectus. You should read
this prospectus and the accompanying prospectus supplement
carefully before you make your investment decision.
THIS PROSPECTUS MAY NOT BE USED TO SELL SECURITIES UNLESS
ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.
MetLife, Inc., MetLife Capital Trust II and MetLife Capital
Trust III may offer securities through underwriting
syndicates managed or co-managed by one or more underwriters,
through agents, or directly to purchasers. The prospectus
supplement for each offering of securities will describe in
detail the plan of distribution for that offering. For general
information about the distribution of securities offered, please
see Plan of Distribution in this prospectus.
MetLife, Inc.s common stock is listed on the New York
Stock Exchange under the trading symbol MET. Unless
otherwise stated in this prospectus or an accompanying
prospectus supplement, none of these securities will be listed
on a securities exchange, other than MetLife, Inc.s common
stock.
None of the Securities and Exchange Commission, any state
securities commission, the New York Superintendent of Insurance
or any other regulatory body has approved or disapproved of
these securities or determined if this prospectus or the
accompanying prospectus supplement is truthful or complete. They
have not made, nor will they make, any determination as to
whether anyone should buy these securities. Any representation
to the contrary is a criminal offense.
The date of this prospectus is April 27, 2005
TABLE OF CONTENTS
|
|
|
|
|
About This Prospectus
|
|
|
1 |
|
Where You Can Find More Information
|
|
|
1 |
|
Special Note Regarding Forward-Looking Statements
|
|
|
2 |
|
MetLife, Inc.
|
|
|
3 |
|
The Trusts
|
|
|
3 |
|
Use of Proceeds
|
|
|
5 |
|
Ratio of Earnings to Fixed Charges
|
|
|
5 |
|
Description of Securities
|
|
|
5 |
|
Description of Debt Securities
|
|
|
6 |
|
Description of Capital Stock
|
|
|
15 |
|
Description of Depositary Shares
|
|
|
21 |
|
Description of Warrants
|
|
|
23 |
|
Description of Purchase Contracts
|
|
|
24 |
|
Description of Units
|
|
|
25 |
|
Description of Trust Preferred Securities
|
|
|
26 |
|
Description of Guarantees
|
|
|
28 |
|
Plan of Distribution
|
|
|
31 |
|
Legal Opinions
|
|
|
33 |
|
Experts
|
|
|
33 |
|
ABOUT THIS PROSPECTUS
Unless otherwise stated or the context otherwise requires,
references in this prospectus to MetLife,
we, our, or us refer to
MetLife, Inc., together with Metropolitan Life Insurance
Company, and their respective direct and indirect subsidiaries,
while references to MetLife, Inc. refer only to
MetLife, Inc. on an unconsolidated basis. References in this
prospectus to the trusts refer to MetLife Capital
Trust II and MetLife Capital Trust III.
This prospectus is part of a registration statement that
MetLife, Inc., MetLife Capital Trust II and MetLife Capital
Trust III filed with the U.S. Securities and Exchange
Commission (the SEC) using a shelf
registration process. Under this shelf process, MetLife, Inc.
may, from time to time, sell any combination of debt securities,
preferred stock, depositary shares, common stock, warrants,
purchase contracts and units and MetLife Capital Trust II
and MetLife Capital Trust III may, from time to time, sell
trust preferred securities guaranteed by MetLife, Inc., as
described in this prospectus, in one or more offerings up to a
total dollar amount of $14,876,994,500 or the equivalent thereof
on the date of issuance in one or more foreign currencies,
foreign currency units or composite currencies. This prospectus
provides you with a general description of the securities
MetLife, Inc. and the trusts may offer. Each time that
securities are sold, a prospectus supplement that will contain
specific information about the terms of that offering will be
provided. The prospectus supplement may also add, update or
change information contained in this prospectus. You should read
both this prospectus and any prospectus supplement together with
additional information described under the heading Where
You Can Find More Information.
You should rely on the information contained or incorporated by
reference in this prospectus. Neither MetLife, Inc. nor the
trusts have authorized anyone to provide you with different
information. If anyone provides you with different or
inconsistent information, you should not rely on it. Neither
MetLife, Inc. nor the trusts are making an offer to sell these
securities in any jurisdiction where the offer or sale is not
permitted.
You should assume that the information in this prospectus is
accurate as of the date of the prospectus. Our business,
financial condition, results of operations and prospects may
have changed since that date.
WHERE YOU CAN FIND MORE INFORMATION
MetLife, Inc. files reports, proxy statements and other
information with the SEC. These reports, proxy statements and
other information, including the registration statement of which
this prospectus is a part, can be read and copied at the
SECs public reference room at 450 Fifth Street, N.W.,
Washington, D.C. 20549. Please call the SEC at
1-800-SEC-0330 for further information on the operation of the
public reference room. The SEC maintains an internet site at
www.sec.gov that contains reports, proxy and information
statements and other information regarding companies that file
electronically with the SEC, including MetLife, Inc. MetLife,
Inc.s common stock is listed and traded on the New York
Stock Exchange. These reports, proxy statements and other
information can also be read at the offices of the New York
Stock Exchange, 11 Wall Street, New York, New York 10005.
The SEC allows incorporation by reference into this
prospectus of information that MetLife, Inc. files with the SEC.
This permits MetLife, Inc. to disclose important information to
you by referencing these filed documents. Any information
referenced this way is considered part of this prospectus, and
any information filed with the SEC subsequent to the date of
this prospectus will automatically be deemed to update and
supersede this information. Information furnished under
Item 2.02 and Item 7.01 of MetLife, Inc.s
Current Reports on Form 8-K is not incorporated by
reference in this registration statement and prospectus.
MetLife, Inc. incorporates by reference the following documents
which have been filed with the SEC:
|
|
|
|
|
Registration Statement on Form 8-A, dated March 31,
2000, relating to registration of shares of MetLife, Inc.s
common stock and Registration Statement on Form 8-A, dated
March 31, 2000, relating to registration of MetLife,
Inc.s Series A Junior Participating Preferred Stock
purchase rights; |
|
|
|
Annual Report on Form 10-K for the year ended
December 31, 2004; and |
1
|
|
|
|
|
Current Reports on Form 8-K filed February 1, 2005,
February 4, 2005, February 28, 2005, March 15,
2005, March 30, 2005, April 4, 2005, April 15,
2005 and April 22, 2005. |
MetLife, Inc. incorporates by reference the documents listed
above and any future filings made with the SEC in accordance
with Sections 13(a), 13(c), 14 or 15(d) of the Securities
Exchange Act of 1934 until MetLife, Inc., MetLife Capital
Trust II and MetLife Capital Trust III file a
post-effective amendment which indicates the termination of the
offering of the securities made by this prospectus.
MetLife, Inc. will provide without charge upon written or oral
request, a copy of any or all of the documents which are
incorporated by reference into this prospectus, other than
exhibits to those documents, unless those exhibits are
specifically incorporated by reference into those documents.
Requests should be directed to Investor Relations, MetLife,
Inc., 1 MetLife Plaza, Long Island City, New York 11101 by
electronic mail (metir@metlife.com) or by telephone
(212-578-2211). You may also obtain some of the documents
incorporated by reference into this document at MetLifes
website, www.metlife.com. You should be aware that all other
information contained on MetLifes website is not a part of
this document.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus and the accompanying prospectus supplement may
contain or incorporate by reference information that includes or
is based upon forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements give expectations or forecasts of
future events. You can identify these statements by the fact
that they do not relate strictly to historical or current facts.
They use words such as anticipate,
estimate, expect, project,
intend, plan, believe, and
other words and terms of similar meaning in connection with a
discussion of future operating or financial performance. In
particular, these include statements relating to future actions,
prospective services or products, future performance or results
of current and anticipated services or products, sales efforts,
expenses, the outcome of contingencies such as legal
proceedings, trends in operations and financial results.
Any or all forward-looking statements may turn out to be wrong.
They can be affected by inaccurate assumptions or by known or
unknown risks and uncertainties. Many such factors will be
important in determining MetLifes actual future results.
These statements are based on current expectations and the
current economic environment. They involve a number of risks and
uncertainties that are difficult to predict. These statements
are not guarantees of future performance, and there are no
guarantees about the performance of any securities offered by
this prospectus. Actual results could differ materially from
those expressed or implied in the forward-looking statements.
Among factors that could cause actual results to differ
materially are:
|
|
|
|
|
changes in general economic conditions, including the
performance of financial markets and interest rates; |
|
|
|
heightened competition, including with respect to pricing, entry
of new competitors and the development of new products by new
and existing competitors; |
|
|
|
unanticipated changes in industry trends; |
|
|
|
MetLife, Inc.s primary reliance, as a holding company, on
dividends from its subsidiaries to meet debt payment obligations
and the existence of regulatory restrictions on the ability of
its subsidiaries to pay such dividends; |
|
|
|
deterioration in the experience of the closed block
established in connection with the reorganization of
Metropolitan Life Insurance Company; |
|
|
|
catastrophe losses; |
|
|
|
adverse results from litigation, arbitration or regulatory
investigations; |
|
|
|
regulatory, accounting or tax changes that may affect the cost
of, or demand for, our products or services; |
2
|
|
|
|
|
downgrades in our and our affiliates claims paying
ability, financial strength or credit ratings; |
|
|
|
changes in rating agency policies or practices; |
|
|
|
discrepancies between actual claims experience and assumptions
used in setting prices for our products and establishing the
liabilities for our obligations for future policy benefits and
claims; |
|
|
|
discrepancies between actual experience and assumptions used in
establishing liabilities related to other contingencies or
obligations; |
|
|
|
the effects of business disruption or economic contraction due
to terrorism or other hostilities; |
|
|
|
our ability to identify and consummate on successful terms any
pending or future acquisitions, including our announced
agreement to acquire Travelers Insurance Company, certain
affiliated companies and substantially all of the international
insurance business of Citigroup Inc., and to successfully
integrate acquired businesses with minimal disruption; |
|
|
|
other risks and uncertainties described from time to time in
MetLife, Inc.s or the trusts filings with the SEC; |
|
|
|
the risk factors or uncertainties set forth herein or listed
from time to time in prospectus supplements or any document
incorporated by reference herein; and |
|
|
|
other risks and uncertainties that have not been identified at
this time. |
Neither MetLife, Inc. nor the trusts undertake any obligation to
publicly correct or update any forward-looking statement if any
of MetLife, Inc. or the trusts later become aware that it is not
likely to be achieved. You are advised, however, to consult any
further disclosures MetLife, Inc. or the trusts make on related
subjects in reports to the SEC.
METLIFE, INC.
We are a leading provider of insurance and other financial
services to a broad spectrum of individual and institutional
customers. We offer life insurance, annuities, automobile and
homeowners insurance and mutual funds to individuals, as well as
group insurance, reinsurance, and retirement and savings
products and services to corporations and other institutions. We
serve individuals in approximately 13 million households in
the United States and provide benefits to 37 million
employees and family members through their plan sponsors.
We distribute our products and services nationwide through
multiple channels, with the primary distribution systems being
our core career agency system, our general agency distribution
systems, our regional sales forces, our dedicated sales forces,
financial intermediaries, independent agents and product
specialists. We operate in the international markets that we
serve through subsidiaries and joint ventures. Our international
segment focuses on the Asia/ Pacific region and Latin America
and currently has insurance operations in 11 countries serving
approximately 9 million customers.
MetLife, Inc. is incorporated under the laws of the State of
Delaware. MetLife, Inc.s principal executive offices are
located at 200 Park Avenue, New York, New York 10166-0188,
and its telephone number is 212-578-2211.
THE TRUSTS
MetLife Capital Trust II and MetLife Capital Trust III
are statutory trusts formed on May 17, 2001 under Delaware
law pursuant to declarations of trust between the trustees named
therein and MetLife, Inc. and the filing of certificates of
trust with the Secretary of State of the State of Delaware.
MetLife, Inc., as sponsor of the trusts, and the trustees named
in the declarations of trust will amend and restate the
declarations of trust in their entirety substantially in the
forms which are incorporated by reference as exhibits to the
registration statement of which this prospectus forms a part, as
of or prior to the date the trusts issue any
3
trust preferred securities. The declarations of trust will be
qualified as indentures under the Trust Indenture Act of
1939.
The trusts exist for the exclusive purposes of:
|
|
|
|
|
issuing preferred securities offered by this prospectus and
common securities to MetLife, Inc.; |
|
|
|
investing the gross proceeds of the preferred securities and
common securities in related series of debt securities, which
may be senior or subordinated, issued by MetLife, Inc.; and |
|
|
|
engaging in only those other activities which are necessary,
appropriate, convenient or incidental to the purposes set forth
above. |
The payment of periodic cash distributions on the trust
preferred securities and payments on liquidation and redemption
with respect to the trust preferred securities, in each case to
the extent the trusts have funds legally and immediately
available, will be guaranteed by MetLife, Inc. to the extent set
forth under Description of Guarantees.
MetLife, Inc. will own, directly or indirectly, all of the
common securities of the trusts. The common securities will
represent an aggregate liquidation amount equal to at least 3%
of each trusts total capitalization. The preferred
securities of each trust will represent the remaining 97% of
each trusts total capitalization. The common securities
will have terms substantially identical to, and will rank equal
in priority of payment with, the preferred securities. However,
if MetLife, Inc. defaults on the related series of debt
securities, then cash distributions and liquidation, redemption
and other amounts payable on the common securities will be
subordinate to the trust preferred securities in priority of
payment.
The trusts each have a term of approximately 55 years, but
may dissolve earlier as provided in their respective
declarations of trust. The trusts business and affairs
will be conducted by the trustees appointed by MetLife, Inc., as
the direct or indirect holder of all of the common securities.
The holder of the common securities of each trust will be
entitled to appoint, remove or replace any of, or increase or
reduce the number of, the trustees of the trust. However, the
number of trustees shall be at least two, at least one of which
shall be an administrative trustee. The duties and obligations
of the trustees will be governed by the declaration of trust for
each trust. A majority of the trustees of each trust will be
persons who are employees or officers of or affiliated with
MetLife, Inc. One trustee of each trust will be a financial
institution which will be unaffiliated with MetLife, Inc. and
which will act as property trustee and as indenture trustee for
purposes of the Trust Indenture Act of 1939, pursuant to the
terms set forth in a prospectus supplement. In addition, unless
the property trustee maintains a principal place of business in
the State of Delaware, and otherwise meets the requirements of
applicable law, one trustee of each trust will have its
principal place of business or reside in the State of Delaware.
The property trustee will hold title to the debt securities for
the benefit of the holders of the trust securities and the
property trustee will have the power to exercise all rights,
powers and privileges under the indenture as the holder of the
debt securities. In addition, the property trustee will maintain
exclusive control of a segregated non-interest bearing bank
account to hold all payments made in respect of the debt
securities for the benefit of the holders of the trust
securities. The property trustee will make payments of
distributions and payments on liquidation, redemption and
otherwise to the holders of the trust securities out of funds
from this property account.
The rights of the holders of the trust preferred securities,
including economic rights, rights to information and voting
rights, are provided in the declarations of trust of MetLife
Capital Trust II and MetLife Capital Trust III,
including any amendments thereto, the trust preferred
securities, the Delaware Statutory Trust Act and the Trust
Indenture Act.
MetLife, Inc. will pay all fees and expenses related to the
trusts and the offering of trust preferred securities. The
principal offices of each trust is: c/o Chase Bank USA,
National Association, 500 Stanton Christiana Road,
3rd Floor/ OPS4, Newark, Delaware 19713, Attention:
Institutional Trust Services. The telephone number of each
trust is: 302-552-6279.
4
For financial reporting purposes,
|
|
|
|
|
the trusts will not be treated as MetLife, Inc.s
subsidiaries; and |
|
|
|
the accounts of the trusts will not be included in MetLife,
Inc.s consolidated financial statements. |
In January 2003, the Financial Accounting Standards Board issued
Interpretation No. 46 (FIN 46),
Consolidation of Variable Interest Entities, and, in December
2003, issued Revised Interpretation No. 46
(FIN 46R), Consolidation of Variable Interest
Entities, which amended FIN 46. Prior to the issuance of
FIN 46 and FIN 46R, issuer trusts that issued capital
securities were generally consolidated by their parent
companies. Under FIN 46 and FIN 46R, MetLifes
issuer trusts will no longer be consolidated. MetLife, Inc. is a
bank holding company, subject to the rules and regulations of
the Board of Governors of the Federal Reserve System regarding
capital treatment of trust preferred securities. On
March 1, 2005, the Federal Reserve Board adopted a final
rule that allows the continued inclusion of trust preferred
securities in the Tier 1 capital of bank holding companies.
Please read the prospectus supplement relating to the trust
preferred securities for further information concerning the
trusts and the trust preferred securities.
USE OF PROCEEDS
We may use the proceeds of securities sold under this
registration statement for, among other things, general
corporate purposes and to finance a portion of the purchase
price of MetLifes proposed acquisition of the life
insurance and annuity operations commonly known as Travelers
Life & Annuity and certain international insurance
businesses from Citigroup Inc. The prospectus supplement for
each offering of securities will specify the intended use of the
proceeds of that offering. The trusts will use all of the
proceeds they receive from the sale of trust preferred
securities to purchase debt securities issued by MetLife, Inc.
RATIO OF EARNINGS TO FIXED CHARGES
The following table sets forth our ratio of earnings to fixed
charges.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Ratio of Earnings to Fixed Charges(1)
|
|
|
2.09 |
|
|
|
1.78 |
|
|
|
1.53 |
|
|
|
1.14 |
|
|
|
1.32 |
|
|
|
(1) |
For purposes of this computation, earnings are defined as income
from continuing operations before provision for income taxes
excluding undistributed income and losses from equity method
investments, minority interest and fixed charges. Fixed charges
are the sum of interest and debt issue costs, interest credited
to policyholder account balances, interest on bank deposits and
an estimated interest component of rent expense. As of the date
of this prospectus, there is no preferred stock outstanding and
accordingly, the ratio of earnings to fixed charges and
preferred stock dividends is equal to the ratio of earnings to
fixed charges and is not disclosed separately. |
DESCRIPTION OF SECURITIES
This prospectus contains summary descriptions of the debt
securities, preferred stock, depositary shares, common stock,
warrants, purchase contracts and units that MetLife, Inc. may
sell from time to time, and the trust preferred securities
guaranteed by MetLife, Inc. that MetLife Capital Trust II
and MetLife Capital Trust III may sell from time to time.
These summary descriptions are not meant to be complete
descriptions of each security. However, this prospectus and the
accompanying prospectus supplement contain the material terms of
the securities being offered.
5
DESCRIPTION OF DEBT SECURITIES
As used in this prospectus, debt securities means the
debentures, notes, bonds and other evidences of indebtedness
that MetLife, Inc. may issue from time to time. The debt
securities will either be senior debt securities or subordinated
debt securities. Unless the applicable prospectus supplement
states otherwise, senior debt securities will be issued under
the Senior Indenture dated as of November 9, 2001 between
us and Bank One Trust Company, N.A. (predecessor to
J.P. Morgan Trust Company, National Association) (the
Senior Indenture) and subordinated debt securities
will be issued under a Subordinated Indenture to be
entered into with J.P. Morgan Trust Company, National
Association. This prospectus sometimes refers to the Senior
Indenture and the Subordinated Indenture collectively as the
Indentures.
The Senior Indenture and form of Subordinated Indenture are
incorporated by reference as exhibits to the registration
statement of which this prospectus forms a part. The statements
and descriptions in this prospectus or in any prospectus
supplement regarding provisions of the Indentures and debt
securities are summaries thereof, do not purport to be complete
and are subject to, and are qualified in their entirety by
reference to, all of the provisions of the Indentures and the
debt securities, including the definitions therein of certain
terms.
The debt securities will be direct unsecured obligations of
MetLife, Inc. The senior debt securities will rank equally with
all of MetLife, Inc.s other senior and unsubordinated
debt. The subordinated debt securities will be subordinate and
junior in right of payment to all of MetLife, Inc.s
present and future senior indebtedness.
Because MetLife, Inc. is principally a holding company, its
right to participate in any distribution of assets of any
subsidiary, including Metropolitan Life Insurance Company, upon
the subsidiarys liquidation or reorganization or
otherwise, is subject to the prior claims of creditors of the
subsidiary, except to the extent MetLife, Inc. may be recognized
as a creditor of that subsidiary. Accordingly, MetLife,
Inc.s obligations under the debt securities will be
effectively subordinated to all existing and future indebtedness
and liabilities of its subsidiaries, including liabilities under
contracts of insurance and annuities written by MetLife,
Inc.s insurance subsidiaries, and holders of debt
securities should look only to MetLife, Inc.s assets for
payment thereunder.
The Indentures do not limit the aggregate principal amount of
debt securities that MetLife, Inc. may issue and provide that
MetLife, Inc. may issue debt securities from time to time in one
or more series, in each case with the same or various
maturities, at par or at a discount. MetLife, Inc. may issue
additional debt securities of a particular series without the
consent of the holders of the debt securities of such series
outstanding at the time of the issuance. Any such additional
debt securities, together with all other outstanding debt
securities of that series, will constitute a single series of
debt securities under the applicable Indenture. The Indentures
also do not limit our ability to incur other debt.
Each prospectus supplement will describe the terms relating to
the specific series of debt securities being offered. These
terms will include some or all of the following:
|
|
|
|
|
the title of debt securities and whether they are subordinated
debt securities or senior debt securities; |
|
|
|
any limit on the aggregate principal amount of the debt
securities; |
|
|
|
the price or prices at which MetLife, Inc. will sell the debt
securities; |
|
|
|
the maturity date or dates of the debt securities; |
|
|
|
the rate or rates of interest, if any, which may be fixed or
variable, per annum at which the debt securities will bear
interest, or the method of determining such rate or rates, if
any; |
|
|
|
the date or dates from which any interest will accrue, the dates
on which interest will be payable, or the method by which such
date or dates will be determined; |
6
|
|
|
|
|
the right, if any, to extend the interest payment periods and
the duration of any such deferral period, including the maximum
consecutive period during which interest payment periods may be
extended; |
|
|
|
whether the amount of payments of principal of (and premium, if
any) or interest on the debt securities may be determined with
reference to any index, formula or other method, such as one or
more currencies, commodities, equity indices or other indices,
and the manner of determining the amount of such payments; |
|
|
|
the dates on which MetLife, Inc. will pay interest on the debt
securities and the regular record date for determining who is
entitled to the interest payable on any interest payment date; |
|
|
|
the place or places where the principal of (and premium, if any)
and interest on the debt securities will be payable; |
|
|
|
if MetLife, Inc. possesses the option to do so, the periods
within which and the prices at which MetLife, Inc. may redeem
the debt securities, in whole or in part, pursuant to optional
redemption provisions, and the other terms and conditions of any
such provisions; |
|
|
|
MetLife, Inc.s obligation, if any, to redeem, repay or
purchase debt securities by making periodic payments to a
sinking fund or through an analogous provision or at the option
of holders of the debt securities, and the period or periods
within which and the price or prices at which MetLife, Inc. will
redeem, repay or purchase the debt securities, in whole or in
part, pursuant to such obligation, and the other terms and
conditions of such obligation; |
|
|
|
the denominations in which the debt securities will be issued,
if other than denominations of $1,000 and integral multiples of
$1,000; |
|
|
|
the portion, or methods of determining the portion, of the
principal amount of the debt securities which MetLife, Inc. must
pay upon the acceleration of the maturity of the debt securities
in connection with an Event of Default (as described below), if
other than the full principal amount; |
|
|
|
the currency, currencies or currency unit in which MetLife, Inc.
will pay the principal of (and premium, if any) or interest, if
any, on the debt securities, if not United States dollars and
the manner of determining the equivalent thereof in United
States dollars; |
|
|
|
provisions, if any, granting special rights to holders of the
debt securities upon the occurrence of specified events; |
|
|
|
any deletions from, modifications of or additions to the Events
of Default or MetLife, Inc.s covenants with respect to the
applicable series of debt securities, and whether or not such
Events of Default or covenants are consistent with those
contained in the applicable Indenture; |
|
|
|
the application, if any, of the terms of the Indenture relating
to defeasance and covenant defeasance (which terms are described
below) to the debt securities; |
|
|
|
whether the subordination provisions summarized below or
different subordination provisions will apply to the debt
securities; |
|
|
|
the terms, if any, upon which the holders may or are required to
convert or exchange such debt securities into or for MetLife,
Inc.s common stock or other securities or property or into
Securities of a third party, including conversion price (which
may be adjusted), the method of calculating the conversion
price, or the conversion period; |
|
|
|
whether any of the debt securities will be issued in global or
certificated form and, if so, the terms and conditions upon
which global debt securities may be exchanged for certificated
debt securities; |
|
|
|
any change in the right of the trustee or the requisite holders
of debt securities to declare the principal amount thereof due
and payable because of an Event of Default; |
|
|
|
the depositary for global or certificated debt securities; |
7
|
|
|
|
|
if applicable, a discussion of the U.S. federal income tax
considerations applicable to specific debt securities; |
|
|
|
any trustees, authenticating or paying agents, transfer agents
or registrars or other agents with respect to the debt
securities; |
|
|
|
any other terms of the debt securities not inconsistent with the
provisions of the Indentures, as amended or supplemented. |
Unless otherwise specified in the applicable prospectus
supplement, the debt securities will not be listed on any
securities exchange.
Unless otherwise specified in the applicable prospectus
supplement, the debt securities will be issued in fully
registered form without coupons.
Debt securities may be sold at a substantial discount below
their stated principal amount, bearing no interest or interest
at a rate which at the time of issuance is below market rates.
The applicable prospectus supplement will describe the federal
income tax consequences and special considerations applicable to
any such debt securities. The debt securities may also be issued
as indexed securities or securities denominated in foreign
currencies or currency units, as described in more detail in the
prospectus supplement relating to any of the particular debt
securities. The prospectus supplement relating to specific debt
securities will also describe any special considerations and
certain additional tax considerations applicable to such debt
securities.
The prospectus supplement relating to any offering of
subordinated debt securities will describe the specific
subordination provisions. However, unless otherwise noted in the
prospectus supplement, subordinated debt securities will be
subordinate and junior in right of payment to all of MetLife,
Inc.s Senior Indebtedness (as described below).
Under the Subordinated Indenture, Senior
Indebtedness means all amounts due on obligations in
connection with any of the following, whether outstanding at the
date of execution of the Subordinated Indenture or thereafter
incurred or created:
|
|
|
|
|
the principal of (and premium, if any) and interest in respect
of indebtedness of MetLife, Inc. for borrowed money and
indebtedness evidenced by securities, debentures, bonds or other
similar instruments issued by MetLife, Inc.; |
|
|
|
all capital lease obligations of MetLife, Inc.; |
|
|
|
all obligations of MetLife, Inc. issued or assumed as the
deferred purchase price of property, all conditional sale
obligations of MetLife, Inc. and all obligations of MetLife,
Inc. under any title retention agreement (but excluding trade
accounts payable in the ordinary course of business); |
|
|
|
all obligations of MetLife, Inc. for the reimbursement on any
letter of credit, bankers acceptance, security purchase
facility or similar credit transaction; |
|
|
|
all obligations of MetLife, Inc. in respect of interest rate
swap, cap or other agreements, interest rate future or options
contracts, currency swap agreements, currency future or option
contracts and other similar agreements; |
|
|
|
all obligations of the types referred to above of other persons
for the payment of which MetLife, Inc. is responsible or liable
as obligor, guarantor or otherwise; and |
|
|
|
all obligations of the types referred to above of other persons
secured by any lien on any property or asset of MetLife, Inc.
whether or not such obligation is assumed by MetLife, Inc. |
Senior Indebtedness does not include:
|
|
|
|
|
indebtedness or monetary obligations to trade creditors created
or assumed by MetLife, Inc. in the ordinary course of business
in connection with the obtaining of materials or services; |
8
|
|
|
|
|
indebtedness that is, by its terms, subordinated to, or ranks
equal with, the subordinated debt securities; and |
|
|
|
any indebtedness of MetLife, Inc. to its affiliates (including
all debt securities and guarantees in respect of those debt
securities issued to any trust, partnership or other entity
affiliated with MetLife, Inc. that is a financing vehicle of
MetLife, Inc. in connection with the issuance by such financing
entity of preferred securities or other securities guaranteed by
MetLife, Inc.) unless otherwise expressly provided in the terms
of any such indebtedness. |
At December 31, 2004, Senior Indebtedness aggregated
approximately $5.7 billion. The amount of Senior
Indebtedness which MetLife, Inc. may issue is subject to
limitations imposed by its board of directors.
Senior Indebtedness shall continue to be Senior Indebtedness and
be entitled to the benefits of the subordination provisions
irrespective of any amendment, modification or waiver of any
term of such Senior Indebtedness.
Unless otherwise noted in the accompanying prospectus
supplement, if MetLife, Inc. defaults in the payment of any
principal of (or premium, if any) or interest on any Senior
Indebtedness when it becomes due and payable, whether at
maturity or at a date fixed for prepayment or by declaration or
otherwise, then, unless and until such default is cured or
waived or ceases to exist, MetLife, Inc. will make no direct or
indirect payment (in cash, property, securities, by set-off or
otherwise) in respect of the principal of or interest on the
subordinated debt securities or in respect of any redemption,
retirement, purchase or other requisition of any of the
subordinated debt securities.
In the event of the acceleration of the maturity of any
subordinated debt securities, the holders of all senior debt
securities outstanding at the time of such acceleration will
first be entitled to receive payment in full of all amounts due
on the senior debt securities before the holders of the
subordinated debt securities will be entitled to receive any
payment of principal (and premium, if any) or interest on the
subordinated debt securities.
If any of the following events occurs, MetLife, Inc. will pay in
full all Senior Indebtedness before it makes any payment or
distribution under the subordinated debt securities, whether in
cash, securities or other property, to any holder of
subordinated debt securities:
|
|
|
|
|
any dissolution or winding-up or liquidation or reorganization
of MetLife, Inc., whether voluntary or involuntary or in
bankruptcy, insolvency or receivership; |
|
|
|
any general assignment by MetLife, Inc. for the benefit of
creditors; or |
|
|
|
any other marshaling of MetLife, Inc.s assets or
liabilities. |
In such event, any payment or distribution under the
subordinated debt securities, whether in cash, securities or
other property, which would otherwise (but for the subordination
provisions) be payable or deliverable in respect of the
subordinated debt securities, will be paid or delivered directly
to the holders of Senior Indebtedness in accordance with the
priorities then existing among such holders until all Senior
Indebtedness has been paid in full. If any payment or
distribution under the subordinated debt securities is received
by the trustee of any subordinated debt securities in
contravention of any of the terms of the Subordinated Indenture
and before all the Senior Indebtedness has been paid in full,
such payment or distribution or security will be received in
trust for the benefit of, and paid over or delivered and
transferred to, the holders of the Senior Indebtedness at the
time outstanding in accordance with the priorities then existing
among such holders for application to the payment of all Senior
Indebtedness remaining unpaid to the extent necessary to pay all
such Senior Indebtedness in full.
The Subordinated Indenture does not limit the issuance of
additional Senior Indebtedness.
If debt securities are issued to a trust in connection with the
issuance of trust preferred securities, such debt securities may
thereafter be distributed pro rata to the holders of such trust
securities in connection with the dissolution of such trust upon
the occurrence of certain events described in the applicable
prospectus supplement.
9
Unless an accompanying prospectus supplement states otherwise,
the following restrictive covenants shall apply to each series
of senior debt securities:
Limitation on Liens. So long as any senior debt
securities are outstanding, neither MetLife, Inc. nor any of its
subsidiaries will create, assume, incur or guarantee any debt
which is secured by any mortgage, pledge, lien, security
interest or other encumbrance on any capital stock of:
|
|
|
|
|
Metropolitan Life Insurance Company; |
|
|
|
any successor to substantially all of the business of
Metropolitan Life Insurance Company which is also a subsidiary
of MetLife, Inc.; or |
|
|
|
any corporation (other than MetLife, Inc.) having direct or
indirect control of Metropolitan Life Insurance Company or any
such successor. |
However, this restriction will not apply if the debt securities
then outstanding are secured at least equally and ratably with
the otherwise prohibited secured debt so long as it is
outstanding.
Limitations on Dispositions of Stock of Certain
Subsidiaries. So long as any senior debt securities are
outstanding and subject to the provisions of the Senior
Indenture regarding mergers, consolidations and sales of assets,
neither MetLife, Inc. nor any of its subsidiaries will sell or
otherwise dispose of any shares of capital stock (other than
preferred stock having no voting rights of any kind) of:
|
|
|
|
|
Metropolitan Life Insurance Company; |
|
|
|
any successor to substantially all of the business of
Metropolitan Life Insurance Company which is also a subsidiary
of MetLife, Inc.; or |
|
|
|
any corporation (other than MetLife, Inc.) having direct or
indirect control of Metropolitan Life Insurance Company or any
such successor; |
except for, in each case:
|
|
|
|
|
a sale or other disposition of any of such stock to a
wholly-owned subsidiary of MetLife, Inc. or of such subsidiary;
or |
|
|
|
a sale or other disposition of all of such stock for at least
fair value (as determined by MetLife, Inc.s board of
directors acting in good faith); or a sale or other disposition
required to comply with an order of a court or regulatory
authority of competent jurisdiction, other than an order issued
at MetLife, Inc.s request or the request of any of
MetLife, Inc.s subsidiaries. |
|
|
|
Consolidation, Merger, Sale of Assets and Other
Transactions |
(i) MetLife, Inc. may not merge with or into or consolidate
with another corporation or sell, assign, transfer, lease or
convey all or substantially all of its properties and assets to,
any other corporation other than a direct or indirect
wholly-owned subsidiary of MetLife, Inc., and (ii) no
corporation may merge with or into or consolidate with MetLife,
Inc. or, except for any direct or indirect wholly-owned
subsidiary of MetLife, Inc., sell, assign, transfer, lease or
convey all or substantially all of its properties and assets to
MetLife, Inc., unless:
|
|
|
|
|
MetLife, Inc. is the surviving corporation or the corporation
formed by or surviving such merger or consolidation or to which
such sale, assignment, transfer, lease or conveyance has been
made, if other than MetLife, Inc., has expressly assumed by
supplemental indenture all the obligations of MetLife, Inc.
under the debt securities, the Indentures, and any guarantees of
preferred securities or common securities issued by the trusts; |
|
|
|
immediately after giving effect to such transaction, no default
or Event of Default has occurred and is continuing; |
10
|
|
|
|
|
if at the time any preferred securities of the trusts are
outstanding, such transaction is not prohibited under the
applicable declaration of trust and the applicable preferred
securities guarantee of each trust; and |
|
|
|
MetLife, Inc. delivers to the trustee an officers
certificate and an opinion of counsel, each stating that the
supplemental indenture complies with the applicable Indenture. |
|
|
|
Events of Default, Notice and Waiver |
Unless an accompanying prospectus supplement states otherwise,
the following shall constitute Events of Default
under the Indentures with respect to each series of debt
securities:
|
|
|
|
|
MetLife, Inc.s failure to pay any interest on any debt
security of such series when due and payable, continued for
30 days; |
|
|
|
MetLife, Inc.s failure to pay principal (or premium, if
any) on any debt security of such series when due, regardless of
whether such payment became due because of maturity, redemption,
acceleration or otherwise, or is required by any sinking fund
established with respect to such series; |
|
|
|
MetLife, Inc.s failure to observe or perform any other of
its covenants or agreements with respect to such series for
90 days after MetLife, Inc. receives notice of such failure; |
|
|
|
certain defaults with respect to MetLife, Inc.s debt which
result in a principal amount in excess of $100,000,000 becoming
or being declared due and payable prior to the date on which it
would otherwise have become due and payable (other than the debt
securities or non-recourse debt); |
|
|
|
certain events of bankruptcy, insolvency or reorganization of
MetLife, Inc.; and |
|
|
|
certain events of dissolution or winding-up of the trusts in the
event that debt securities are issued to the trusts or a trustee
of the trusts in connection with the issuance of securities by
the trusts. |
If an Event of Default with respect to any debt securities of
any series outstanding under either of the Indentures shall
occur and be continuing, the trustee under such Indenture or the
holders of at least 25% in aggregate principal amount of the
debt securities of that series outstanding may declare, by
notice as provided in the applicable Indenture, the principal
amount (or such lesser amount as may be provided for in the debt
securities of that series) of all the debt securities of that
series outstanding to be due and payable immediately; provided
that, in the case of an Event of Default involving certain
events in bankruptcy, insolvency or reorganization, acceleration
is automatic; and, provided further, that after such
acceleration, but before a judgment or decree based on
acceleration, the holders of a majority in aggregate principal
amount of the outstanding debt securities of that series may,
under certain circumstances, rescind and annul such acceleration
if all Events of Default, other than the nonpayment of
accelerated principal, have been cured or waived. Upon the
acceleration of the maturity of original issue discount
securities, an amount less than the principal amount thereof
will become due and payable. Reference is made to the prospectus
supplement relating to any original issue discount securities
for the particular provisions relating to acceleration of
maturity thereof.
Any past default under either Indenture with respect to debt
securities of any series, and any Event of Default arising
therefrom, may be waived by the holders of a majority in
principal amount of all debt securities of such series
outstanding under such Indenture, except in the case of
(i) default in the payment of the principal of (or premium,
if any) or interest on any debt securities of such series or
(ii) default in respect of a covenant or provision which
may not be amended or modified without the consent of the holder
of each outstanding debt security of such series affected.
The trustee is required, within 90 days after the
occurrence of a default (which is known to the trustee and is
continuing), with respect to the debt securities of any series
(without regard to any grace period or notice requirements), to
give to the holders of the debt securities of such series notice
of such default; provided, however, that, except in the case of
a default in the payment of the principal of (and premium, if
any) or interest, or in the payment of any sinking fund
installment, on any debt securities of such series, the
11
trustee shall be protected in withholding such notice if it in
good faith determines that the withholding of such notice is in
the interests of the holders of the debt securities of such
series.
The trustee, subject to its duties during default to act with
the required standard of care, may require indemnification by
the holders of the debt securities of any series with respect to
which a default has occurred before proceeding to exercise any
right or power under the Indentures at the request of the
holders of the debt securities of such series. Subject to such
right of indemnification and to certain other limitations, the
holders of a majority in aggregate principal amount of the
outstanding debt securities of any series under either Indenture
may direct the time, method and place of conducting any
proceeding for any remedy available to the trustee, or
exercising any trust or power conferred on the trustee with
respect to the debt securities of such series.
No holder of a debt security of any series may institute any
action against MetLife, Inc. under either of the Indentures
(except actions for payment of overdue principal of (and
premium, if any) or interest on such debt security or for the
conversion or exchange of such debt security in accordance with
its terms) unless (i) the holder has given to the trustee
written notice of an Event of Default and of the continuance
thereof with respect to the debt securities of such series
specifying an Event of Default, as required under the applicable
Indenture, (ii) the holders of at least 25% in aggregate
principal amount of the debt securities of that series then
outstanding under such Indenture shall have requested the
trustee to institute such action and offered to the trustee
reasonable indemnity against the costs, expenses and liabilities
to be incurred in compliance with such request, and
(iii) the trustee shall not have instituted such action
within 60 days of such request.
MetLife, Inc. is required to furnish annually to the trustee
statements as to MetLife, Inc.s compliance with all
conditions and covenants under each Indenture.
|
|
|
Discharge, Defeasance and Covenant Defeasance |
If indicated in the applicable prospectus supplement, MetLife,
Inc. may discharge or defease its obligations under each
Indenture as set forth below.
MetLife, Inc. may discharge certain obligations to holders of
any series of debt securities issued under either the Senior
Indenture or the Subordinated Indenture which have not already
been delivered to the trustee for cancellation and which have
either become due and payable or are by their terms due and
payable within one year (or scheduled for redemption within one
year) by irrevocably depositing with the trustee cash or, in the
case of debt securities payable only in U.S. dollars,
U.S. government obligations (as defined in either
Indenture), as trust funds in an amount certified to be
sufficient to pay when due, whether at maturity, upon redemption
or otherwise, the principal of (and premium, if any) and
interest on such debt securities.
If indicated in the applicable prospectus supplement, MetLife,
Inc. may elect either (i) to defease and be discharged from
any and all obligations with respect to the debt securities of
or within any series (except as otherwise provided in the
relevant Indenture) (defeasance) or (ii) to be
released from its obligations with respect to certain covenants
applicable to the debt securities of or within any series
(covenant defeasance), upon the deposit with the
relevant Indenture trustee, in trust for such purpose, of money
and/or government obligations which, through the payment of
principal and interest in accordance with their terms, will
provide money in an amount sufficient, without reinvestment, to
pay the principal of (and premium, if any) or interest on such
debt securities to maturity or redemption, as the case may be,
and any mandatory sinking fund or analogous payments thereon. As
a condition to defeasance or covenant defeasance, MetLife, Inc.
must deliver to the trustee an opinion of counsel to the effect
that the holders of such debt securities will not recognize
income, gain or loss for federal income tax purposes as a result
of such defeasance or covenant defeasance and will be subject to
federal income tax on the same amounts and in the same manner
and at the same times as would have been the case if such
defeasance or covenant defeasance had not occurred. Such opinion
of counsel, in the case of defeasance under clause (i)
above, must refer to and be based upon a ruling of the Internal
Revenue Service or a change in applicable federal income tax law
occurring after the date of the relevant Indenture. In addition,
in the case of either defeasance or covenant defeasance,
MetLife, Inc. shall have delivered to the trustee (i) an
officers certificate to the effect that the relevant debt
securities
12
exchange(s) have informed it that neither such debt securities
nor any other debt securities of the same series, if then listed
on any securities exchange, will be delisted as a result of such
deposit, and (ii) an officers certificate and an
opinion of counsel, each stating that all conditions precedent
with respect to such defeasance or covenant defeasance have been
complied with.
MetLife, Inc. may exercise its defeasance option with respect to
such debt securities notwithstanding its prior exercise of its
covenant defeasance option.
Under the Indentures, MetLife, Inc. and the applicable trustee
may supplement the Indentures for certain purposes which would
not materially adversely affect the interests or rights of the
holders of debt securities of a series without the consent of
those holders. MetLife, Inc. and the applicable trustee may also
modify the Indentures or any supplemental indenture in a manner
that affects the interests or rights of the holders of debt
securities with the consent of the holders of at least a
majority in aggregate principal amount of the outstanding debt
securities of each affected series issued under the Indenture.
However, the Indentures require the consent of each holder of
debt securities that would be affected by any modification which
would:
|
|
|
|
|
extend the fixed maturity of any debt securities of any series,
or reduce the principal amount thereof, or reduce the rate or
extend the time of payment of interest thereon, or reduce any
premium payable upon the redemption thereof; |
|
|
|
reduce the amount of principal of an original issue discount
debt security or any other debt security payable upon
acceleration of the maturity thereof; |
|
|
|
change the currency in which any debt security or any premium or
interest is payable; |
|
|
|
impair the right to enforce any payment on or with respect to
any debt security; |
|
|
|
adversely change the right to convert or exchange, including
decreasing the conversion rate or increasing the conversion
price of, any debt security (if applicable); |
|
|
|
reduce the percentage in principal amount of outstanding debt
securities of any series, the consent of whose holders is
required for modification or amendment of the Indentures or for
waiver of compliance with certain provisions of the Indentures
or for waiver of certain defaults; |
|
|
|
reduce the requirements contained in the Indentures for quorum
or voting; or |
|
|
|
modify any of the above provisions. |
If debt securities are held by a trust or a trustee of a trust,
a supplemental indenture that affects the interests or rights of
the holders of debt securities will not be effective until the
holders of not less than a majority in liquidation preference of
the preferred securities and common securities of the applicable
trust, collectively, have consented to the supplemental
indenture; provided, further, that if the consent of the holder
of each outstanding debt security is required, the supplemental
indenture will not be effective until each holder of the
preferred securities and the common securities of the applicable
trust has consented to the supplemental indenture.
The Indentures permit the holders of at least a majority in
aggregate principal amount of the outstanding debt securities of
any series issued under the Indenture which is affected by the
modification or amendment to waive MetLife, Inc.s
compliance with certain covenants contained in the Indentures.
|
|
|
Payment and Paying Agents |
Unless otherwise indicated in the applicable prospectus
supplement, payment of interest on a debt security on any
interest payment date will be made to the person in whose name a
debt security is registered at the close of business on the
record date for the interest.
Unless otherwise indicated in the applicable prospectus
supplement, principal, interest and premium on the debt
securities of a particular series will be payable at the office
of such paying agent or paying agents as
13
MetLife, Inc. may designate for such purpose from time to time.
Notwithstanding the foregoing, at MetLife, Inc.s option,
payment of any interest may be made by check mailed to the
address of the person entitled thereto as such address appears
in the security register.
Unless otherwise indicated in the applicable prospectus
supplement, a paying agent designated by MetLife, Inc. and
located in the Borough of Manhattan, The City of New York, will
act as paying agent for payments with respect to debt securities
of each series. All paying agents initially designated by
MetLife, Inc. for the debt securities of a particular series
will be named in the applicable prospectus supplement. MetLife,
Inc. may at any time designate additional paying agents or
rescind the designation of any paying agent or approve a change
in the office through which any paying agent acts, except that
MetLife, Inc. will be required to maintain a paying agent in
each place of payment for the debt securities of a particular
series.
All moneys paid by MetLife, Inc. to a paying agent for the
payment of the principal, interest or premium on any debt
security which remain unclaimed at the end of two years after
such principal, interest or premium has become due and payable
will be repaid to MetLife, Inc. upon request, and the holder of
such debt security thereafter may look only to MetLife, Inc. for
payment thereof.
|
|
|
Denominations, Registrations and Transfer |
Unless an accompanying prospectus supplement states otherwise,
debt securities will be represented by one or more global
certificates registered in the name of a nominee for The
Depository Trust Company (DTC). In such case, each
holders beneficial interest in the global securities will
be shown on the records of DTC and transfers of beneficial
interests will only be effected through DTCs records.
A holder of debt securities may only exchange a beneficial
interest in a global security for certificated securities
registered in the holders name if:
|
|
|
|
|
DTC notifies MetLife, Inc. that it is unwilling or unable to
continue serving as the depositary for the relevant global
securities or DTC ceases to maintain certain qualifications
under the Securities Exchange Act of 1934 and no successor
depositary has been appointed for 90 days; or |
|
|
|
MetLife, Inc. determines, in its sole discretion and subject to
the procedures of DTC, that the global security shall be
exchangeable. |
If debt securities are issued in certificated form, they will
only be issued in the minimum denomination specified in the
accompanying prospectus supplement and integral multiples of
such denomination. Transfers and exchanges of such debt
securities will only be permitted in such minimum denomination.
Transfers of debt securities in certificated form may be
registered at the trustees corporate office or at the
offices of any paying agent or trustee appointed by MetLife,
Inc. under the Indentures. Exchanges of debt securities for an
equal aggregate principal amount of debt securities in different
denominations may also be made at such locations.
The Indentures and debt securities will be governed by, and
construed in accordance with, the internal laws of the State of
New York, without regard to its principles of conflicts of laws.
|
|
|
Relationship with the Trustees |
The trustee under the Indentures is J.P. Morgan Trust
Company, National Association (as successor to Bank One Trust
Company, N.A.). MetLife, Inc. and its subsidiaries maintain
ordinary banking and trust relationships with a number of banks
and trust companies, including the trustee under the Indentures.
|
|
|
Conversion or Exchange Rights |
The prospectus supplement will describe the terms, if any, on
which a series of debt securities may be convertible into or
exchangeable for securities described in this prospectus. These
terms will include provisions as to whether conversion or
exchange is mandatory, at the option of the holder or at
MetLife, Inc.s option.
14
These provisions may allow or require the number of shares of
MetLife, Inc.s common stock or other securities to be
received by the holders of such series of debt securities to be
adjusted.
DESCRIPTION OF CAPITAL STOCK
MetLife, Inc.s authorized capital stock consists of:
|
|
|
|
|
200,000,000 shares of preferred stock, par value
$0.01 per share, of which no shares were issued or
outstanding as of the date of this prospectus; |
|
|
|
10,000,000 shares of Series A Junior Participating
Preferred Stock, par value $0.01 per share, of which no
shares were issued or outstanding as of the date of this
prospectus; and |
|
|
|
3,000,000,000 shares of common stock, par value
$0.01 per share, of which 732,487,999 shares, as well
as the same number of rights to purchase shares of Series A
Junior Participating Preferred Stock pursuant to the stockholder
rights plan adopted by MetLife, Inc.s board of directors
on September 29, 1999, were outstanding as of
December 31, 2004. See Stockholder Rights
Plan for a description of the Series A Junior
Participating Preferred Stock. The remaining shares of
authorized and unissued common stock will be available for
future issuance without additional stockholder approval. |
Dividends. The holders of common stock, after any
preferences of holders of any preferred stock, are entitled to
receive dividends as determined by the board of directors. The
issuance of dividends will depend upon, among other factors
deemed relevant by MetLife, Inc.s board of directors,
MetLifes financial condition, results of operations, cash
requirements, future prospects and regulatory restrictions on
the payment of dividends by Metropolitan Life Insurance Company
and MetLife, Inc.s other subsidiaries. There is no
requirement or assurance that MetLife, Inc. will declare and pay
any dividends. In addition, the indenture, as supplemented by a
supplemental indenture, governing the terms of MetLife,
Inc.s 3.911% Debentures due May 15, 2005,
prohibits the payment of dividends on common stock of MetLife,
Inc. during a deferral of interest payments on such securities
or an event of default under the indenture, as supplemented, or
the related guarantee.
Voting Rights. The holders of common stock are entitled
to one vote per share on all matters on which the holders of
common stock are entitled to vote and do not have any cumulative
voting rights.
Liquidation and Dissolution. In the event of MetLife,
Inc.s liquidation, dissolution or winding-up, the holders
of common stock are entitled to share equally and ratably in
MetLife, Inc.s assets, if any, remaining after the payment
of all of MetLife, Inc.s liabilities and the liquidation
preference of any outstanding class or series of preferred stock.
Other Rights. The holders of common stock have no
preemptive, conversion, redemption or sinking fund rights. The
holders of shares of MetLife, Inc.s common stock are not
required to make additional capital contributions.
Transfer Agent and Registrar. The transfer agent and
registrar for MetLife, Inc.s common stock is Mellon
Investor Services, successor to ChaseMellon Shareholder
Services, L.L.C.
General. MetLife, Inc.s board of directors has the
authority to issue preferred stock in one or more series and to
fix the title and number of shares constituting any such series
and the designations, powers, preferences, limitations and
relative rights including offering price, any dividend rights
(including whether dividends will be cumulative or
non-cumulative), dividend rate, voting rights, terms of any
redemption, any redemption price or prices, conversion or
exchange rights and any liquidation preferences of the shares
constituting any series, without any further vote or action by
stockholders. The specific terms of the preferred stock will be
described in the prospectus supplement.
15
MetLife, Inc. has authorized 10,000,000 shares of
Series A Junior Participating Preferred Stock for issuance
in connection with its stockholder rights plan. See
Stockholder Rights Plan for a
description of the Series A Junior Participating Preferred
Stock.
Voting Rights. The Delaware General Corporation Law
provides that the holders of preferred stock will have the right
to vote separately as a class on any proposal involving
fundamental changes in the rights of holders of such preferred
stock. The prospectus supplement will describe the voting
rights, if any, of the preferred stock.
Conversion or Exchange. The prospectus supplement will
describe the terms, if any, on which the preferred stock may be
convertible into or exchangeable for securities described in
this prospectus. These terms will include provisions as to
whether conversion or exchange is mandatory, at the option of
the holder or at MetLife, Inc.s option. These provisions
may set forth the conversion price, the method of determining
the conversion price and the conversion period and may allow or
require the number of shares of MetLife, Inc.s common
stock or other securities to be received by the holders of
preferred stock to be adjusted.
Redemption. The prospectus supplement will describe the
obligation, if any, to redeem the preferred stock in whole or in
part at the times and at the redemption prices set forth in the
applicable prospectus supplement.
Unless otherwise indicated in the applicable prospectus
supplement, MetLife, Inc. may not purchase or redeem any of the
outstanding shares or any series of preferred stock unless full
cumulative dividends, if any, have been paid or declared and set
apart for payment upon all outstanding shares of any series of
preferred stock for all past dividend periods, and unless all of
MetLife, Inc.s matured obligations with respect to all
sinking funds, retirement funds or purchase funds for all series
of preferred stock then outstanding have been met.
|
|
|
Certain Provisions in MetLife, Inc.s Certificate of
Incorporation and By-Laws and in Delaware and New York
Law |
A number of provisions of MetLife, Inc.s certificate of
incorporation and by-laws deal with matters of corporate
governance and rights of stockholders. The following discussion
is a general summary of selected provisions of MetLife,
Inc.s certificate of incorporation and by-laws and
regulatory provisions that might be deemed to have a potential
anti-takeover effect. These provisions may have the
effect of discouraging a future takeover attempt which is not
approved by MetLife, Inc.s board of directors but which
individual stockholders may deem to be in their best interests
or in which stockholders may receive a substantial premium for
their shares over then current market prices. As a result,
stockholders who might desire to participate in such a
transaction may not have an opportunity to do so. Such
provisions will also render the removal of the incumbent board
of directors or management more difficult. Some provisions of
the Delaware General Corporation Law and the New York Insurance
Law may also have an anti-takeover effect. The following
description of selected provisions of MetLife, Inc.s
certificate of incorporation and by-laws and selected provisions
of the Delaware General Corporation Law and the New York
Insurance Law is necessarily general and reference should be
made in each case to MetLife, Inc.s certificate of
incorporation and by-laws, which are incorporated by reference
as exhibits to the registration statement of which this
prospectus forms a part, and to the provisions of those laws.
|
|
|
Classified Board of Directors and Removal of
Directors |
Pursuant to MetLife, Inc.s certificate of incorporation,
the directors are divided into three classes, as nearly equal in
number as possible, with each class having a term of three
years. The classes serve staggered terms, such that the term of
one class of directors expires each year. Any effort to obtain
control of MetLife, Inc.s board of directors by causing
the election of a majority of the board may require more time
than would be required without a staggered election structure.
MetLife, Inc.s certificate of incorporation also provides
that, subject to the rights of the holders of any class of
preferred stock, directors may be removed only for cause at a
meeting of stockholders by a vote of a majority of the shares
then entitled to vote. This provision
16
may have the effect of slowing or impeding a change in
membership of MetLife, Inc.s board of directors that would
effect a change of control.
|
|
|
Exercise of Duties by Board of Directors |
MetLife, Inc.s certificate of incorporation provides that
while the MetLife Policyholder Trust (as described below) is in
existence, each MetLife, Inc. director is required, in
exercising his or her duties as a director, to take the
interests of the trust beneficiaries into account as if they
were holders of the shares of common stock held in the trust,
except to the extent that any such director determines, based on
advice of counsel, that to do so would violate his or her duties
as a director under Delaware law.
|
|
|
Restriction on Maximum Number of Directors and Filling of
Vacancies on MetLife, Inc.s Board of Directors |
Pursuant to MetLife, Inc.s by-laws and subject to the
rights of the holders of any class of preferred stock, the
number of directors may be fixed and increased or decreased from
time to time by resolution of the board of directors, but the
board of directors will at no time consist of fewer than three
directors. Subject to the rights of the holders of any class of
preferred stock, stockholders can only remove a director for
cause by a vote of a majority of the shares entitled to vote, in
which case the vacancy caused by such removal may be filled at
such meeting by the stockholders entitled to vote for the
election of the director so removed. Any vacancy on the board of
directors, including a vacancy resulting from an increase in the
number of directors or resulting from a removal for cause where
the stockholders have not filled the vacancy, subject to the
rights of the holders of any class of preferred stock, may be
filled by a majority of the directors then in office, although
less than a quorum. If the vacancy is not so filled it will be
filled by the stockholders at the next annual meeting of
stockholders. The stockholders are not permitted to fill
vacancies between annual meetings, except where the vacancy
resulted from a removal for cause. These provisions give
incumbent directors significant authority that may have the
effect of limiting the ability of stockholders to effect a
change in management.
|
|
|
Advance Notice Requirements for Nomination of Directors
and Presentation of New Business at Meetings of Stockholders;
Action by Written Consent |
MetLife, Inc.s by-laws provide for advance notice
requirements for stockholder proposals and nominations for
director. In addition, pursuant to the provisions of both the
certificate of incorporation and the by-laws, action may not be
taken by written consent of stockholder. Rather, any action
taken by the stockholders must be effected at a duly called
meeting. Moreover, the stockholders do not have the power to
call a special meeting. Only the chief executive officer or the
secretary pursuant to a board resolution or, under some
circumstances, the president or a director who also is an
officer, may call a special meeting. These provisions make it
more difficult for a stockholder to place a proposal or
nomination on the meeting agenda and prohibit a stockholder from
taking action without a meeting, and therefore may reduce the
likelihood that a stockholder will seek to take independent
action to replace directors or with respect to other matters
that are not supported by management for stockholder vote.
|
|
|
Limitations on Director Liability |
MetLife, Inc.s certificate of incorporation contains a
provision that is designed to limit the directors
liability to the extent permitted by the Delaware General
Corporation Law and any amendments to that law. Specifically,
directors will not be held liable to MetLife, Inc. or its
stockholders for an act or omission in their capacity as a
director, except for liability as a result of:
|
|
|
|
|
a breach of the duty of loyalty to MetLife, Inc. or its
stockholders; |
|
|
|
acts or omissions not in good faith or which involve intentional
misconduct or a knowing violation of law; |
|
|
|
payment of an improper dividend or improper repurchase of
MetLife, Inc.s stock under Section 174 of the
Delaware General Corporation Law; or |
17
|
|
|
|
|
actions or omissions pursuant to which the director received an
improper personal benefit. |
The principal effect of the limitation on liability provision is
that a stockholder is unable to prosecute an action for monetary
damages against a director of MetLife, Inc. unless the
stockholder can demonstrate one of the specified bases for
liability. This provision, however, does not eliminate or limit
director liability arising in connection with causes of action
brought under the federal securities laws. MetLife, Inc.s
certificate of incorporation also does not eliminate the
directors duty of care. The inclusion of the limitation on
liability provision in the certificate may, however, discourage
or deter stockholders or management from bringing a lawsuit
against directors for a breach of their fiduciary duties, even
though such an action, if successful, might otherwise have
benefited MetLife, Inc. and its stockholders. This provision
should not affect the availability of equitable remedies such as
injunction or rescission based upon a directors breach of
the duty of care.
MetLife, Inc.s by-laws also provide that MetLife, Inc.
indemnify its directors and officers to the fullest extent
permitted by Delaware law. MetLife, Inc. is required to
indemnify its directors and officers for all judgments, fines,
settlements, legal fees and other expenses reasonably incurred
in connection with pending or threatened legal proceedings
because of the directors or officers position with
MetLife, Inc. or another entity, including Metropolitan Life
Insurance Company, that the director or officer serves at
MetLife, Inc.s request, subject to certain conditions, and
to advance funds to MetLife, Inc.s directors and officers
to enable them to defend against such proceedings. To receive
indemnification, the director or officer must succeed in the
legal proceeding or act in good faith and in a manner reasonably
believed to be in or not opposed to the best interests of
MetLife, Inc. and with respect to any criminal action or
proceeding, in a manner he or she reasonably believed to be
lawful.
|
|
|
Supermajority Voting Requirement for Amendment of Certain
Provisions of the Certificate of Incorporation and
By-Laws |
Some of the provisions of MetLife, Inc.s certificate of
incorporation, including those that authorize the board of
directors to create stockholder rights plans, that set forth the
duties, election and exculpation from liability of directors and
that prohibit stockholders from taking actions by written
consent, may not be amended, altered, changed or repealed unless
the amendment is approved by the vote of holders of 75% of the
then outstanding shares entitled to vote at an election of
directors. This requirement exceeds the majority vote of the
outstanding stock that would otherwise be required by the
Delaware General Corporation Law for the repeal or amendment of
such provisions of the certificate of incorporation. MetLife,
Inc.s by-laws may be amended, altered or repealed by the
board of directors or by the vote of holders of 75% of the then
outstanding shares entitled to vote in the election of
directors. These provisions make it more difficult for any
person to remove or amend any provisions that have an
anti-takeover effect.
|
|
|
Business Combination Statute |
In addition, as a Delaware corporation, MetLife, Inc. is subject
to Section 203 of the Delaware General Corporation Law,
unless it elects in its certificate of incorporation not to be
governed by the provisions of Section 203. MetLife, Inc.
has not made that election. Section 203 can affect the
ability of an interested stockholder of MetLife,
Inc. to engage in certain business combinations, including
mergers, consolidations or acquisitions of additional shares of
MetLife, Inc. for a period of three years following the time
that the stockholder becomes an interested
stockholder. An interested stockholder is
defined to include any person owning, directly or indirectly,
15% or more of the outstanding voting stock of a corporation.
The provisions of Section 203 are not applicable in some
circumstances, including those in which (1) the business
combination or transaction which results in the stockholder
becoming an interested stockholder is approved by
the corporations board of directors prior to the time the
stockholder becomes an interested stockholder or
(2) the interested stockholder, upon
consummation of such transaction, owns at least 85% of the
voting stock of the corporation outstanding prior to such
transaction.
|
|
|
Restrictions on Acquisitions of Securities |
The insurance laws and regulations of New York, the jurisdiction
in which MetLife, Inc.s principal insurance subsidiary,
Metropolitan Life Insurance Company, is organized, may delay or
impede a business
18
combination involving MetLife, Inc. In addition to the
limitations described in the immediately preceding paragraph,
the New York Insurance Law prohibits any person from acquiring
control of MetLife, Inc., and thus indirect control of
Metropolitan Life Insurance Company, without the prior approval
of the New York Superintendent of Insurance. That law presumes
that control exists where any person, directly or indirectly,
owns, controls, holds the power to vote or holds proxies
representing 10% or more of MetLife, Inc.s outstanding
voting stock, unless the New York Superintendent, upon
application, determines otherwise. Even persons who do not
acquire beneficial ownership of more than 10% of the outstanding
shares of MetLife, Inc.s common stock may be deemed to
have acquired such control, if the New York Superintendent
determines that such persons, directly or indirectly, exercise a
controlling influence over MetLife, Inc.s management or
policies. Therefore, any person seeking to acquire a controlling
interest in MetLife, Inc. would face regulatory obstacles which
may delay, deter or prevent an acquisition.
The insurance holding company law and other insurance laws of
many states also regulate changes of control (generally presumed
upon acquisitions of 10% or more of voting securities) of
insurance holding companies such as MetLife, Inc.
MetLife, Inc.s board of directors has adopted a
stockholder rights plan under which each outstanding share of
MetLife, Inc.s common stock issued between April 4,
2000 and the earlier of the distribution date (as described
below) and the expiration of the rights (as described below)
will be coupled with a stockholder right. Initially, the
stockholder rights will be attached to the certificates
representing outstanding shares of common stock, and no separate
rights certificates will be distributed. Each right will entitle
the holder to purchase one one-hundredth of a share of MetLife,
Inc.s Series A Junior Participating Preferred Stock.
Each one one-hundredth of a share of Series A Junior
Participating Preferred Stock will have economic and voting
terms equivalent to one share of MetLife, Inc.s common
stock. Until it is exercised, the right itself will not entitle
the holder thereof to any rights as a stockholder, including the
right to receive dividends or to vote at stockholder meetings.
The description and terms of the rights are set forth in a
rights agreement entered into between MetLife, Inc. and Mellon
Investor Services, successor to ChaseMellon Shareholder
Services, L.L.C., as rights agent. Although the material
provisions of the rights agreement have been accurately
summarized, the statements below concerning the rights agreement
are not necessarily complete and in each instance reference is
made to the rights agreement itself, which is incorporated by
reference into this prospectus in its entirety. Each statement
is qualified in its entirety by such reference.
Stockholder rights are not exercisable until the distribution
date and will expire at the close of business on April 4,
2010, unless earlier redeemed or exchanged by MetLife, Inc. A
distribution date would occur upon the earlier of:
|
|
|
|
|
the tenth day after the first public announcement or
communication to MetLife, Inc. that a person or group of
affiliated or associated persons (referred to as an
acquiring person) has acquired beneficial ownership
of 10% or more of MetLife, Inc.s outstanding common stock
(the date of such announcement or communication is referred to
as the stock acquisition time); or |
|
|
|
the tenth business day after the commencement or announcement of
the intention to commence a tender offer or exchange offer that
would result in a person or group becoming an acquiring person. |
If any person becomes an acquiring person, each holder of a
stockholder right will be entitled to exercise the right and
receive, instead of Series A Junior Participating Preferred
Stock, common stock (or, in certain circumstances, cash, a
reduction in purchase price, property or other securities of
MetLife, Inc.) having a value equal to two times the purchase
price of the stockholder right. All stockholder rights that are
beneficially owned by an acquiring person or its transferee will
become null and void.
If at any time after a public announcement has been made or
MetLife, Inc. has received notice that a person has become an
acquiring person, (1) MetLife, Inc. is acquired in a merger
or other business combination, or (2) 50% or more of
MetLife, Inc.s and its subsidiaries assets, cash
flow or earning power is sold or transferred, each holder of a
stockholder right (except rights which previously have been
voided as set
19
forth above) will have the right to receive, upon exercise,
common stock of the acquiring company having a value equal to
two times the purchase price of the right.
The purchase price payable, the number of one one-hundredths of
a share of Series A Junior Participating Preferred Stock or
other securities or property issuable upon exercise of rights
and the number of rights outstanding, are subject to adjustment
from time to time to prevent dilution. With certain exceptions,
no adjustment in the purchase price or the number of shares of
Series A Junior Participating Preferred Stock issuable upon
exercise of a stockholder right will be required until the
cumulative adjustment would require an increase or decrease of
at least one percent in the purchase price or number of shares
for which a right is exercisable.
At any time until the earlier of (1) the stock acquisition
time, or (2) the final expiration date of the rights
agreement, MetLife, Inc. may redeem all the stockholder rights
at a price of $0.01 per right. At any time after a person
has become an acquiring person and prior to the acquisition of
beneficial ownership by such person of 50% or more of the
outstanding shares of MetLife, Inc.s common stock,
MetLife, Inc. may exchange the stockholder rights, in whole or
in part, at an exchange ratio of one share of common stock, or
one one-hundredth of a share of Series A Junior
Participating Preferred Stock (or of a share of a class or
series of preferred stock having equivalent rights, preferences
and privileges), per right.
The stockholder rights plan is designed to protect stockholders
in the event of unsolicited offers to acquire MetLife, Inc. and
other coercive takeover tactics which, in the opinion of its
board of directors, could impair its ability to represent
stockholder interests. The provisions of the stockholder rights
plan may render an unsolicited takeover more difficult or less
likely to occur or may prevent such a takeover, even though such
takeover may offer MetLife, Inc.s stockholders the
opportunity to sell their stock at a price above the prevailing
market rate and may be favored by a majority of MetLife,
Inc.s stockholders.
|
|
|
MetLife Policyholder Trust |
Under a plan of reorganization adopted in September 1999,
Metropolitan Life Insurance Company converted from a mutual life
insurance company to a stock life insurance company subsidiary
of MetLife, Inc. MetLife established the MetLife Policyholder
Trust to hold the shares of common stock allocated to eligible
policyholders. A total of 494,466,664 shares of common
stock were distributed to the MetLife Policyholder Trust on the
effective date of the plan of reorganization. As of
December 31, 2004, the trust held 321,314,794 shares
of MetLife, Inc.s common stock. Because of the number of
shares held by the trust and the voting provisions of the trust,
the trust may affect the outcome of matters brought to a
stockholder vote.
The trustee will generally vote all of the shares of common
stock held in the trust in accordance with the recommendations
given by MetLife, Inc.s board of directors to its
stockholders or, if the board gives no such recommendation, as
directed by the board, except on votes regarding certain
fundamental corporate actions. As a result of the voting
provisions of the trust, MetLife, Inc.s board of directors
will effectively be able to control votes on all matters
submitted to a vote of stockholders, excluding those fundamental
corporate actions described below, so long as the trust holds a
substantial number of shares of MetLife, Inc.s common
stock.
If the vote relates to fundamental corporate actions specified
in the trust, the trustee will solicit instructions from the
beneficiaries and vote all shares held in the trust in
proportion to the instructions it receives, which would give
disproportionate weight to the instructions actually given by
trust beneficiaries. These actions include:
|
|
|
|
|
an election or removal of directors in which a stockholder has
properly nominated one or more candidates in opposition to a
nominee or nominees of MetLife, Inc.s board of directors
or a vote on a stockholders proposal to oppose a board
nominee for director, remove a director for cause or fill a
vacancy caused by the removal of a director by stockholders,
subject to certain conditions; |
|
|
|
a merger or consolidation, a sale, lease or exchange of all or
substantially all of the assets, or a recapitalization or
dissolution of MetLife, Inc., in each case requiring a vote of
MetLife, Inc.s stockholders under applicable Delaware law; |
20
|
|
|
|
|
any transaction that would result in an exchange or conversion
of shares of common stock held by the trust for cash, securities
or other property; and |
|
|
|
any proposal requiring MetLife, Inc.s board of directors
to amend or redeem the rights under the stockholder rights plan,
other than a proposal with respect to which MetLife, Inc. has
received advice of nationally-recognized legal counsel to the
effect that the proposal is not a proper subject for stockholder
action under Delaware law. |
DESCRIPTION OF DEPOSITARY SHARES
The following outlines some of the general terms and provisions
of the depositary shares. Further terms of the depositary shares
and the applicable deposit agreement will be stated in the
applicable prospectus supplement. The following description and
any description of the depositary shares in a prospectus
supplement may not be complete and is subject to and qualified
in its entirety by reference to the terms and provisions of the
deposit agreement, a form of which has been filed as an exhibit
to the registration statement of which this prospectus forms a
part.
The particular terms of the depositary shares offered by any
prospectus supplement and the extent to which the general
provisions described below may apply to such depositary shares
will be outlined in the applicable prospectus supplement.
MetLife, Inc. may choose to offer fractional interests in debt
securities or fractional shares of common stock or preferred
stock. MetLife, Inc. may issue fractional interests in debt
securities, common stock or preferred stock, as the case may be,
in the form of depositary shares. Each depositary share would
represent a fractional interest in a security of a particular
series of debt securities or a fraction of a share of common
stock or of a particular series of preferred stock, as the case
may be, and would be evidenced by a depositary receipt.
MetLife, Inc. will deposit the debt securities or shares of
common stock or preferred stock represented by depositary shares
under a deposit agreement between MetLife, Inc. and a depositary
which will be named in the applicable prospectus supplement.
Subject to the terms of the deposit agreement, as an owner of a
depositary share, you will be entitled, in proportion to the
applicable fraction of a debt security or share of common stock
or preferred stock represented by the depositary share, to all
the rights and preferences of the debt security, common stock or
preferred stock, as the case may be, represented by the
depositary share, including, as the case may be, interest,
dividend, voting, conversion, redemption, sinking fund,
repayment at maturity, subscription and liquidation rights.
|
|
|
Interest, Dividends and Other Distributions |
The depositary will distribute all payments of interest, cash
dividends or other cash distributions received on the debt
securities, common stock or preferred stock, as the case may be,
to you in proportion to the number of depositary shares that you
own. In the event of a distribution other than in cash, the
depositary will distribute property received by it to you in an
equitable manner, unless the depositary determines that it is
not feasible to make a distribution. In that case, the
depositary may sell the property and distribute the net proceeds
from the sale to you.
|
|
|
Redemption of Depositary Shares |
If a debt security, common stock or series of preferred stock
represented by depositary shares is redeemed, the depositary
will redeem your depositary shares from the proceeds received by
the depositary resulting from the redemption. The redemption
price per depositary share will be equal to the applicable
fraction of the redemption price per debt security or share of
common stock or preferred stock, as the case may be, payable in
relation to the redeemed series of debt securities, common stock
or preferred stock. Whenever MetLife, Inc. redeems debt
securities or shares of common stock or preferred stock held by
the depositary, the depositary will redeem, as of the same
redemption date, the number of depositary shares
21
representing, as the case may be, fractional interests in the
debt securities or shares of common stock or preferred stock
redeemed. If fewer than all the depositary shares are to be
redeemed, the depositary shares to be redeemed will be selected
by lot, proportionately or by any other equitable method as the
depositary may determine.
|
|
|
Exercise of Rights under the Indentures or Voting the
Common Stock or Preferred |
Upon receipt of notice of any meeting at which you are entitled
to vote, or of any request for instructions or directions from
you as holder of fractional interests in debt securities, common
stock or preferred stock, the depositary will mail to you the
information contained in that notice. Each record holder of the
depositary shares on the record date will be entitled to
instruct the depositary how to give instructions or directions
with respect to the debt securities represented by that
holders depositary shares or how to vote the amount of the
common stock or preferred stock represented by that
holders depositary shares. The record date for the
depositary shares will be the same date as the record date for
the debt securities, common stock or preferred stock, as the
case may be. The depositary will endeavor, to the extent
practicable, to give instructions or directions with respect to
the debt securities or to vote the amount of the common stock or
preferred stock, as the case may be, represented by the
depositary shares in accordance with those instructions.
MetLife, Inc. will agree to take all reasonable action which the
depositary may deem necessary to enable the depositary to do so.
The depositary will abstain from giving instructions or
directions with respect to your fractional interests in the debt
securities or voting shares of the common stock or preferred
stock, as the case may be, if it does not receive specific
instructions from you.
|
|
|
Amendment and Termination of the Deposit Agreement |
MetLife, Inc. and the depositary may amend the form of
depositary receipt evidencing the depositary shares and any
provision of the deposit agreement at any time. However, any
amendment which materially and adversely affects the rights of
the holders of the depositary shares will not be effective
unless the amendment has been approved by the holders of at
least a majority of the depositary shares then outstanding.
The deposit agreement will terminate if:
|
|
|
|
|
all outstanding depositary shares have been redeemed; |
|
|
|
if applicable, the debt securities and the preferred stock
represented by depositary shares have been converted into or
exchanged for common stock or, in the case of debt securities,
repaid in full; or |
|
|
|
there has been a final distribution in respect of the common
stock or preferred stock, including in connection with the
liquidation, dissolution or winding-up of MetLife, Inc., and the
distribution proceeds have been distributed to you. |
|
|
|
Resignation and Removal of Depositary |
The depositary may resign at any time by delivering to MetLife,
Inc. notice of its election to do so. MetLife, Inc. also may, at
any time, remove the depositary. Any resignation or removal will
take effect upon the appointment of a successor depositary and
its acceptance of such appointment. MetLife, Inc. must appoint
the successor depositary within 60 days after delivery of
the notice of resignation or removal. The successor depositary
must be a bank or trust company having its principal office in
the United States and having total assets of not less than
$1,000,000,000.
MetLife, Inc. will pay all transfer and other taxes and
governmental charges arising solely from the existence of the
depositary arrangements. MetLife, Inc. will pay charges of the
depositary in connection with the initial deposit of the debt
securities or preferred stock, as the case may be, and issuance
of depositary receipts, all withdrawals of depositary shares of
debt securities or preferred stock, as the case may be, by you
and any repayment or redemption of the debt securities or
preferred stock, as the case may be. You will pay
22
other transfer and other taxes and governmental charges, as well
as the other charges that are expressly provided in the deposit
agreement to be for your account.
The depositary will forward all reports and communications from
MetLife, Inc. which are delivered to the depositary and which
MetLife, Inc. is required or otherwise determines to furnish to
holders of debt securities, common stock or preferred stock, as
the case may be. Neither MetLife, Inc. nor the depositary will
be liable under the deposit agreement to you other than for its
gross negligence, willful misconduct or bad faith. Neither
MetLife, Inc. nor the depositary will be obligated to prosecute
or defend any legal proceedings relating to any depositary
shares, debt securities, common stock or preferred stock unless
satisfactory indemnity is furnished. MetLife, Inc. and the
depositary may rely upon written advice of counsel or
accountants, or upon information provided by persons presenting
debt securities or shares of common stock or preferred stock for
deposit, you or other persons believed to be competent and on
documents which MetLife, Inc. and the depositary believe to be
genuine.
DESCRIPTION OF WARRANTS
MetLife, Inc. may issue warrants to purchase debt securities,
preferred stock, common stock or other securities described in
this prospectus, or any combination of these securities, and
these warrants may be issued independently or together with any
underlying securities and may be attached or separate from the
underlying securities. MetLife, Inc. will issue each series of
warrants under a separate warrant agreement to be entered into
between MetLife, Inc. and a warrant agent. The warrant agent
will act solely as MetLife, Inc.s agent in connection with
the warrants of such series and will not assume any obligation
or relationship of agency for or with holders or beneficial
owners of warrants.
The following outlines some of the general terms and provisions
of the warrants. Further terms of the warrants and the
applicable warrant agreement will be stated in the applicable
prospectus supplement. The following description and any
description of the warrants in a prospectus supplement may not
be complete and is subject to and qualified in its entirety by
reference to the terms and provisions of the warrant agreement,
a form of which has been filed as an exhibit to the registration
statement of which this prospectus forms a part.
The applicable prospectus supplement will describe the terms of
any warrants that MetLife, Inc. may offer, including the
following:
|
|
|
|
|
the title of the warrants; |
|
|
|
the total number of warrants; |
|
|
|
the price or prices at which the warrants will be issued; |
|
|
|
the currency or currencies investors may use to pay for the
warrants; |
|
|
|
the designation and terms of the underlying securities
purchasable upon exercise of the warrants; |
|
|
|
the price at which and the currency, currencies, or currency
units in which investors may purchase the underlying securities
purchasable upon exercise of the warrants; |
|
|
|
the date on which the right to exercise the warrants will
commence and the date on which the right will expire; |
|
|
|
whether the warrants will be issued in registered form or bearer
form; |
|
|
|
information with respect to book-entry procedures, if any; |
|
|
|
if applicable, the minimum or maximum amount of warrants which
may be exercised at any one time; |
|
|
|
if applicable, the designation and terms of the underlying
securities with which the warrants are issued and the number of
warrants issued with each underlying security; |
23
|
|
|
|
|
if applicable, the date on and after which the warrants and the
related underlying securities will be separately transferable; |
|
|
|
if applicable, a discussion of material United States federal
income tax considerations; |
|
|
|
the identity of the warrant agent; |
|
|
|
the procedures and conditions relating to the exercise of the
warrants; and |
|
|
|
any other terms of the warrants, including terms, procedures and
limitations relating to the exchange and exercise of the
warrants. |
Warrant certificates may be exchanged for new warrant
certificates of different denominations, and warrants may be
exercised at the warrant agents corporate trust office or
any other office indicated in the applicable prospectus
supplement. Prior to the exercise of their warrants, holders of
warrants exercisable for debt securities will not have any of
the rights of holders of the debt securities purchasable upon
such exercise and will not be entitled to payments of principal
(or premium, if any) or interest, if any, on the debt securities
purchasable upon such exercise. Prior to the exercise of their
warrants, holders of warrants exercisable for shares of
preferred stock or common stock will not have any rights of
holders of the preferred stock or common stock purchasable upon
such exercise and will not be entitled to dividend payments, if
any, or voting rights of the preferred stock or common stock
purchasable upon such exercise. Prior to the exercise of their
warrants, holders of warrants exercisable for other securities
described in this prospectus will not have any rights of holders
of such securities purchasable upon such exercise.
A warrant will entitle the holder to purchase for cash an amount
of securities at an exercise price that will be stated in, or
that will be determinable as described in, the applicable
prospectus supplement. Warrants may be exercised at any time up
to the close of business on the expiration date set forth in the
applicable prospectus supplement. After the close of business on
the expiration date, unexercised warrants will become void.
Warrants may be exercised as set forth in the applicable
prospectus supplement. Upon receipt of payment and the warrant
certificate properly completed and duly executed at the
corporate trust office of the warrant agent or any other office
indicated in the prospectus supplement, MetLife, Inc. will, as
soon as practicable, forward the securities purchasable upon
such exercise. If less than all of the warrants represented by
such warrant certificate is exercised, a new warrant certificate
will be issued for the remaining warrants.
|
|
|
Enforceability of Rights; Governing Law |
The holders of warrants, without the consent of the warrant
agent, may, on their own behalf and for their own benefit,
enforce, and may institute and maintain any suit, action or
proceeding against MetLife, Inc. to enforce their rights to
exercise and receive the securities purchasable upon exercise of
their warrants. Unless otherwise stated in the prospectus
supplement, each issue of warrants and the applicable warrant
agreement will be governed by, and construed in accordance with,
the internal laws of the State of New York, without regard to
its principles of conflicts of laws.
DESCRIPTION OF PURCHASE CONTRACTS
As may be specified in a prospectus supplement, MetLife, Inc.
may issue purchase contracts obligating holders to purchase from
MetLife, Inc., and MetLife, Inc. to sell to the holders, a
number of debt securities, shares of common stock or preferred
stock, or other securities described in this prospectus or the
applicable prospectus supplement at a future date or dates. The
purchase contracts may require MetLife, Inc. to make periodic
payments to the holders of the purchase contracts. These
payments may be unsecured or prefunded on some basis to be
specified in the applicable prospectus supplement.
24
The prospectus supplement relating to any purchase contracts
will specify the material terms of the purchase contracts and
any applicable pledge or depositary arrangements, including one
or more of the following:
|
|
|
|
|
The stated amount that a holder will be obligated to pay under
the purchase contract in order to purchase debt securities,
common stock, preferred stock, or other securities described in
this prospectus or the formula by which such amount shall be
determined. |
|
|
|
The settlement date or dates on which the holder will be
obligated to purchase such securities. The prospectus supplement
will specify whether the occurrence of any events may cause the
settlement date to occur on an earlier date and the terms on
which an early settlement would occur. |
|
|
|
The events, if any, that will cause MetLife, Inc.s
obligations and the obligations of the holder under the purchase
contract to terminate. |
|
|
|
The settlement rate, which is a number that, when multiplied by
the stated amount of a purchase contract, determines the number
of securities that MetLife, Inc. or a trust will be obligated to
sell and a holder will be obligated to purchase under that
purchase contract upon payment of the stated amount of that
purchase contract. The settlement rate may be determined by the
application of a formula specified in the prospectus supplement.
If a formula is specified, it may be based on the market price
of such securities over a specified period or it may be based on
some other reference statistic. |
|
|
|
Whether the purchase contracts will be issued separately or as
part of units consisting of a purchase contract and an
underlying security with an aggregate principal amount equal to
the stated amount. Any underlying securities will be pledged by
the holder to secure its obligations under a purchase contract. |
|
|
|
The type of underlying security, if any, that is pledged by the
holder to secure its obligations under a purchase contract.
Underlying securities may be debt securities, common stock,
preferred stock, or other securities described in this
prospectus or the applicable prospectus supplement. |
|
|
|
The terms of the pledge arrangement relating to any underlying
securities, including the terms on which distributions or
payments of interest and principal on any underlying securities
will be retained by a collateral agent, delivered to MetLife,
Inc. or be distributed to the holder. |
|
|
|
The amount of the contract fee, if any, that may be payable by
MetLife, Inc. to the holder or by the holder to MetLife, Inc.,
the date or dates on which the contract fee will be payable and
the extent to which MetLife, Inc. or the holder, as applicable,
may defer payment of the contract fee on those payment dates.
The contract fee may be calculated as a percentage of the stated
amount of the purchase contract or otherwise. |
The descriptions of the purchase contracts and any applicable
underlying security or pledge or depository arrangements in this
prospectus and in any prospectus supplement are summaries of the
material provisions of the applicable agreements and are subject
to and qualified in their entirety by reference to the terms and
provisions of the purchase contract agreement, pledge agreement
and deposit agreement, forms of which have been or will be filed
as exhibits to the registration statement of which this
prospectus forms a part.
DESCRIPTION OF UNITS
As specified in the applicable prospectus supplement, MetLife,
Inc. may issue units comprised of one or more of the other
securities described in this prospectus in any combination. Each
unit may also include debt obligations of third parties, such as
U.S. Treasury securities. Each unit will be issued so that
the holder of the unit is also the holder of each security
included in the unit. Thus, the holder of a unit will have the
rights and obligations of a holder of each included security.
The prospectus supplement will describe:
|
|
|
|
|
the designation and terms of the units and of the securities
comprising the units, including whether and under what
circumstances the securities comprising the units may be held or
transferred separately; |
25
|
|
|
|
|
a description of the terms of any unit agreement governing the
units; |
|
|
|
a description of the provisions for the payment, settlement,
transfer or exchange of the units; and |
|
|
|
whether the units will be issued in fully registered or global
form. |
The descriptions of the units and any applicable underlying
security or pledge or depositary arrangements in this prospectus
and in any prospectus supplement are summaries of the material
provisions of the applicable agreements and are subject to, and
qualified in their entirety by reference to, the terms and
provisions of the applicable agreements, forms of which have
been or will be filed as exhibits to the registration statement
of which this prospectus forms a part.
DESCRIPTION OF TRUST PREFERRED SECURITIES
The following outlines some of the general terms and provisions
of the trust preferred securities. Further terms of the trust
preferred securities and the amended and restated declarations
of trust will be stated in the applicable prospectus supplement.
The prospectus supplement will also indicate whether the general
terms described in this section apply to that particular series
of trust preferred securities. The following description and any
description of the trust preferred securities and amended and
restated declarations of trust in a prospectus supplement may
not be complete and are subject to and qualified in their
entirety by reference to the terms and provisions of the amended
and restated declarations of trust, forms of which have been or
will be filed as exhibits to the registration statement of which
this prospectus forms a part.
Each trust may issue only one series of trust preferred
securities having terms described in the prospectus supplement.
The declaration of trust of each trust will authorize the
administrative trustees, on behalf of the trust, to issue the
trust preferred securities of the trust. The trusts will use all
of the proceeds they receive from the sale of trust preferred
securities and common securities to purchase debt securities
issued by MetLife, Inc. The debt securities will be held in
trust by the trusts property trustee for the benefit of
the holders of the trust preferred securities and common
securities.
The trust preferred securities of each trust will have such
terms as are set forth in the trusts declaration of trust,
including as relates to distributions, redemption, voting,
liquidation rights and the other preferred, deferral and special
rights and restrictions. A prospectus supplement relating to the
trust preferred securities being offered will include specific
terms relating to the offering. These terms will include some or
all of the following:
|
|
|
|
|
the distinctive designation of the trust preferred securities; |
|
|
|
the number of trust preferred securities issued by the trust; |
|
|
|
the total and per-security liquidation amount of the trust
preferred securities; |
|
|
|
the annual distribution rate, or method of determining such
rate, for trust preferred securities of the trust; |
|
|
|
the date or dates on which distributions will be payable and any
corresponding record dates; |
|
|
|
whether distributions on the trust preferred securities will be
cumulative; |
|
|
|
if the trust preferred securities have cumulative distribution
rights, the date or dates, or method of determining the date or
dates, from which distributions on the trust preferred
securities will be cumulative; |
|
|
|
the amount or amounts that will be paid out of the assets of the
trust to the holders of the trust preferred securities of the
trust upon voluntary or involuntary dissolution, winding-up or
termination of the trust; |
|
|
|
the obligation, if any, of the trust to purchase or redeem the
trust preferred securities; |
26
|
|
|
|
|
if the trust is to purchase or redeem the trust preferred
securities: |
|
|
|
the price or prices at which the trust preferred securities will
be purchased or redeemed in whole or in part; |
|
|
|
the period or periods within which the trust preferred
securities will be purchased or redeemed, in whole or in part; |
|
|
|
the terms and conditions upon which the trust preferred
securities will be purchased or redeemed, in whole or in part; |
|
|
|
the voting rights, if any, of the trust preferred securities in
addition to those required by law, including: |
|
|
|
|
|
the number of votes per trust preferred security; and |
|
|
|
any requirement for the approval by the holders of trust
preferred securities as a condition to specified action or
amendments to the trusts declaration of trust; |
|
|
|
|
|
the rights, if any, to defer distributions on the trust
preferred securities by extending the interest payment period on
the related debt securities; |
|
|
|
if the trust preferred securities may be converted into or
exercised or exchanged for MetLifes common stock or
preferred stock or any other securities, the terms on which
conversion, exercise or exchange is mandatory, at the option of
the holder or at the option of each trust, the date on or the
period during which conversion, exercise or exchange may occur,
the initial conversion, exercise or exchange price or rate and
the circumstances or manner in which the amount of common stock
or preferred stock or other securities issuable upon conversion,
exercise or exchange may be adjusted; |
|
|
|
the terms upon which the debt securities may be distributed to
holders of trust preferred securities; |
|
|
|
whether the preferred securities are to be issued in book-entry
form and represented by one or more global certificates; |
|
|
|
certain U.S. federal income tax considerations; |
|
|
|
if applicable, any securities exchange upon which the trust
preferred securities shall be listed; |
|
|
|
provisions relating to events of default and the rights of
holders of trust preferred securities in the event of default; |
|
|
|
other agreements or other rights including upon the
consolidation or merger of the trust; and |
|
|
|
any other relative rights, preferences, privileges, limitations
or restrictions of the trust preferred securities not
inconsistent with the trusts declaration of trust or
applicable law. |
All trust preferred securities offered will be guaranteed by
MetLife, Inc. to the extent set forth under Description of
Guarantees. Any material United States federal income tax
considerations applicable to an offering of trust preferred
securities will be described in the applicable prospectus
supplement.
In connection with the issuance of preferred securities, each
trust will issue one series of common securities. The
declaration of each trust authorizes the regular trustees to
issue on behalf of such trust one series of common securities
having such terms including distributions, redemption, voting,
liquidation rights or such restrictions as shall be set forth
therein. The terms of the common securities issued by the trust
will be substantially identical to the terms of the preferred
securities issued by such trust and the common securities will
rank equally, and payments will be made thereon pro rata, with
the preferred securities. However, upon an event of default
under the declaration of trust, the rights of the holders of the
common securities to payment in respect of distributions and
payments upon liquidation, redemption and otherwise will be
subordinated to the rights of the holders of the preferred
securities. Except in certain limited circumstances, the common
securities will also carry the right to vote, and appoint,
remove or replace any of the trustees of a trust. MetLife, Inc.
will own, directly or indirectly, all of the common securities
of each trust.
27
|
|
|
Enforcement of Certain Rights by Holders of
Trust Preferred Securities |
If an event of default occurs, and is continuing, under the
declaration of trust of MetLife Capital Trust II or MetLife
Capital Trust III, the holders of the preferred securities
of that trust would typically rely on the property trustee to
enforce its rights as a holder of the related debt securities
against MetLife, Inc. Additionally, those who together hold a
majority of the liquidation amount of the trusts preferred
securities will have the right to:
|
|
|
|
|
direct the time, method and place of conducting any proceeding
for any remedy available to the property trustee; or |
|
|
|
direct the exercise of any trust or power that the property
trustee holds under the declaration of trust, including the
right to direct the property trustee to exercise the remedies
available to it as a holder of MetLife, Inc.s debt
securities. |
If the property trustee fails to enforce its rights under the
applicable series of debt securities, to the fullest extent
permitted by law, a holder of trust preferred securities of such
trust may institute a legal proceeding directly against MetLife,
Inc. to enforce the property trustees rights under the
applicable series of debt securities without first instituting
any legal proceeding against the property trustee or any other
person or entity.
Notwithstanding the foregoing, if an event of default occurs and
the event is attributable to MetLife, Inc.s failure to pay
interest or principal on the debt securities when due, including
any payment on redemption, and this debt payment failure is
continuing, a preferred securities holder of the trust may
directly institute a proceeding for the enforcement of this
payment. Such a proceeding will be limited, however, to
enforcing the payment of this principal or interest only up to
the value of the aggregate liquidation amount of the
holders preferred securities as determined after the due
date specified in the applicable series of debt securities.
DESCRIPTION OF GUARANTEES
The following outlines some of the general terms and provisions
of the guarantees. Further terms of the guarantees will be
stated in the applicable prospectus supplement. The prospectus
supplement will also indicate whether the general terms
described in this section apply to those guarantees. The
following description and any description of the guarantees in a
prospectus supplement may not be complete and is subject to and
qualified in its entirety by reference to the terms and
provisions of the guarantee agreements, forms of which have been
or will be filed as exhibits to the registration statement of
which this prospectus forms a part, and the Trust Indenture Act.
MetLife, Inc. will execute and deliver the guarantees for the
benefit of the holders of the trust preferred securities. Each
guarantee will be held by the guarantee trustee for the benefit
of holders of the trust preferred securities to which it relates.
Each guarantee will be qualified as an indenture under the Trust
Indenture Act. J.P. Morgan Trust Company, National
Association (as successor to Bank One Trust Company, N.A.) will
act as indenture trustee under each guarantee for purposes of
the Trust Indenture Act.
Pursuant to each guarantee, MetLife, Inc. will irrevocably and
unconditionally agree, to the extent set forth in the guarantee,
to pay in full, to the holders of the related trust preferred
securities, the following guarantee payments, to the extent
these guarantee payments are not paid by, or on behalf of, the
related trust, regardless of any defense, right of set-off or
counterclaim that MetLife, Inc. may have or assert against any
person:
|
|
|
|
|
any accrued and unpaid distributions required to be paid on the
trust preferred securities of the trust, but if and only if and
to the extent that the trust has funds legally and immediately
available to make those payments; |
28
|
|
|
|
|
any distributions of MetLifes common stock or preferred
stock or any of its other securities, in the event that the
trust preferred securities may be converted into or exercised
for our common stock or preferred stock, to the extent the
conditions of such conversion or exercise have occurred or have
been satisfied and the trust does not distribute such shares or
other securities but has received such shares or other
securities; |
|
|
|
the redemption price, including all accrued and unpaid
distributions to the date of redemption, with respect to any
trust preferred securities called for redemption by the trust,
but if and only to the extent the trust has funds legally and
immediately available to make that payment; and |
|
|
|
upon a dissolution, winding-up or termination of the trust,
other than in connection with the distribution of debt
securities to the holders of trust preferred securities of the
trust, the lesser of: |
|
|
|
|
|
the total of the liquidation amount and all accrued and unpaid
distributions on the trust preferred securities of the trust to
the date of payment, to the extent the trust has funds legally
and immediately available to make that payment; and |
|
|
|
the amount of assets of the trust remaining available for
distribution to holders of trust preferred securities of the
trust in liquidation of the trust. |
MetLife, Inc. may satisfy its obligation to make a guarantee
payment by directly paying the required amounts to the holders
of the related trust preferred securities or by causing the
related trust to pay such amounts to such holders.
Each guarantee will constitute a guarantee of payments with
respect to the related trust preferred securities from the time
of issuance of the trust preferred securities. The guarantees
will not apply to the payment of distributions and other
payments on the trust preferred securities when the related
trust does not have sufficient funds legally and immediately
available to make the distributions or other payments. If
MetLife, Inc. does not make interest payments on the debt
securities purchased by a trust, such trust will not pay
distributions on the preferred securities issued by such trust
and will not have funds available therefor. The guarantee, when
taken together with MetLife, Inc.s obligations under the
debt securities, the Indentures and the declarations of trust,
will provide a full and unconditional guarantee by MetLife, Inc.
of payments due on the trust preferred securities.
MetLife, Inc. will also agree separately, through guarantees of
the common securities, to irrevocably and unconditionally
guarantee the obligations of the trusts with respect to the
common securities to the same extent as the guarantees of the
preferred securities. However, upon an event of default under
the Indentures, holders of preferred securities shall have
priority over holders of common securities with respect to
distributions and payments on liquidation, redemption or
otherwise.
MetLife, Inc.s obligation under each guarantee to make the
guarantee payments will be an unsecured obligation of MetLife,
Inc. and, if subordinated debt securities are issued to the
applicable trust and unless otherwise noted in the prospectus
supplement, will rank:
|
|
|
|
|
subordinate and junior in right of payment to all of MetLife,
Inc.s other liabilities, including the subordinated debt
securities, except those obligations or liabilities ranking
equal or subordinate to the guarantees by their terms; |
|
|
|
equally with any other securities, liabilities or obligations
that may have equal ranking by their terms; and |
|
|
|
senior to all of MetLife, Inc.s common stock. |
If subordinated debt securities are issued to the applicable
trust, the terms of the trust preferred securities will provide
that each holder of trust preferred securities, by accepting the
trust preferred securities, agrees to the subordination
provisions and other terms of the guarantee related to
subordination.
29
Each guarantee will constitute a guarantee of payment and not of
collection. This means that the holder of trust preferred
securities may institute a legal proceeding directly against
MetLife, Inc. to enforce its rights under the guarantee without
first instituting a legal proceeding against any other person or
entity.
Each guarantee will be unsecured and, because MetLife, Inc. is
principally a holding company, will be effectively subordinated
to all existing and future liabilities of MetLife, Inc.s
subsidiaries, including liabilities under contracts of insurance
and annuities written by MetLife, Inc.s insurance
subsidiaries. The guarantee does not limit the incurrence or
issuance of other secured or unsecured debt by MetLife, Inc.
|
|
|
Amendments and Assignment |
For any changes that materially and adversely affect the rights
of holders of the related trust preferred securities, each
guarantee may be amended only if there is prior approval of the
holders of more than 50% in liquidation amount of the
outstanding trust preferred securities issued by the applicable
trust. All guarantees and agreements contained in each guarantee
will bind the successors, assigns, receivers, trustees and
representatives of MetLife, Inc. and will inure to the benefit
of the holders of the related trust preferred securities of the
applicable trust then outstanding.
Each guarantee will terminate and will have no further force and
effect as to the related trust preferred securities upon:
|
|
|
|
|
distribution of debt securities to the holders of all trust
preferred securities of the applicable trust; or |
|
|
|
full payment of the amounts payable upon liquidation of the
applicable trust. |
Each guarantee will continue to be effective or will be
reinstated, as the case may be, if at any time any holder of the
related trust preferred securities must restore payment of any
sums paid with respect to the trust preferred securities or
under the guarantee.
Each guarantee provides that an event of default under a
guarantee occurs upon MetLife, Inc.s failure to perform
any of its obligations under the applicable guarantee.
The holders of a majority or more in liquidation amount of the
trust preferred securities to which any guarantee relates may
direct the time, method and place of conducting any proceeding
for any remedy available to the guarantee trustee with respect
to the guarantee or may direct the exercise of any trust or
power conferred upon the guarantee trustee in respect of the
guarantee.
If the guarantee trustee fails to enforce the guarantee, any
holder of the related trust preferred securities may institute a
legal proceeding directly against MetLife, Inc. to enforce the
holders rights under such guarantee without first
instituting a legal proceeding against the trust, the guarantee
trustee or any other person or entity.
Furthermore, if MetLife, Inc. fails to make a guarantee payment,
a holder of trust preferred securities may directly institute a
proceeding against MetLife, Inc. for enforcement of the
preferred securities guarantee for such payment.
The holders of a majority or more in liquidation amount of trust
preferred securities of any series may, by vote, on behalf of
the holders of all the trust preferred securities of the series,
waive any past event of default and its consequences.
|
|
|
Information Concerning the Guarantee Trustee |
Prior to an event of default with respect to any guarantee and
after the curing or waiving of all events of default with
respect to the guarantee, the guarantee trustee may perform only
the duties that are specifically set forth in the guarantee.
30
Once a guarantee event of default has occurred and is
continuing, the guarantee trustee is to exercise, with respect
to the holder of the trust preferred securities of the series,
the same degree of care as a prudent individual would exercise
in the conduct of his or her own affairs. Unless the guarantee
trustee is offered reasonable indemnity against the costs,
expenses and liabilities which may be incurred by the guarantee
trustee by a holder of the related trust preferred securities,
the guarantee trustee is not required to exercise any of its
powers under any guarantee at the request of the holder.
Additionally, the guarantee trustee is not required to expend or
risk its own funds or otherwise incur any financial liability in
the performance of its duties if the guarantee trustee
reasonably believes that it is not assured repayment or adequate
indemnity.
The guarantee trustee is J.P. Morgan Trust Company,
National Association (as successor to Bank One Trust Company,
N.A.), which is one of a number of banks and trust companies
with which MetLife, Inc. and its subsidiaries maintain ordinary
banking and trust relationships.
Each guarantee will be governed by, and construed in accordance
with, the internal laws of the State of New York, without regard
to its principles of conflicts of laws.
PLAN OF DISTRIBUTION
MetLife, Inc. may sell the securities being offered hereby in
one or more of the following ways from time to time:
|
|
|
|
|
to underwriters or dealers for resale to the public or to
institutional investors; |
|
|
|
directly to institutional investors; or |
|
|
|
through agents to the public or to institutional investors. |
The prospectus supplement with respect to each series of
securities will state the terms of the offering of the
securities, including:
|
|
|
|
|
the name or names of any underwriters or agents; |
|
|
|
the purchase price of the securities and the proceeds to be
received by MetLife, Inc. or the applicable trust from the sale; |
|
|
|
any underwriting discounts or agency fees and other items
constituting underwriters or agents compensation; |
|
|
|
any initial public offering price; |
|
|
|
any discounts or concessions allowed or reallowed or paid to
dealers; and |
|
|
|
any securities exchange on which the securities may be listed. |
If MetLife, Inc. or the trusts use underwriters in the sale, the
securities will be acquired by the underwriters for their own
account and may be resold from time to time in one or more
transactions, including:
|
|
|
|
|
negotiated transactions; |
|
|
|
at a fixed public offering price or prices, which may be changed; |
|
|
|
at market prices prevailing at the time of sale; |
|
|
|
at prices related to prevailing market prices; or |
|
|
|
at negotiated prices. |
The securities may also be offered and sold, if so indicated in
the prospectus supplement, in connection with a remarketing upon
their purchase, in accordance with a redemption or repayment
pursuant to their terms, or otherwise, by one or more
remarketing firms, acting as principals for their own accounts
or as agents
31
for MetLife, Inc. or the trusts. The prospectus supplement will
identify any remarketing firm and will describe the terms of its
agreement, if any, with MetLife, Inc. or the trusts and its
compensation.
Unless otherwise stated in a prospectus supplement, the
obligations of the underwriters to purchase any securities will
be conditioned on customary closing conditions and the
underwriters will be obligated to purchase all of such series of
securities, if any are purchased.
If MetLife, Inc. sells the securities directly or through agents
designated by it, MetLife, Inc. will identify any agent involved
in the offering and sale of the securities and will list any
commissions payable by MetLife, Inc. to the agent in the
accompanying prospectus supplement. Unless indicated otherwise
in the prospectus supplement, any such agent will be acting on a
best efforts basis to solicit purchases for the period of its
appointment.
MetLife, Inc. may authorize agents, underwriters or dealers to
solicit offers by certain institutional investors to purchase
securities and provide for payment and delivery on a future date
specified in an accompanying prospectus supplement. MetLife,
Inc. will describe any such arrangement in the prospectus
supplement. Any such institutional investor may be subject to
limitations on the minimum amount of securities that it may
purchase or on the portion of the aggregate principal amount of
such securities that it may sell under such arrangements.
Institutional investors from which such authorized offers may be
solicited include:
|
|
|
|
|
commercial and savings banks; |
|
|
|
insurance companies; |
|
|
|
pension funds; |
|
|
|
investment companies; |
|
|
|
educational and charitable institutions; and |
|
|
|
such other institutions as MetLife, Inc. may approve. |
Underwriters, dealers, agents and remarketing firms may be
entitled under agreements entered into with MetLife, Inc. and/or
the applicable trust, or both, to indemnification by MetLife,
Inc. against certain civil liabilities, including liabilities
under the Securities Act, or to contribution with respect to
payments which the underwriters, dealers, agents and remarketing
firms may be required to make. Underwriters, dealers, agents and
remarketing agents may be customers of, engage in transactions
with, or perform services for MetLife, Inc., any trust and/or
MetLife, Inc.s affiliates in the ordinary course of
business.
Each series of securities will be a new issue of securities and
will have no established trading market other than the common
stock which is listed on the New York Stock Exchange. Any common
stock sold will be listed on the New York Stock Exchange, upon
official notice of issuance. The securities, other than the
common stock, may or may not be listed on a national securities
exchange. Any underwriters to whom securities are sold by
MetLife, Inc. or any trust for public offering and sale may make
a market in the securities, but such underwriters will not be
obligated to do so and may discontinue any market making at any
time without notice.
Any offering of trust preferred securities will be made in
compliance with Rule 2810 of the NASD Conduct Rules.
32
LEGAL OPINIONS
Unless otherwise indicated in the applicable prospectus
supplement, the validity of the securities offered hereby will
be passed upon for MetLife, Inc. by Richard S. Collins,
Chief Counsel General Corporate, of MetLife, Inc.
Mr. Collins is paid a salary by MetLife, is a participant
in various employee benefit plans offered by MetLife to
employees generally and has options to purchase shares of
MetLife, Inc. common stock. Certain matters of Delaware law
relating to the validity of the trust preferred securities of
MetLife Capital Trust II and MetLife Capital Trust III
will be passed upon for the trust by Richards, Layton &
Finger, P.A., Wilmington, Delaware, special Delaware counsel for
the trusts.
EXPERTS
The consolidated financial statements and consolidated financial
statement schedules, and managements report on the
effectiveness of internal control over financial reporting
incorporated in this prospectus by reference from MetLife,
Inc.s Annual Report on Form 10-K have been audited by
Deloitte & Touche LLP, an independent registered public
accounting firm, as stated in their reports, which are
incorporated by reference herein, (which reports
(1) express an unqualified opinion on the consolidated
financial statements and consolidated financial statements
schedules and include an explanatory paragraph relating to
MetLife, Inc.s change of its method of accounting for
certain non-traditional long duration contracts and separate
accounts, and for embedded derivatives in certain insurance
products as required by new accounting guidance which became
effective on January 1, 2004 and October 1, 2003,
respectively, (2) express an unqualified opinion on
managements assessment regarding the effectiveness of
internal control over financial reporting, and (3) express
an unqualified opinion on the effectiveness of internal control
over financial reporting), and have been so incorporated in
reliance upon the reports of such firm given upon their
authority as experts in accounting and auditing.
33